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Success only opens up new avenues of brilliant possibility.
Such a task is eternal and its joys without bounds.




Biology provides many examples of materials that are able to arrange themselves
into complicated, ordered structures. Protein molecules, for instance, form most
of the machinery within a biological cell, but in order to perform their function
they must first "fold" into a compact form and then, in many cases, assemble into
larger structures containing multiple proteins. This ability to self-assemble is of
great interest for the development of new materials; for example, the formation of
silk inspired the creation of Nylon. There are, however, situations where the self-
assembly of certain molecules can cause problems for an organism; for example,
the presence of amyloid fibrils has been linked with Alzheimer’s, Huntington’s
and CreutzfeldtJakob diseases, among many others.
Amyloid fibrils are long chains formed from protein molecules, and may appear
stiff (like dry spaghetti) or flexible (like hair). Each fibril grows by the addition
of more protein molecules to its ends. It is theoretically possible for any protein
to assemble into a fibril, although some do so more readily than others. These
chains may be many thousands of proteins long, but the typical thickness of an
amyloid fibril is only 1/10, 000th that of a human hair.
It is difficult to analyse how amyloid fibrils self-assemble due to their small size.
This is particularly true in the early stages of self-assembly because the amyloid
fibrils will be few in number and very short. Thus, in order to study them
it is necessary to create models of the self-assembly process. The predications
provided by these models can then be compared to the effects which can be seen
in experiments.
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In one of the most recent models, the self-assembly of proteins into amyloid fibrils
is accelerated by the autocatalytic creation of extra fibrils by the fragmentation
of existing ones. Autocatalysis is a form of positive feedback, whereby new
material is created in proportion to the existing material. In this case, fibril
ends are created when an existing fibril breaks. This happens in proportion to
the total length of all fibrils; the more fibril ends that exist, the faster the protein
can aggregate. Since this model involves the breaking of fibrils into smaller pieces,
it is expected to result in the formation of a large number of short fibrils once they
are no longer able to grow. This is concerning because current theories indicate
that short fibrils may cause cell damage that leads to the onset of disease, while
longer fibrils are inert.
This "fragmentation model" is the one that I will be mainly discussing in this
thesis. Using it, I have developed predictions for the early stages of amyloid
fibril self-assembly which indicate that some experimentally observable effects
will depend on the sample volume. This means that some of the effects which are
observed in experiments conducted in volumes typically used in the laboratory,
may change or vanish when similar experiments are conduced in a smaller volume
comparable with a biological cell.
I have also explored the separate effects of modifications to this model. In the first
of these I prevent fibrils from breaking once a critical threshold concentration of
fibrils is reached. This modified model appears to explain experimentally observed
effects, and also suggests that altering the environmental conditions (such as
adding salt to the sample) can reduce the number of short fibrils produced. The
other modification to the model allows fibril ends to join together. This also
reduces the number of short fibrils and can lead to the formation of loops. Such
loops have been observed experimentally, and this model offers a first glimpse at
understanding their importance to amyloid fibril self-assembly.
Combined, my findings show that changes in the environment — for example
by adding salt or changing the volume of the container — could be expected




The self-assembly of proteins into filamentous structures underpins many aspects
of biology, from dynamic cell scaffolding proteins such as actin, to the amyloid
plaques responsible for a number of degenerative diseases. Typically, these self-
assembly processes have been treated as nucleated, reversible polymerisation
reactions, where dynamic fluctuations in a population of monomers eventually
overcome an energy barrier, forming a stable aggregate that can then grow and
shrink by the addition and loss of more protein from its ends.
The nucleated, reversible polymerisation framework is very successful in describ-
ing a variety of protein systems such as the cell scaffolds actin and tubulin, and the
aggregation of haemoglobin. Historically, amyloid fibrils were also thought to be
described by this model, but measurements of their aggregation kinetics failed to
match the model’s predictions. Instead, recent work indicates that autocatalytic
polymerisation — a process by which the number of growth competent species
is increased through secondary nucleation, in proportion to the amount already
present — is better at describing their formation. In this thesis, I will extend the
predictions made in this mean-field, autocatalytic polymerisation model through
use of kinetic Monte Carlo simulations.
The ubiquitous sigmoid-like growth curve of amyloid fibril formation often
possesses a notable quiescent lag phase which has been variously attributed to
primary and secondary nucleation processes. Substantial variability in the length
of this lag phase is often seen in replicate experimental growth curves, and naively
may be attributed to fluctuations in one or both of these nucleation processes.
By comparing analytic waiting-time distributions, to those produced by kinetic
Monte Carlo simulation of the processes thought to be involved, I will demonstrate
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that this cannot be the case in sample volumes comparable with typical laboratory
experiments.
Experimentally, the length of the lag phase, or "lag time", is often found to scale
with the total protein concentration, according to a power law with exponent γ.
The models of nucleated polymerisation and autocatalytic polymerisation predict
different values for this scaling exponent, and these are sometimes used to identify
which of the models best describes a given protein system. I show that this
approach is likely to result in a misidentification of the dominant mechanisms
under conditions where the lag phase is dominated by a different process to
the rest of the growth curve. Furthermore, I demonstrate that a change of the
dominant mechanism associated with total protein concentration will produce
"kinks" in the scaling of lag time with total protein concentration, and that
these may be used to greater effect in identifying the dominant mechanisms from
experimental kinetic data.
Experimental data for bovine insulin aggregation, which is well described by
the autocatalytic polymerisation model for low total protein concentrations,
displays an intriguing departure from the predicted behaviour at higher protein
concentrations. Additionally, the protein concentration at which the transition
occurs, appears to be affected by the presence of salt. Coincident with this,
an apparent change in the fibril structure indicates that different aggregation
mechanisms may operate at different total protein concentrations. I demonstrate
that a transition whereby the self-assembly mechanisms change once a critical
concentration of fibrils or fibrillar protein is reached, can explain the observed
behaviour and that this predicts a substantially higher abundance of shorter
filaments — which are thought to be pathogenic — at lower total protein
concentrations than if self-assembly were consistently autocatalytic at all protein
concentration.
Amyloid-like loops have been observed in electron and atomic-force microscographs,
together with non-looped fibrils, for a number of different proteins including
ovalbumin. This implies that fibrils formed of these proteins are able to grow
by fibrillar end-joining, and not only monomer addition as is more commonly
assumed. I develop a simple analytic expression for polymerisation by monomer
addition and fibrillar end-joining, (without autocatalysis) and show that this is
not sufficient to explain the growth curves obtained experimentally for ovalbumin.
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I then demonstrate that the same data can be explained by combining fibrillar
end-joining and fragmentation. Through the use of an analytic expression,
I estimate the kinetic rates from the experimental growth curves and, via
simulation, investigate the distribution of filament and loop lengths.
Together, my findings demonstrate the relative importance of different molecular
mechanisms in amyloid fibril formation, how these might be affected by various
environmental parameters, and characteristic behaviour by which their involve-
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1.1 An overview of polymers
Polymers are a diverse class of macromolecules, consisting of long chains of smaller
molecules referred to as monomers; the class encompasses a wide variety of natural
and synthetic materials. A polymer may consist entirely of one type of monomer
(homopolymers), or a mixture of different monomers (copolymers). In either
case the chemical properties of the monomers determine the polymer’s flexibility,
solubility, strength, and other mechanical and chemical properties; in many cases
the scaling of the polymer’s physical properties with chain length can be explained
by simple theories, independent of the chemical nature of the monomers [22].
This thesis will focus on a group of biological polymers known as "amyloid fibrils".
However, microscopic detail of the monomers and mechanisms will be largely
neglected, and many of the results are expected to hold for polymer self-assembly
processes in general.
Typically, polymers grow longer by the addition of monomers to one or both of
their ends in a process called polymerisation, but some can also grow when two
individual strands of polymer join, end-to-end. Depolymerisation is the process
by which a polymer looses material from its ends, but in most cases the monomers
are covalently bound within the polymer and this is not a significant process.
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Synthetic polymers have become a familiar part of modern industry and medicine
due to their diverse properties and easy customisation. Plastics such as polythene,
polystyrene and nylon (the group of polyamides) form the packaging, casing
and gearing of numerous machines and devices, while other polymers such as
polyepoxides (epoxy) and polyvinyl acetate (PVA) form the core component of
resins and glues. In the constant search to design new materials, researchers have
increasingly turning to biology for inspiration.
Biochemistry is heavily reliant on polymers: the instructions necessary for a
biological cell to function are preserved and propagated in the ordered sequence
of nucleotides forming a deoxyribonucleic acid (DNA) molecule; while the
arrangement of sugars in a polysaccharide can provide either an energy store
or structural support. Of the myriad bio-polymers, perhaps the most remarkable
group are the polypeptides, which include proteins (1). Proteins form the core
machinery for the entire biological cell. They control and facilitate the activation
of genes, mediate most intracellular and extracellular reactions, form sensors,
scaffolding, motors, and more. Together, proteins constitute more than half of a
cell’s dry mass [77].
Polypeptides are built from amino acids and are typically copolymers. Many
varieties of amino acid exist but life typically only utilises a small subset [77]. All
share a common chemical backbone but with different sidechain group which can
be used to categorise amino acids by their preferred chemical environment. Some
are non-polar, and often strongly hydrophobic as a consequence, while the rest
are either charged or able to be polarised by neighbouring charge, and prefer an
aqueous environment.
In order to minimise the free energy of the copolymer as a whole, a polypeptide
tends to fold itself into a configuration that reduces the exposure of hydrophobic
groups to surrounding water while also reducing exposure of hydrophilic groups
to surrounding lipids [86]. This is thought to be the primary driver for what
is typically referred to as "protein folding", whereby the polypeptide assembles
itself into a compact structure. As it becomes more compact, however, charge
distribution becomes important too, either aiding or preventing certain parts
of the polypeptide from coming into close proximity. These electrostatic
(1) Conventionally, polypeptide is used to refer to any amino acid polymer, while protein is
reserved for those with biological function.
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interactions, along with hydrogen and sulphur bonding, also help to stabilise
the preferred folded state — often referred to as the native conformation — once
it has been found [21].
Many proteins assemble into small complexes to perform a function. These con-
tain several folded protein molecules held together by hydrophobic or electrostatic
interactions. However, some proteins self-assemble into much larger complexes:
polymers in their own right, with individual proteins as their monomers. Two
examples are actin and tubulin which form the filaments and microtubules that
function as both cell structure and highways along which motile proteins pull their
cargo. These protein filaments are dynamic and are constantly being assembled
and dismantled, as required. Other polymer-forming proteins, for example silk,
cannot be readily dismantled and are immensely strong. While these particular
examples of proteins self-assembling into larger structures are desirable, in other
cases this kind of aggregation can cause problems for the cell.
The cellular environment is extremely crowded and many reactions take place in
close proximity, simultaneously. Alterations to the amino acid sequence due to
point mutations in the genetic information, can affect the native conformation
of a protein molecule [77]. In most cases these substitutions either have no
apparent effect or render the protein completely dysfunctional, potentially leading
to dysfunction or death of the cell [2]. However, in some cases alterations
the amino acid sequence only affects the folding process, leading to a higher
propensity for unfolding, partial folding, or missfolding [20, 21]. Under these
circumstances, proteins in a crowded environment are likely to aggregate due to
the exposure of their hydrophobic regions, to one another. Temperature, pH and
other environmental factors also have an impact on the strength of attraction
between certain side chains and hence the stability of the protein, leading to
similar problems. This makes protein aggregation a limiting factor to the range
of environmental conditions over which a particular organism can live.
Most protein aggregates are disordered clumps of misfolded proteins which form
in the cell near the sites of protein synthesis; here, the newly formed proteins may
not have had sufficient time to find their native conformation before bumping into
one another. Most cells have mechanisms for coping with these aggregates and in
a healthy cell they will be quickly broken up. However, not all protein aggregates
are disordered or easily removed.
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Amyloid fibrils are a group of highly ordered and extremely resilient protein
aggregates [21]. They have been implicated in a number of degenerative
disorders such as Alzheimer’s disease and Creutzfeldt-Jakob disease, but are also
increasingly being found to be functionally employed by organisms, owing to
their structural strength and ability to self-assemble. Amyloid fibrils are another
example of a polymer formed of proteins, and for the remainder of the thesis
the word "monomer" will be used to refer to the individual proteins within an
amyloid-like fibril.
(a) Schematic of the cross-β
structure of amyloid fibrils, by
Nelson and Eisenberg [78].
parallel arrangement of linear substructure in the amyloid deposits (Puchtler
et al., 1962; Wolman and Bubis, 1965).
The ordered nature of amyloid fibrils was further demonstrated by
Eanes and Glenner (1968) in their X‐ray fiber diffraction experiments.
Amyloid fibrils give a cross‐b diffraction pattern, with perpendicular reflec-
tions at 4.7 Å (along the fiber axis or meridional direction) and 10 Å
(equatorial direction) (Fig. 1A). This pattern was first reported by Astbury
et al. (1935) for diffraction from ‘‘poached,’’ stretched egg albumin, which
today would be termed an amyloid‐like substance. The pattern suggested
that the albumin chains pack in an extended (i.e., b) conformation, with
the chains perpendicular to the ‘‘axis of extension,’’ or fibril axis (Fig. 1B).
The 4.7‐Å reflection corresponds to the 4.7‐Å stacking of b‐sheet strands,
with hydrogen bonding parallel to the fibril axis. The 10‐Å reflection
corresponds to the spacing of b‐sheets, with the sheet‐to‐sheet packing of
side chains determining the exact packing distance (Fändrich and Dobson,
2002). Because this cross‐b pattern was found for all amyloid fibrils tested,
Eanes and Glenner (1968) suggested that the fibrils have a common,
cross‐b, core structure.
Fig. 1. Cross‐b structure of amyloid fibrils. (A) Cartoon representation of a cross‐b
X‐ray diffraction pattern. The defining features are a meridional reflection at4.7 Å and
an equatorial reflection on the order of 10 Å. The 4.7‐Å reflection is generally much
brighter and sharper than the reflection at 10 Å. (B) The cross‐b core structure of
amyloid fibrils. Parallel b‐sheets are depicted, but the structure could equivalently be
composed of antiparallel b‐sheets or a mix of parallel and antiparallel. The 4.7‐Å
spacing of b‐strands within each b‐sheet is parallel to the long fibril axis. The depicted
10‐Å sheet‐to‐sheet spacing actually ranges from about 5 to 14 Å (Fändrich and Dobson,
2002), depending on the size and packing of amino acid side chains. Amyloid fibrils have
diameters on the order of 100 Å.
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(b) Schematic of the arrangement of
peptides in a β-sheet configuration,
by Caporini et al. [8].
the effects of the CSA and could be a useful approach in cases
where the CSA is large.
The DQF-DRAWS buildup curves, consisting of experimental
data and simulations, for two of the seven samples are shown
in Figure 6. The agreement between experimental data and
simulations (A and C) is excellent, allowing estimation of the
distances (B and D) to a far greater accuracy than has previously
been possible by SSNMR. Further, all of the distances measured
indicate clearly that the peptide molecules are arranged in
parallel, in-register -sheets with interstrand 13C-13C distances
ranging from 4.41 to 4.59 Å with an average error of (0.11 Å
(Figure 7). The double quantum relaxation parameter is found
to be in the range of 6-10 ms, which is consistent with the
measurements of Liu et al. (9.4 ms) in a similar system (amyloid
nanotubes).57 However, we note several important differences
between our approach and that of Liu et al. and others in the
field. First, while the spin chain was approximated in the
previous study by a linear array of three spins, we have found
in our analysis that this method fails to converge even for seven
spins and have instead used a periodic boundary condition to
model the spin system more accurately. Second, while the
relaxation behavior was measured previously in separate experi-
ments, we avoid the need to construct and acquire appropriate
control experiments by fitting the relaxation behavior directly
and including the effects of the CSA in the numerical simulation.
Finally, while previous approaches involve the presence of a
single spin interaction with a precision of 0.3 Å, we are able to
measure seven spins with an average precision of (0.11 Å. The
ability to obtain this number of distances with this degree of
accuracy enables the objective determination of a high-resolution
structure to be achieved rather than inferring a model from a
limited number of structural restraints.
We have also compared our results to those reported
previously for A peptides,16,17 which reveal that our distances
are significantly shorter (∼0.3-1.4 Å) than these cited values.
Furthermore, the method may yield systematically smaller values
of distances when compared to X-ray crystallographic measure-
ments, as indicated by the succinate distance which is ∼4%
shorter than the distance obtained by X-ray diffraction measure-
ments (3.76 vs 3.91 Å).21 If one assumes that internuclear
distances in the fibrils systematically diverge from those
measured by X-ray crystallography due to intrinsic differences
in the methods, then the scaling by 4% results in our measure-
ment of the average interfibril distance of 4.50 ( 0.11 scaling
to 4.68 ( 0.11 agrees within the experimental error with those
measured by powder diffraction (4.7 Å).58 Powder diffraction,
however, lacks site-specific resolution and therefore cannot
distinguish between the many possible topological arrangements
of strands in the fibrils. Finally, it is also interesting to compare
our data qualitatively to those reported by Balbach et al. using
the constant-time RFDR sequence. On qualitative grounds, the
agreement between data and experiment is significantly better
Figure 6. Double quantum buildup curves for TTR fibrils labeled with 1-13C-L111 (A) and 1-13C-S112 (C). Circles represent experimental data
and lines the best-fit simulation. The corresponding probability surfaces for the two fits are shown in (B) and (D) for the L111 and S112, respectively.
Both data sets fit to intermolecular distances consistent with parallel -sheets with relatively small errors, which were extracted from the
SPINEVOLUTION fitting routines.
Figure 7. Schematic arrangement of the peptide strands in amyloid
fibrils of TTR105-115 illustrating the seven 13C-13C distances measured
with the DQF-DRAWS experiments together with estimates of their
errors.
Interstrand Distance & Alignment in Amyloid Fibrils J. Phys. Chem. B, Vol. 114, No. 42, 2010 13559
Figure 1.1 Illustrations of the β-sheet structure of amyloid fibrils. The schematic
in (aA) shows the X-ray diffraction pattern produced by this cross-β
structure, with meridional and equatorial reflections indicating spacings
of ∼ 4.7 Å and ∼ 10 Å, respectively for this fibril. These are
also indicated in (aB) as the interstrand and intersheet spacings,
respectively, where the strands are individual polypeptide chains, and
the sheets are individual amyloid filaments The fibril i self is made
of several of these filaments and has a diameter of ∼ 00 Å. These
dimensions vary between proteins, although the interstrand spacing
is constrained by the range of a hydrogen bond [8, 23, 78, 99]; a
schematic representation of the hydrogen bond network between the
peptide backbones of adjacent peptide strands is shown in (b), using
the protein TTR105−115 [8] for illustration purposes.
Amyloid fibrils have a high aspect ratio, typically with lengths of several
micrometres and widths of only a few tens of nanometres. They are characterised
by a so-called cross β-sheet structure (illustrated in figure 1.1a), which is a
common motif found in the native conformation of many proteins and provides
a great deal of structural strength [77]. In this structure, polypeptide chains are
aligned with their backbones parallel to one another as illustrated in figure 1.1b.
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The peptide backbone of every polypeptide consists of alternating amine and
carboxyl groups which possess very slightly different charge distributions. When
two sections of peptide backbone align, the difference in charge distribution
creates a network of hydrogen bonds. While these bonds are individually weak,
a large number of them can provide a high degree of resistance to tensile and
sheer stress. This ubiquitous β-sheet structure means that any polypeptide has
the potential to form amyloid fibrils which, once formed, are very difficult for the
cell to remove.
While the presence of amyloid fibrils has been linked with neurodegenerative
diseases, increasing evidence indicates that it is not the mature fibrils, but rather
the smaller, precursor aggregates that cause the damage; however, the reason for
their toxicity remains unknown [7]. Given that any protein can adopt the amyloid
β-sheet structure, the plethora of diseases in which they have been implicated is
unsurprising. However, most of these are associated with later life — even those
with a known genetic link — which suggests that the initial steps in the formation
of amyloid fibrils have a low probability of happening.
1.2 Probing the formation of amyloid fibrils
An understanding of all of the mechanisms involved in the formation of amyloid
fibrils is necessary if their formation is to be controlled for use as novel materials
or in disease prevention. The initial stages of self-assembly are of particular
importance in both cases, owing to their apparently low probability of occurring
and the possible toxicity of small aggregates. Unfortunately, these are also the
hardest part of the process to probe, and so they often have to be inferred from
measurements taken later in the self-assembly process, once fibrils have become
large enough to be detectable.
Images of mature fibrils are much easier to obtain than those of early-stage
aggregates. Electron microscopy and atomic force microscopy reveal apparent
differences in fibril length, thickness, and flexibility, depending on the environ-
mental conditions and protein from which the fibrils formed. The images in
figure 1.2 were obtained by my collaborator, Ryan Morris using a transmission
electron microscope (TEM). The image on the left is for bovine insulin, while
5
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(a) Fibrils formed from bovine insulin. (b) Fibrils formed from ovalbumin.
Figure 1.2 Transmission electron micrographs of amyloid fibrils formed from
(a) bovine insulin, and (b) ovalbumin. These samples were taken
from experiments after the fluorescence signals had plateaued, by my
collaborators Ryan Morris [74] and Jason Kalapothakis. Both images
have a 0.1 µm scale bar.
that on the right is for ovalbumin, highlighting the contrasting appearance of
fibrils from different proteins. From images such as these, distributions of fibril
lengths can be obtained, as well as differences in the apparent fibril structure.
For example, under the conditions which produced these images, the persistence
length of insulin fibrils is much greater than that of ovalbumin. This information
can provide corroborative insight into the mechanisms at work during the fibril’s
formation. However, taking images of growing fibrils is extremely difficult and
has only been achieved a few times using an atomic force microscope [34, 66, 69].
Much simpler techniques exist which can provide time course data on the
aggregation process, albeit with little or no spatial resolution. These include
light scattering [38, 64], turbidity [38, 90], and fluorescence and absorption
spectroscopy [75]. One of the most commonly used techniques employs the
dye Thioflavin T (ThT) which is known to fluoresce when attached to proteins
containing β-sheet structures, such as the cross-β amyloid fibril structure. By
measuring the change in fluorescence intensity, a change in the prevalence of
β-sheet, and hence amyloid fibril, can be inferred. This technique allows the time
course of the self-assembly process, also known as the kinetic curve or growth
curve, to be established.
The relationship between the concentration of fibrillar protein and the strength of
the ThT fluorescence signal is not generally known and is likely to be specific to
the combination of dye concentration, protein, environment, and instrument used
6
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(a) Growth curves of recorded ThT fluorescence values in arbitrary
units.

















(b) Growth curves of fluorescence values normalised by the maximum
in each growth curve.


























Replicate bovine insulin experiments
Figure 1.3 Replicate growth curves for the self-assembly of amyloid fibrils
from 131 µM bovine insulin. These 68 replicates were obtained
simultaneously, and are shown in terms of (a) the recorded, and
(b) the normalised fluorescence values, where the latter indicates the
fraction of total protein that has been incorporated into fibrils. The
experiments were performed by my collaborator Ryan Morris, using a
BMG Labtech Fluostar plate reader, by measuring ThT fluorescence
at 10 minute intervals, with each 100 µl sample incubated at 60◦C in
25 mM HCl [74].
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to measure the fluorescence. Because of this, the easiest method for calibrating
the fluorescence resulting from a particular concentration of fibrillar protein is to
make use of the long time "end-point" state, where the fluorescence signal has
reached a plateau and aggregation appears to have stopped. At this point, the
concentration of protein in amyloid fibrils can be determined accurately using
other methods, such as measuring the concentration of protein still in solution.
These often reveal that all except a negligible fraction of the total protein
concentration has been incorporated into fibrils. Figure 1.3b shows examples of
growth curves that have been normalised in this way [74], where the maximal
(end-point) fluorescence values correspond to almost complete conversion of
protein into fibrils; hence, these growth curves are thought to indicate the fraction
of the starting protein concentration that has been converted into fibrils, as a
function of time.













Peak fluorescence of the growth curve
Linear fit to the steepest section of the growth curve
Figure 1.4 Illustration of a typical sigmoidal growth curve. This is annotated
with the definitions of the maximum fluorescence value Fpeak, the lag
times τk and τφM=0.03, the maximum aggregation rate kmax, and the
point in time τmax when the maximum aggregation rate is reached.
These kinetic measurements often result in a characteristic sigmoid-shaped
growth curve, as illustrated in figure 1.4. The quiescent lag phase at early
times may be more or less prominent for different protein systems, and can be
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absent in some. Following the lag phase there is a rapid increase in aggregation
rate, followed by an inflection point after which aggregation slows and tends to
a plateau with a maximum fluorescence value of Fpeak. The inflection point,
between the increasing and decreasing aggregation rates, is termed the point of
maximum aggregation and is typically seen to occur at round 50% of the plateau
value; in figure 1.4 this point is labelled with the gradient kmax, which occurs
at the time τmax. The plateau almost always represents complete incorporation
of the free monomer into amyloid fibril, and this was indeed the case for bovine
insulin under the conditions used to produce the data in figure 1.3.
The length of the lag phase is commonly referred to as the lag time (τlag) and can
be defined in a number of ways; the two most common being to measure the time
to reach a threshold fraction of the plateau value, or to linearly extrapolate the
slopes at the point of maximum aggregation point down to the time axis. These
are labelled as τ3 (for 3% aggregation) and τk respectively in figure 1.4.
Several theories have been proposed about the mechanisms which could give
rise to such sigmoidal growth curves, and in particular the nature of the lag
phase [17, 54, 72]; these will be discussed next.
1.3 Mechanistic models for amyloid fibril
polymerisation
Amyloid fibrils, like most linear polymers, typically grow by the addition
of individual protein "monomers". However, most proteins need to change
conformation into a "misfolded state" (as described in §1.1) before they can be
incorporated into a fibril. For most proteins, this does not happen spontaneously
on time scales accessible experimentally, without external influences such as an
increase in temperature. Even under these conditions however, the self-assembly
kinetics of many proteins exhibit a considerable lag before a significant amount
of protein becomes incorporated into fibrils. This lag phase can be removed, as























Figure 1.5 A sketch of two growth curves to illustrate the effect of "seeding"
amyloid fibril self-assembly with preformed fibrils. The typical sigmoidal
growth curve (red) displays a lag phase at early times that can be
removed by inoculating the sample with preformed fibrils at t = 0. This
results in a growth curve with a shape similar to an exponential approach
(blue).
These factors have lead to the widely accepted view that amyloid fibril formation
is a nucleation-dependent polymerisation process, where the de novo creation
of fibrils occurs via a homogeneous, primary nucleation mechanism (henceforth
simply referred to as primary nucleation), and elongation occurs via reversible
polymerisation at both fibril ends. The term "primary" is used to distinguish this
from other types of nucleation process which appear in more complex models, and
also to indicate that (in most cases) it is thought to be responsible for initiating
the self-assembly process. As in classical nucleation theory, homogeneous
nucleation refers to nucleation in bulk solution, in contrast to heterogeneous
nucleation which is catalysed by the presence of a surface or interface as described




The nucleation-dependent polymerisation model was first introduced by Oosawa
and Kasai [82] to describe the assembly of actin and tubulin filaments, and
was later improved by Hofrichter [45] to describe the aggregation of sickle cell
haemoglobin. The model consists of two processes: the formation of a primary
nucleus consisting of nc monomers, and its subsequent growth by reversible
polymerisation.
Figure 1.6 A cartoon depicting the formation of a primary nucleus (the shortest
stable filament) via a sequence of monomer addition steps (with
equilibrium rate constants Ki, where i is the number of monomers
involved in the resulting aggregate) and an irreversible conformational
change (with rate constant k′n). Later, this entire sequence will be
considered as a single step process with a single rate constant, kn. This
corresponds to reaction 1.1.
In these models, it is assumed that the nucleus forms through a series of reversible
polymerisation and conformational rearrangement processes (illustrated by fig-
ure 1.6), some or all of which may be energetically or entropically unfavourable.
This type of nucleation processes is closely related to classical nucleation theory,
originally used to explain crystal formation in supersaturated solutions. It
should be noted that the definition of what constitutes the "nucleus" is often
ambiguous, as the rate limiting step — prior to becoming a growth competent
fibril — may constitute the addition of a final monomer or a conformational
rearrangement, and the nucleus size may thus be chosen with respect to either
side of this final step. Throughout this thesis — and in almost all other work
— it is assumed that the processes which lead to this rate limiting step are
comparatively rapid and that their products are in equilibrium with the free
monomer population; however, in most cases I will neglect these intermediates
when considering nucleation processes. For clarity in later discussion, I choose
to define the nucleus as the smallest stable, growth competent species consisting
of nc monomers. This constrains the nucleus size to nc ≥ 2 due to the fact that
a conformational change in an aggregate of size nc to produce the nucleus must
11
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be equivalent to the addition of a monomer to an aggregate of size nc − 1, and
hence allows the equilibrium constants and the rate constant for the final step to
be subsumed into a single nucleation rate constant kn.
These concepts — the one-step formation of a stable, growth competent nucleus
comprising nc monomers, and equilibrium of all filaments containing fewer than nc





fi<nc −−−−−−−−−→ i ·m (1.2)
In reaction 1.1, nc monomers are converted into a nucleus with a rate proportional
to the free monomer concentration m(t) raised to the power nc and rate
constant kn as defined above. The term m(t)
x comes from x− 1 monomer
addition steps involved in going from a single monomer to an aggregate of size x.
The order in which these monomers come together is not important and so the
factor nc! is introduced to correct for the number of permutations.
Reaction 1.2 simply states the condition that all aggregates smaller than the
nucleus are in equilibrium with the free monomer population and can be
considered as part of that population. This will be needed in the event that
a filament becomes shorter than the minimum stable length nc via either
depolymerisation or filament breakage, both of which will be considered later.
Figure 1.7 A cartoon depicting reversible polymerisation, where elongation by
monomer addition occurs with rate constant k+, and depolymerisation
of monomer occurs with rate constant k−. These correspond to
reactions 1.3 and 1.4, respectively.
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Reversible polymerisation of a filament fi containing i monomers can be modelled




2k−−−−−−−−−−→ fi−1 +m (1.4)
In reaction 1.3, a filament grows longer by the addition of one monomer m, with
a rate proportional to the free monomer concentration m(t) and rate constant k+.
In reaction 1.4, one monomer is removed from a filament of length i, with a rate
proportional to the rate constant k−. The factor of 2 in both reactions is to
account for the fact that fibrils can grow and shrink from both ends. These are
illustrated together in figure 1.7.
A set of time-dependent differential equations for the concentrations of fib-
rils of length fi can be constructed from reactions 1.1, 1.2, 1.3, and 1.4.
Oosawa and Kasai [82] showed that this system of equations could be solved by
assuming that the formation of nuclei was limited only by the rate of the final
conformation step shown in figure 1.6 and that this was a slow process such that
the monomer population would be much larger than the population of nuclei at
early times; i.e. m(t) = mtot −M(t) ' mtot where M(t) is the concentration of
fibrillar protein at time t. These assumptions guarantee that depolymerisation
can be neglected, making it possible to find a closed-form analytic description of
the time evolution of the fibrillar protein concentration M(t) =
∑
∀i≥nc ifi(t) [82,














tot/nc!. This equation produces sigmoid-like growth curves
with a time scale determined by the parameter δ−1. From this parameter the
scaling behaviour of the lag time with total protein concentration can be shown
to be τlag ∼ m−γtot where γ = nc/2 ≥ 1 because nc ≥ 2 according the to definition
chosen earlier.
Thus, the nucleation-dependent polymerisation model makes a strong prediction
about the way in which the lag phase will scale with total protein concentration.















Bovine insulin experiments (γ = 0.358(16))
Figure 1.8 The scaling behaviour of τ3 with mtot in bovine insulin experiments;
each point represents the mean lag-time of between 140 and
200 replicate experiments at a particular protein concentration with
error bars (smaller than the symbol size) indicating the standard
deviation. The line is the best fit of the power law τlag ∝ m−γtot to these
data; the value γ < 1 indicates that bovine insulin fibril formation can
be better described by the fragmentation model (§1.3.4), than either the
primary, or heterogeneous nucleation models. The lag times (extracted
from growth curves such as those shown in figure 1.3) and value of γ
were both determined using to the methods described in §2.3.2.
proteins have been reported to give a value of γ < 1 [15, 18, 55, 58]; for example,
bovine insulin as shown in figure 1.8. Moreover, for some of those protein systems
where γ < 1, the shape of the growth profile at early times is found to be steeper
than predicted by this model [26]; i.e. the time evolution of the fibrillar protein
concentration M(t) is better described by an exponential than by the parabolic
approximation (M(t) ∼ t2) of equation 1.5. These and other observations have led
to many additions and modifications to this nucleation-dependent polymerisation
model, one of which I will now describe.
1.3.2 Autocatalytic polymerisation
Autocatalytic polymerisation involves a feedback mechanism by which existing
polymer stimulates the formation of new polymer. In this context, the
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concentration of polymerised material acts like a catalyst, enhancing the rate
of formation of new growth-competent ends beyond that normally produced by
primary nucleation; for example, the surface of an existing polymer may act as a
template to which free monomers can bind and form a new fibril (shown below
in figure 1.9). By creating additional growth-competent ends, the rate at which
free monomers are added to polymer ends, is increased. When additional growth-
competent ends form at a rate proportional to the concentration of polymerised
material, then a higher rate of polymerisation will lead to a higher rate of end
formation, and vice versa.
A number of autocatalytic mechanisms have been proposed to explain aspects
of amyloid fibril formation which depart from the nucleation-dependent poly-
merisation model [25, 106]. The two which are most relevant to this thesis are
heterogeneous secondary nucleation and filament fragmentation [16].
Figure 1.9 A cartoon depicting the heterogeneous nucleation of a new filament.
Here an existing filament acts as a template to which free monomers
can reversibly bind until ns monomers are in close enough proximity and
in the appropriate conformation to form a stable fibril. This involves
similar steps to those during the formation of a primary nucleus in
figure 1.6, and this sequence is also treated as a single step with a
single rate constant, kh, as given by reaction 1.11.
In the 1980s, Ferrone et al. [25] noted that sickle haemoglobin aggregation pro-
gressed more rapidly than predicted by the nucleation-dependent polymerisation
model, and proposed that heterogeneous, secondary nucleation of new fibrils
was occurring on the surface of mature fibrils: this is illustrated in figure 1.9
and will be hereafter referred to simply as heterogeneous nucleation. They
proposed a modification to the nucleation-dependent polymerisation model which
accounted for autocatalytic formation of new, growth-competent filaments, at a
rate proportional to the current concentration of fibrillar protein. This mechanism
succeeded in reproducing a lag phase and exponential early growth profile, but
only to first order in their analytic solution [26], noting that higher order iteration
and exact numerical solutions underestimated the contribution from secondary
nucleation and hence recovered the parabolic approximation of equation 1.5.
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Figure 1.10 A cartoon depicting filament fragmentation where one of the junctions
between the monomers of a filament, breaks, with the rate constant kf .
So long as both fragments are of a stable length, this results
in an additional, growth competent filament, corresponding to
reaction 1.10. If either, or both fragments are unstably short, then
they are expected to disintegrate into free monomer in accordance
with reaction 1.2.
At around the same time Wegner and Savko [106] developed an alternative
autocatalytic model, to describe the self-assembly of actin filaments. Again based
on the nucleated-polymerisation model, they incorporated filament fragmentation
as a secondary process: this is illustrated in figure 1.10. Again, new filament ends
are created at a rate proportional to the current concentration of fibrillar protein,
but unlike the heterogeneous nucleation mechanism of Ferrone et al. [26], the
rate of fragmentation does not depend on the free monomer population since
a filament is capable of breaking and forming two additional growth-competent
ends without consuming free monomer. In 2009, Knowles et al. [55] published
an analytic solution to a similar fragmentation model, describing the change in
fibrillar protein concentration over time, in the mean-field limit. This solution
reproduces the sigmoidal growth curves and crucially predicts that their lag
times will scale with total protein concentration according to a power law with
exponent γ = 1/2.
In a later series of publications, Cohen et al. [15] showed that both fragmentation
and heterogeneous nucleation could be treated with similar analytic techniques
and thus result in similar, mean-field expressions for the time evolution of the
fibrillar protein concentration [12, 13, 15]. The full autocatalytic model they
presented involves the set of reactions in table 1, where fi represents a filament
containing i monomers.
Reactions 1.6, 1.7, 1.8, and 1.9 in table 1 are clearly identical to those of
the nucleation-dependent polymerisation model in §1.3.1. The two additions
are reaction 1.10, which describes the fragmentation of a filament with rate
constant kf , and reaction 1.11 which describes the heterogeneous nucleation of a










2k−−−−−−−−−−→ fi−1 +m (1.9)
fi
(i− 1)kf−−−−−−−−−→ fj + fi−j (1.10)
fi + ns ·m
ikhm(t)
ns/ns!−−−−−−−−−→ fi + fns (1.11)
Table 1 The reaction set for a model for autocatalytic amyloid fibril self-
assembly: primary nucleation (1.6), disintegration of filaments of
unstable length (1.7), polymerisation (1.8), depolymerisation (1.9),
fragmentation (1.10), heterogeneous nucleation (1.11). Where they
appear, nc is the critical nucleus size and ns is the heterogeneous
nucleus size, and kn, k+, k−, kf , and kh are the rate constants for
primary nucleation, elongation, depolymerisation, fragmentation, and
heterogeneous nucleation, respectively.
Heterogeneous nucleation forms a new filament fns , when ns monomers come
together on the surface of an existing filament. In the same way as primary
nucleation, this can be approximated by a single step with rate proportional
to m(t)ns , and the filament populations fi<ns are assumed to also be in rapid
equilibrium with the free monomer population. Similarly, the factor ns! in
reaction 1.11 is included to correct for the indistinguishability of the monomers
in the resulting filament.
In the fragmentation reaction, a filament fi is effectively destroyed in order to
create two new filaments, fj and fi−j. Unlike heterogeneous nucleation, this does
not appear catalytic because the filament which forms the new growth-competent
ends is effectively destroyed by the process. However, as I stated earlier, it is
the total concentration of aggregated protein that acts as the catalyst, and this
remains unchanged.
The propensities of both fragmentation and heterogeneous-nucleation mecha-
nisms are linearly proportional to the length of the filament which aided in
the formation of a few filament; the assumption being that longer filaments
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have a higher probability of breaking, or equivalently a larger surface on which
heterogeneous nucleation can occur. The difference in the length dependence of
the two mechanisms comes from the fact that fragmentation can occur at i− 1
places along a fibril of length i (i.e. between the monomers), while heterogeneous
nucleation can occur at i places (i.e. on the monomers). Alternatives to this linear
scaling of the mechanisms with filament length have been proposed and in some
cases solved [44, 47]. However, they are considerably more complex and do not
provide a significant improvement over the original, linear assumption in terms
of fitting to experimental data.
It is also worth pointing out at this juncture that fragmentation can cause
the loss of a single monomer from the end of a growth-competent filament.
This is not accounted for in the heterogeneous nucleation model without also
considering depolymerisation of monomer from all stable filaments (reation 1.9).
If either process results in a filaments containing fewer than nc monomers, these
disintegrate in accordance with reaction 1.7.
1.3.3 A mean-field analytic solution to the autocatalytic
polymerisation model of amyloid fibril self-assembly
The autocatalytic reaction scheme presented in table 1, can be summarised
as: primary nucleation of a filament of size nc; equilibrium of all aggregates
containing fewer than nc monomers with the free monomer population; growth of
filaments by polymerisation of free monomer to their ends; shrinkage of filaments
by depolymerisation of monomer from their ends; autocatalytic generation of
new, growth-competent filament ends by fragmentation of existing filaments; and
autocatalytic creation of new filaments containing ns monomers by heterogeneous
nucleation on the surface of existing filaments, dependent on the free monomer
concentration.
Starting from this set of reactions, Cohen et al. [15] constructed a set of
differential equations for the evolution of the concentration of fibrils of length i,
{fi} [12, 13, 15]. By summing this set over all lengths, differential equations
for the first two moments of the filament population, N(t) and M(t), were
constructed. These describe the change in the number concentration of growth-
competent filaments (or half the number of growth-competent ends), and the
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where m(t) is the time dependent free monomer concentration and all other
symbols are as defined for the reactions in table 1. The first term in equation 1.13
describes the change of fibrillar protein concentration, which is increased by
monomer addition (elongation), and reduced by depolymerisation and the
formation of fragments containing fewer than nc monomers. Similarly, the second
term in equation 1.13 describes the increase in fibrillar protein concentration when
a new fibril is formed by heterogeneous nucleation. Thus the first two terms
in equation 1.12 describe the increase in fibril concentration via fragmentation
and heterogeneous nucleation, respectively; and the last term in both equations
accounts for the increase in the concentration of fibrils and fibrillar protein due
to primary nucleation.
The pair of equations 1.12 and 1.13 were then solved iteratively, for each of the
autocatalytic mechanisms independently (i.e. with either of kf or kh set to zero).
This was done using the technique of fixed point analysis, by neglecting depoly-
merisation, taking the early-time approximation m(t) = mtot −M(t) ' mtot, and
assuming monomer consumption by primary nucleation terms O(kn) could be
neglected. Good agreement with numerical solutions of equations 1.12 and 1.13
was reported after one iteration in the case of M(t), and two iterations in the case
of N(t). This approach was first used by Knowles et al. [55] for the fragmentation
model alone, but is presented more generally for both autocatalytic models in
later work by Cohen et al. [12]. The additional non-linearity introduced by the
heterogeneous nucleation mechanism means that further iterations of the above
technique are required in order to produce the same quality of agreement with
numerical solutions as was seen for the fragmentation model [12]. However, these
more exact solutions provide little extra insight into the behaviour of the system
and will not be considered in this thesis.
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The form of M(t) which is obtained by the above method can be expressed

























The parameter δ, which also emerged in the nucleation-polymerisation model
in §1.3.1, is the characteristic rate for primary nucleation driven polymerisation.
This determines the way that the growth curve scales with total protein concen-
tration when primary nucleation is dominant over autocatalysis; i.e. recovering
the prediction of the nucleation-dependent polymerisation model.
The parameter κ similarly describes the characteristic rate for autocatalytic
polymerisation, and its form depends on the specific mechanisms:










Both forms of κ contain the propensity 2k+mtot
(2) from reaction 1.8, along with
either the propensity for fragmentation kf (from reaction 1.10), or the propensity
for heterogeneous nucleation khm
ns
tot/ns! (from reaction 1.11).
The rate at which self-assembly proceeds is thus determined by which of the
parameters δ or κ is largest. In §5, the competition between these rates will
be explored in more detail, but for most of this thesis it can be assumed that
autocatalysis, and hence κ, is dominant.
(2) Here, I have used the early-time approximation m(t) ≈ mtot.
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Figure 1.11 A growth curve produced by equation 1.14, plotted in terms
of the characteristic time scale κ−1, where on the same time
axis δ−1 ≈ 32κ−1 cannot be seen.
Equation 1.14 produces sigmoid-like growth curves (figure 1.11), with initially
exponential growth and a more rapid change in aggregation rate than those of
the nucleation-dependent polymerisation model (equation 1.5).
1.3.4 Predictions of the mean-field analytic description of
autocatalytic self-assembly
In addition to the above expression for the growth curve (equation 1.14), this
mean-field description also provides a way to access analytic expressions for
particular aspects of these growth curves, such as the maximum aggregation rate
and lag time, and also other aspects of the aggregation kinetics, such as the mean
filament length.
Maximum aggregation rate
The maximum aggregation rate can be obtained from equation 1.14 by evalu-
ating dM(t)
dt







, which is obtained
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from the solution to d
2M(t)
dt2
= 0. This gives,
kmax = M(∞)κe−1 (1.19)
which is dependent on the characteristic rate parameter κ, and independent of
the initial conditions M(0) and N(0).
This predicts that the maximum aggregation rate scales with total protein
concentration according to kmax ∼ m1+γtot , where γ = (ns + 1)/2 with secondary
nucleus size ns (where ns = 0 for fragmentation). However, more complex scaling
behaviour has been reported experimentally [74], which will be investigated in §6.
Lag-time expressions
Two expressions for the mean lag-time (illustrated in figure 1.4) can be derived
from equation 1.14. These are the time τφM to reach a threshold fraction of the
total protein concentration, and the time τk which is obtained by extrapolation
of the maximum aggregation rate.
The time τφM at which a threshold fraction of aggregateMφ = M(tthreshold) ≈ φM mtot










where D = δ
2
κ2
and Φ = ln(1− φM). This can be simplified for early self-assembly,
where φM  1 (i.e. Φ→ 0), and when autocatalysis dominates the kinetics,









The lag time found by linear extrapolation of the maximum aggregation rate can
be obtained analytically from the definitions of kmax, tmax and M(tmax):













1.3.4 Autocatalytic polymerisation: analytic predictions
Both lag time expressions 1.21 and 1.22 are almost identical and are both inversely
proportional to κ. This makes sense since κ−1 and δ−1 are the only time scales
involved. When M(0), N(0), and δ are all small, the dominant contribution to
the protein concentration dependence of the lag time will come from κ. Hence,
the autocatalytic model predicts that the lag time will scale with total protein
concentration according to τlag ∼ m−γtot , but in this case γ = (ns + 1)/2 depends on
the autocatalytic mechanism involved: in the case of heterogeneous nucleation
where ns > 0, γ ≥ 1; whereas for fragmentation where ns = 0, γ = 12 .
This fragmentation model was the first to reproduce a lag-time scaling ex-
ponent γ < 1, which is observed experimentally in a number of protein sys-
tems [18, 27, 53, 55, 94, 117]. However, in order to obtain this scaling,
fragmentation-dominated polymerisation, rather than primary nucleation, must
entirely determine the lag phase as will be shown in §5.
Equations 1.20 and 1.22 only provide mean lag-times and do not address the
origin of the variability often observed experimentally in the growth curves.
Naively, this might be thought to reflect underlying fluctuations in the individual
mechanisms of primary nucleation and autocatalytic polymerisation. However,
as will be shown in §4.2, contributions to the lag-time variability from these
mechanisms become vanishingly small under the conditions typically used in
laboratory experiments.
Fibril length distribution
For the nucleation-dependent polymerisation model, Oosawa and Asakura [81]
showed that a differently shaped distributions of filament lengths could be
expected to emerge at different time points in the kinetics. Once the filament
population reaches equilibrium with the free monomer population, they predict
that a Poisson distribution of filament lengths will emerge and persists while the
equilibrium is maintained. After the monomer population has become depleted,
this distribution is expected to evolve into an exponential distribution described
by the parameter combination m(∞)k+
k−
, at long times. This relaxation is expected
to occur via a diffusion-like process where depolymerisation of long fibrils —
which became abundant during the growth process — release material which
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contributes to the growth of shorter fibrils, and gradually shifts the population
towards shorter filament lengths.
For heterogeneous nucleation with reversible polymerisation, Cohen et al. [13]
predicts almost identical behaviour, recovering the same analytic result as
Oosawa and Asakura [81] when kh = 0. From this, they postulated that the
qualitative shape (3) of these length distributions is an inevitable product of a
nucleation processes which produces filaments of a uniform length, and which
satisfies detailed balance in the exchange processes between filaments of different
lengths.
The fragmentation model, by contrast, permits the formation of filaments of any
length and does not satisfy detailed balance without filament re-association. This
leads to very different prediction for the length distributions. In the long time
limit, Cohen et al. [13] found that the length distribution for the fragmentation
model could be described by a "biased Gaussian" (skew normal) determined
almost entirely by the parameter nc [13]
(4). Earlier in the self-assembly process
(when m(t) ≈ mtot), a broader, skew normal distribution is predicted to exist,







The shape and evolution of these distributions can be understood through
competition between the mechanisms of elongation and either fragmentation or
heterogeneous nucleation [13]. Under the action of fragmentation, filaments will
tend to be broken into their smallest stable size, nc. Fragments smaller than nc
will enter equilibrium with the free monomer population and are re-polymerised
onto existing filaments. Similarly, depolymerisation will cause existing filaments
to become shorter until they, too, are no longer stable, leading to the same
disintegration and re-polymerisation behaviour. Polymerisation will act to oppose
both of these so long as sufficient free monomer is available.
(3) The length distribution for heterogeneous nucleation evolves over time, from one which
has a peak into an exponential.
(4) The peak position tends to nc as nc → 2 such that when nc = 2 the distribution can be
approximated as an exponential.
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The peaked length distributions of the intermediate state in both models agree
much better with many of those seen experimentally, than do the exponential
distributions that are predicted for the long-time steady state [1, 3, 9, 46, 84, 97].
This suggests that in typical experiments, the length distribution is unable to
relax, either through fragmentation or depolymerisation, on the time scales of
typical experiments, even though these are much longer than predicted by the
model. It has been suggested that interactions between filaments could create
a stabilising affect, reducing or eliminating fragmentation [74] and retarding the
relaxation process. The impact of disabling fragmentation during aggregation,
will be explored in §6.
The length distribution also provides a constraint on the interpretation of κ,
allowing extraction of the individual rate constants. The mean filament length is





regardless of the model involved. To obtain the filament length distribu-
tion during the aggregation process, Cohen et al. [13] made the approximation
that m(t) = mtot, resulting in exponential growth expressions for both M(t)
and N(t). Curiously, the mean filament length defined by equation 1.23 when















For experimental data where κ is found to scale with the total protein concen-
tration as predicted by the fragmentation model (equation 1.19), equation 1.25
allows k+ or kf to be determined from the mean filament length L.
1.3.5 Fibril end-joining and loop formation
A number of amyloid fibril forming proteins display non-sigmoidal kinetics
that do not fit with the nucleation-dependent polymerisation or autocatalytic
polymerisation models presented above [29, 30, 35, 41, 79, 80, 91, 92, 113, 114].
Many have little or no obvious lag phase, with the maximum aggregation rate
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(b) Growth curves of fluorescence values normalised by the maximum




























Figure 1.12 Replicate growth curves for the self-assembly of amyloid fibrils
from 19 µM ovalbumin. Unlike the growth curves of bovine insulin,
these do not display a lag phase. These 9 replicates are shown
in terms of (a) the recorded, and (b) the normalised fluorescence
values, where the latter indicates the fraction of total protein that
has been incorporated into fibrils. The experiments were performed
by my collaborators Ryan Morris and Jason Kalapothakis, using a
BMG Labtech Fluostar plate reader, by measuring ThT fluorescence
at 10 minute intervals, with each 100 µl sample incubated at 60◦C in
10 mM ammonium acetate and 10 mM DTT buffer.
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occurring close to, or at, t = 0. Typically, the lack of a lag phase and rapid early
growth are associated with the introduction of pre-formed fibrils, or seeds, at the
start [14, 16], but for these proteins this is unnecessary. Example kinetics of this
type are shown in figure 1.12.
Figure 1.13 A cartoon depicting filament end-joining, with rate constant kj. The
two filament ends may belong to the same filament only if it is flexible
enough for the ends to meet; otherwise the two ends will belong to
separate filaments.
Filament end-to-end association has been proposed as an alternative mechanism
to explain such kinetics [42, 71, 72, 103, 104, 114]. Variously referred to as
coagulation, condensation or downhill polymerisation, this mechanism represents
an alternative growth pathway to self-assembly (5); it can also be regarded as the
reverse of filament fragmentation as illustrated in figure 1.13. In a similar way to
polymerisation, I will assume that filament elongation can occur by the addition




with rate constant kj. This mechanism should allow more rapid elongation of
an individual filament than monomer addition alone. However, it will actually
decrease the overall aggregation rate, since it does not change the concentration
of fibrillar protein but does decrease the number of growth-competent ends [44].
The corollary to allowing any two filaments to join in this manner is that an
individual filament may join to itself, forming a closed loop. Such loops would
no longer be growth competent, but would still permit surface processes such as
secondary nucleation. Loops have been reported in AFM and electron microscopy
experiments alongside non-looped fibrils for a number of protein systems [19, 41,
42, 101, 114], and in many of these cases growth curves also exhibit little or
no lag phase and rapid initial growth. Undoubtedly, these loops must form in
a length dependent way [42, 57]; Hatters et al. [42] succeeded in modelling the
(5) An alternative to simple monomer addition.
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loop frequency observed experimetnally for Apolipoprotein C-II (apoC-II) using
a worm-like chain closure model [42, 50].
These processes constitute the reverse of filament formation, since they deplete
the number of filament ends available for polymerisation by either monomer
or filament addition. It is not completely clear what affect this will have
on the kinetics, particularly if fragmentation is also involved, but simulations
incorporating filament end-joining have shown some success in explaining the
distribution of loops and the shape of growth curves produced by apoC-II [42,
114]. While these indicate that end-joining is likely to be the correct explanation,
these simulations fall short of providing a detailed picture of the kinetics.
In §7, I present analytic solutions to models incorporating filament end-joining,
which allows the rate constants to be estimated from experimental data in much
the same way as can be done for the autocatalysis model presented earlier. These
also provide predictions for the effects of reversible filament end-joining on the
kinetics.
1.4 Going beyond mean-field models
Considerable effort has gone into understanding the mechanisms involved in the
formation of amyloid fibrils. Much of this work has focused on the kinetics
at early times, which involve short time- and length-scales rendering them
difficult to probe experimentally. The early nucleation-dependent model of
Oosawa and Asakura [81], and later autocatalytic models of Cohen et al. [17],
make strong predictions about how the events occurring at early times are
expected to influence observable scaling behaviour later on in the aggregation
kinetics.
While these analytic solutions have been very widely used to extract reaction rates
and other parameters from experimental data, they only provide a mean-field
picture of the kinetics. Substantial variability is commonly observed in replicate
experimental growth curves which a mean-field approach cannot explain. This
variability is often assumed to reflect inherent fluctuations in the mechanisms
involved, and in particular primary nucleation. To verify this assumption, an
alternate, stochastic implementation of these models is required.
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Kinetic Monte Carlo simulations provide a way to model chemical reaction kinet-
ics, taking into account fluctuations arising from the discreteness of individual
molecules and the order of reaction events. In §3, I will present the results of
kinetic Monte Carlo simulations for the autocatalytic polymerisation models of
Cohen et al. [15], to which I compare the mean-field analytic solutions. I will
then explore the origins of the variability in lag time of these and experimental
growth curves in §4, by considering the first passage probability distributions for
the processes of primary nucleation, polymerisation and autocatalysis.
The scaling behaviour of the lag time with total protein concentration obtained
from the mean-field analytic solutions predicts that fragmentation dominated
kinetics will scale more weakly than any nucleation dominated kinetics; indeed,
it provides an exact value of the exponent, γ = 1/2 for fragmentation dominated
kinetics. However, that analysis does not consider individual events. Conse-
quently, self-assembly may proceed via a fragmentation dominated mechanism,
but not before the occurrence of other processes with waiting times drawn from
a much wider distribution. Using the kinetic Monte Carlo simulation framework
developed in §3, along with analytic techniques, I will demonstrate the effect of
primary nucleation on this lag-time scaling behaviour, in §5.
The filament length distribution of the fragmentation model changes quite
dramatically from a broad peaked distribution throughout most of the kinetics,
to a very narrow, almost exponential distribution in the long time limit.
The former, peaked distribution has been reported a number of times for
systems exhibiting lag-time scaling behaviour otherwise commensurate with the
fragmentation model. This suggests that the relaxation of the length distribution
is being arrested while still in the peaked form. This will be investigated in §6,
where, in order to explain the observed length distribution and transition in the
maximum aggregation rate scaling with total protein concentration, I implement
a mechanism whereby fragmentation is arrested according to the fraction of total
protein currently incorporated into filaments.
Finally, looped fibrils have been reported experimentally, often in conjunction
with non-sigmoidal growth curves. The presence of loops indicates that filaments
are able to grow by end-joining, and in §7 I will present analytic solutions for
models involving filament end-joining with and without fragmentation.
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Hence, using kinetic Monte Carlo simulations, and analytic techniques, I will
demonstrate how the adjustment of various environmental parameters could be





2.1 Kinetic Monte Carlo Simulation
When choosing which simulation technique to use when modelling a given system
(in this case a set of chemical reactions), the trade-off between computational
speed, resolution of detail, and comparison to the real system need to be
considered in the context of the questions being asked. For example, it would
be wasteful to perform a molecular dynamics simulation if the system could be
modelled as a well mixed solution, because the extra calculations involved do not
contribute significantly to the results.
Kinetic Monte Carlo (Gillespie algorithm) simulations are a useful technique
for probing systems of chemical reactions where kinetic phenomena (as opposed
to steady state) and the discreteness of individual molecules and events are of
interest, but spatial resolution is unimportant. All simulations presented in this
thesis were performed using this technique [31, 32].
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The Gillespie algorithm assumes a well mixed, homogeneous, isotropic, mixture of
active components in an inert solvent (which is ignored). A set of reactions of the
form A+B
µ−→ C describe how the components A and B interact to produce C
at a rate µ. The propensity of each reaction occurring (1) can be calculated from
the abundance of reactants it involves and its rate constant (which is a parameter
of the model). For the above example the propensity is given by µXaXb, where µ
is the rate constant (with units s−1), and Xx denotes the number of particles of
species x. In the case where two molecules of the same species react, this would
become µXa(Xa − 1), since the molecule cannot react with itself in this two-body
manner.
In this algorithm, each species has an integer number of particles. If needed
elsewhere, this can be converted to a concentration [a], using Xa = [a]V , where V
is a chosen system size (2). It is important to note that some rate constants of
some types of reaction (bimolecular and higher order) will also depend on volume;
for example, the rate constant µ will change according to µ = k
V n−1
, where n is
the number of molecules involved in the reaction (3), and k is the more familiar
rate constant typically used in a master equation description of the same system.
Taken together, these considerations make it possible to convert between a master
equation description in terms of molar concentrations, and the kinetic Monte
Carlo framework in terms of discrete molecular population sizes.
The kinetic Monte Carlo algorithm
In a kinetic Monte Carlo simulation, the system is evolved by a single chemical
reaction event at every time step. Each time step involves the selection of a
reaction and a time interval since the last reaction occurred. The chosen reaction
is then implemented by adjusting the populations of reactant and product
molecules, and the total system time is updated according to the chosen reaction
time interval. The time interval and reaction are randomly selected according to
the total propensity of all reactions in the system, using the following method.
(1) The propensity is the probability per unit time that a particular event occurs.
(2) For molar concentrations, the system size must also take into account Avogadro’s
number, NA.
(3) For example, there are n = 2 molecules involved in the bimolecular reaction A+B
µ−→ C.
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Supposing that the next reaction occurs during the time interval (τ + t, τ + t+ dt],
where τ is the current total system time. The waiting time t before this reaction
happens is then determined by the probability that no reactions at all occur in




where K is the sum of all propensities, rt is a random number in the interval (0, 1],
and it has been assumed that all events have Poisson distributed waiting-times.
Compared to a simulation in which the time interval between consecutive updates
is fixed, this algorithm has the advantage that it automatically jumps ahead in
time according to the reaction propensities. Thus, no computational time is
wasted simulating periods when no reactions can occur.
The reaction J , which occurs after this waiting time, can now be determined by
considering the propensity of each reaction ki relative to that total propensity
of all reactions K. The sum of propensities up to a given reaction j can be
written as Rj =
∑j
i=0 ki, such that R∞ = K. Using this, and a random number rr
in the interval (0, K] such that rr = RJ , reaction J can be identified from the
condition Rj−1 < rr ≤ Rj+1. This reaction is then used to adjust the populations
of each species involved.
Once the reaction has been performed and the system time update, the
propensities for all reactions are recalculated and the simulation moves onto the
next time step. In this way, every reaction with a non-zero propensity has a finite
probability of occurring, but those with higher rate or larger number of particles
will have a higher probability and on average will be chosen more often.
Implementation
Using this algorithm, I implemented various kinetic models of amyloid fibril self-
assembly in FORTRAN95, with random numbers generated using the well known
and robust Mersenne-Twister algorithm. In these simulations, the chemical
species involved were either monomers, or fibrils of a given length.
33
CHAPTER 2. METHODS
All simulation parameters were input in SI units from which molar concentrations
were converted into numbers of particles according to the chosen system volume.
No constraint was placed on the maximum length of an individual filament or
the number of filaments produced other than to conserve the total number of
monomers in the system. Typical runs contain 150 replicates for each set of
parameters values.
Data was output for growth curves and distributions of filament lengths in terms
of the number of monomers in a particular state; i.e. free, or within filaments
of a given range of lengths. Growth curves were stored whenever the total
monomer concentration changed by ±0.5%, and the filament length distributions
were written upon reaching specific fractions of the total monomer concentration,
such as 0.5mtot.
2.2 Averaging the kinetic Monte Carlo simulation
data
In order to compare kinetic Monte Carlo simulation results to the mean-field
prediction, I compute the mean behaviour of the simulation results as follows.
Growth curves
By virtue of the kinetic Monte Carlo approach, replicate simulation runs do
not have neatly coinciding time intervals; however, the fraction of monomers
incorporated into filaments can (and do) have intervals which coincide between
replicates. Moreover, as will be seen in later chapters, the lag phase and
subsequent growth are often governed by vastly different time scales, meaning




Hence, I constructed the mean growth curve from a set of replicates by considering
the mean time at which they all reached a particular fraction of the total protein
concentration, for each fraction of the total protein concentration recorded (4).
Thus, for each fraction of the total protein concentration, the mean growth curve
describes the mean time at which that fraction was observed. This trivially
provides the mean lag-time τφM , which is the mean of the times that each replicate
reached the threshold fraction of the total monomer concentration φM .
To find the mean and variance of the maximum aggregation rate, I used the
method presented below in §2.3.2 to extract the maximum aggregation rate from
each replicate growth curve.
Length distributions
Filament length distributions were obtained from kinetic Monte Carlo simulations
at specific events of interest; for example, reaching the fraction of aggregated
material that defines τφM . For each of these I determined the average length
distribution by constructing a histogram covering the entire range of filament
lengths contained in the replicate data sets, with equal bin spacing. The mean
and standard deviation of the number of filaments with lengths that lie within
each bin was then calculated from the replicate data. In this way, I capture the
mean number of filaments for a given range of lengths, and also highlight the
extent of fluctuations between replicate simulations with the same fraction of
aggregated material.
2.3 Extracting model parameters from
experimental data
A key part of the work in this thesis involves fitting the analytic expressions
of a given model for fibril aggregation kinetics, to experimental and simulation
results thought to be described by that model. To do this, I make use of the
Levenberg-Marquardt algorithm in the context of least squares fitting.
(4) In contrast to the mean fraction of the total protein concentration at a specific time, which
is the way that the average of replicate experimental growth curves is typically found.
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2.3.1 The Levenberg-Marquardt algorithm
The Levenberg-Marquardt algorithm is commonly used to find a "best fit"
between an analytic expression and data which the expression is thought to
describe. More generally it provides a fast method for finding the minimum value
of a scalar function by adjusting the parameters on which the function depends;
hence, in this case the function being minimised is Chi-squared (χ2), which is the
sum of the squared residuals for a given analytic expression and dataset, weighted
by the confidence in each data point.
The algorithm finds a minimum value of χ2 by alternating between the Gauss-
Newton algorithm and the method of steepest descent. The Gauss-Newton
algorithm is a reliable method for non-linear least-squares minimisation. Faster
and more robust than Newton’s method for finding the minimum value of a scalar
function, the Gauss-Newton algorithm quickly converges to a local minimum but
takes many small steps to reach it. To speed up the process, the method of
steepest descent is employed when there is a steep local gradient in χ2 with respect
to any of the parameters (5). Thus the Levenberg-Marquardt algorithm takes large
steps down steep gradients in parameter space and slower, more accurate steps
as a minimum is approached.
The Levenberg-Marquardt algorithm is sometimes criticised for finding local
minima, and different minima when started with different initial parameter
values. While these can be problematic, the algorithm’s speed means that a
large portion of parameter space can be quickly mapped. As a result, even if
most of the minima found turn out to be local minima, a picture can be built up
of where the global minimum actually is.
2.3.2 Determining the lag-time and maximum aggregation
rate from growth curves
From experimental and simulation growth curves, I determined the maximum
aggregation rate by taking the first derivative d(
M(t)/mtot)
dt
of the normalised data
(5) Where a small change to one or more of the parameters in the analytic expression yields
a large decrease in χ2.
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Linear fit to the steepest section of the growth curve
Figure 2.1 Illustration showing how the lag times τk and τ3 (i.e. when φM = 0.03),
and the maximum aggregation rate kmax are determined from a growth
curve; the dashed line is the best fit of M(t)/mtot = kmax (t− τk) to the
steepest part of the growth curve.
and finding the maximum k̃max. This value should be the same as the actual
maximum aggregation rate kmax illustrated in figure 2.1, but local fluctuations
in the data mean that this is not guaranteed. For this reason, I obtain a better
estimate using the following method.




data encompass a large portion of the approximately linear section of the growth
curve around the inflection point. By fitting this data to the line described by
M(t)
mtot
= kmax (t− τk)
illustrated by the dashed line in figure 2.1, the values of kmax and τk can be found.
The lag time defined by the time to reach a threshold fraction of aggregate, was
found simply by seeking the value of t for which M(t) first crosses Mφ. This I
did by iterating over the growth curve data and linearly interpolating between
the two values of M(t) closest to φM .
37
CHAPTER 2. METHODS
Extracting the lag-time scaling exponent γ





where A is an arbitrary scale factor. Thus, the lag-time scaling exponent γ was
determined by fitting the lag times in a given range of total protein concentrations
(typically 10 ≤ mtot < 750 µM) to the linear expression
log (τlag) = log (A)− γ log (mtot)
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Chapter 3
The effects of stochasticity on two
autocatalytic polymerisation models
3.1 Introduction
In order to understand the variability in the experimental growth curves in
figure 3.1 it is necessary to move away from the mean-field description of
Cohen et al. [12] (see §1.3.2). To do this, I make use of kinetic Monte Carlo
(kMC) simulations, which provide a way to resolve discrete reaction events and
thus probe the stochastic fluctuations that arise from randomness in the timing
and order of individual molecular reactions.
In this chapter I will compare the effects of stochasticity on the autocatalytic
polymerisation models of fragmentation and heterogeneous nucleation (described
in §1.3.2). This will be done using the reactions for primary nucleation,
elongation, and autocatalysis from table 1, implemented in the kinetic Monte
Carlo simulation framework described in §2.1. The results of these simulations
will also be compared to the mean-field predictions for these models and to
experimental data, both of which reveal interesting behaviour which will be
investigated in subsequent chapters.
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First, however, I must establish realistic values for the rate constants involved in
these models.
3.2 Estimating the rate constants from
experimental data
Estimated values for the rate constants of primary nucleation (kn), elonga-
tion (k+), and fragmentation (kf), were determined from the parameter values
of the mean-field predictions in §1.3.4, by fitting to experimental data. As will be
seen below, the values found appear physically realistic but are unlikely to be the
true rates of the physical processes, due to the limitations of the data available.
These estimated values simply form a baseline, providing information about the
relative contribution of each mechanism to the aggregation process in one case
so that deviations from this behaviour can be understood in terms of changes to
the model parameters.


























Replicate bovine insulin experiments
Figure 3.1 Replicate growth curves for the self-assembly of amyloid fibrils
from 131 µM bovine insulin, previously shown in figure 1.3. These
68 replicates were obtained simultaneously, by my collaborator
Ryan Morris [74], and have been normalised by the maximum
fluorescence of each curve.
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3.2 ESTIMATING RATE CONSTANTS
Replicate experimental growth curves for different concentrations of bovine
insulin in the range 17− 698 µM were averaged by finding the mean of the
normalised fluorescence signal at each time point. To the average growth
curve of each protein concentration, the analytic expression for the mean-field
growth curve (equation 1.14) was then fitted using the least squares minimisation
technique presented in §2.3.1; this gave values of the parameters κ and δ (defined
in §1.3.3). An example fit produced by this process is shown in figure 3.2 for
the 131 µM bovine insulin data shown in figure 3.1.



























Fitted mean-field prediction with κ = 5.81(17)×10−4 s−1
and δ = 9.5(8)×10−6 s−1
Figure 3.2 An example fit of equation 1.14 to experimental data; in this case, the
mean normalised fluorescence value at each time point of the replicate
growth curves shown in figure 3.1 for 131 µM bovine insulin, with error
bars indicating the standard deviation. These experiments were not
"seeded" (i.e. M(0) = 0 and N(0) = 0) and so κ and δ are the only
fitted parameters.
The fitted parameters κ and δ each consist of a combination of rate constants
and the total protein concentration. In the case of κ, this combination depends
on which autocatalysis model is being considered. Inspection of the scaling
behaviour of the average lag time and maximum aggregation rate with total
protein concentration (1) indicates that this experimental data is best described
by the fragmentation model only, with no evidence of heterogeneous nucleation
(1) This will be shown below in figures 3.7 and 3.8, respectively.
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being involved. Thus, I can obtain an estimate for kf from the experimental data,
and I am then free to define kh such that the two models have the same κ at a
particular protein concentration and, hence, a similar maximum aggregation rate
and lag time.
In order to extract the rate constants from κ and δ, additional constraints are
needed. These constraints are provided by additional experimental data, such
as the mean lag time and mean fibril length; however, the nucleus size nc has
not accurately been determined experimentally for any amyloid fibril formation
process, and so I have assumed nc = 2 for convenience.
These experiments were not "seeded" with preformed fibrils and so I can
additionally assume that M(0) = 0 and N(0) = 0, such that the lag times provide
an estimate of the ratio δ/κ; i.e. the ratio kn/kf .
The mean fibril length, obtained from electron micrographs by Morris et al. [74]
after aggregation had completed, provides L(∞) = κ/kf , where each bovine insulin
"monomer" contributes approximately 4 Å to the fibril length. This fixes kf
and allows k+ to be determined from κ. There is no way to separate this
elongation rate into monomer addition and depolymerisation rates, and so I have
assumed k− = 0 for the fragmentation model; as will be seen shortly, a non-zero
depolymerisation rate is necessary for the heterogeneous nucleation model.
Encouragingly, very similar values and confidences for κ/√mtot (2) were found
by fitting the average growth curves of total protein concentrations below
approximately 175 µM, and these values were robust against the choice of starting
values for the fitted parameters. For reasons which will become clearer in §6,
higher protein concentrations give a lower value of κ than expected, but these fits
were still robust against the choice of starting values.
The value of δ, on the other hand, was less consistent: its value turns out to be
far less important to the shape of the growth curve. This is because autocatalysis
and primary nucleation are both contributing to the lag phase and cannot simply
be decoupled by inspecting the growth curve; at best, δ can be said to have a
value significantly smaller than κ. For this reason, the effects of different values
of the primary nucleation rate will be dealt with in §5.
(2) This is the concentration independent form of κ for the fragmentation model.
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Taking account of these considerations and the fact that the rate constants appear
as products within the fitted parameters, it is not possible to determine the
exact reaction rates using this method; however, the values obtained, do appear
physically realistic. In the case of bovine insulin, I find that k+ = 5×104 M−1 s−1,
kf = 3×10−8 s−1, and kn = 3×10−7 M−1 s−1 produce results consistent with the
experimental data (3).
To allow comparison between the fragmentation and heterogeneous nucleation
models of autocatalysis, I now determine an appropriate value for the het-
erogeneous nucleation rate using the two definitions of κ (equations 1.17
and 1.18): kh = kf (ns!)/mns = 24 M
−1 s−1, when m = 50 µM and ns = 2. To
account for the loss of monomers that happens through fragmentation at
filament ends, the heterogeneous nucleation model additionally requires a non-
zero depolymerisation rate: in the case where nc = 2 this is k− = kf = 3×10−8 s−1,
but for higher nc, depolymerisation cannot properly account for fragmentation of
filaments of length 1 < i < nc in these simulations due to the differences between
reactions 1.7 and 1.9.
Since the kinetic Monte Carlo framework considers individual particles in order
to resolve discrete reaction events, the rate constants determined above, and all
concentrations of protein, must be converted into discrete numbers of particles
according to a system volume V , as described in §2.1. Hence, at smaller volumes
the effects of stochasticity are expected to increase due to the reduced number
of particles. This will be seen to be particularly important during the lag phase
when the number of filaments is expected to be very small. For reasons which
will become clear shortly (in §3.3.3), I use a volume of V = 0.83 pl throughout
this thesis unless otherwise stated.
(3) The primary nucleation rate should be expressed in units of M−(nc−1) s−1, unless nc is
defined; for most of this thesis I will assume nc = 2.
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3.3 Comparison of kinetic Monte Carlo
simulations with the mean-field predictions
3.3.1 The stages of autocatalytic polymerisation
In order to add context to the discussion in other chapters, I first present an
overview of the mechanisms which dominate at specific points in the self-assembly
kinetics.
Figure 3.3 A cartoon depicting the mechanisms that dominate different stages of
the sigmoidal growth curve in the fragmentation model for amyloid
fibril self-assembly. At early times (I), few filaments are present and
elongation dominates. Once this has incorporated a sufficient quantity
of protein into fibrils (a), autocatalysis takes over during the exponential
growth phase (II), up to the point where the aggregation rate reaches
its maximum (b). After this, the creation of more filaments through
autocatalysis cannot balance the depletion of monomers by elongation,
causing growth to slow and become elongation dominated again (III);
continued fragmentation during this stage, leads to a large number of
short filaments being present in the long-time limit. The behaviour
of the heterogeneous nucleation model would differ at point b, which
would be shifted to earlier times, and in stage III, where fewer and
longer filaments would be present in the long-time limit.
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The growth curves for either model of autocatalysis can be considered in three
stages, delimited by: (a) the end of the quiescent phase and (b) the point at
which the aggregation rate is maximal. These are illustrated in figure 3.3.
During the quiescent phase (I in figure 3.3), the low rate of primary nucleation
results in few filaments being produced. These grow rapidly due to the abundance
of free monomer, but since they are so few in number the total rate of aggregation
is low. Once a filament reaches a significant length, autocatalytic processes
become important, leading to the formation of more growth-competent filaments.
Once autocatalysis starts to become important, both the number of filaments and
their combined protein content will grow exponentially while sufficient monomer
is available (II in figure 3.3). Thus the end of the lag phase is marked by a strong
increase in the number of filaments. The exponential growth phase continues
until depletion of the monomer population starts to arrest growth more rapidly
than the formation of new filaments accelerates it; this crossover happens at
the maximum aggregation point. Following this point, aggregation slows and
ultimately stops once an equilibrium is reached between polymerisation, and
either depolymerisation or the fragmentation of filaments into pieces shorter
than nc (III in figure 3.3).
3.3.2 The effects of stochasticity on the fragmentation and
heterogeneous nucleation models
Using the rate constants obtained in §3.2 as a starting point, I performed kinetic
Monte Carlo simulations of the fragmentation and heterogeneous nucleation mod-
els. For the fragmentation model, reactions for primary nucleation (reaction 1.6),
the disintegration of filaments smaller than the primary nucleus (reaction 1.7),
polymerisation (reaction 1.8), and breakage of a filament (reaction 1.10) were
used. In the heterogeneous nucleation model, reactions 1.6, 1.7 and 1.8 were also
used, along with those for depolymerisation (reaction 1.9) and heterogeneous
nucleation (reaction 1.11).
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The replicate growth curves that I obtained from these simulations are shown
in figures 3.4 and 3.5 for the fragmentation and heterogeneous nucleation model,
respectively. Here, I also show the average growth curve for the set of replicates,
and the mean-field prediction given in equation 1.14. From these it is obvious





























Mean of the kMC simulations
Mean-field prediction
Figure 3.4 Growth curves produced by kMC simulations of the fragmentation
model for amyloid fibril self-assembly, along with the
mean-field prediction given in equation 1.14, where the
parameter values were mtot = 10 µM, nc = 2, N(0) = 0,
kn = 3×10−7 M−1 s−1, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. The average of the
simulations was obtained from the 150 replicates shown, using the
method in §2.2.
In figure 3.4, the average growth curve of the simulations and mean-field
prediction both have the same shape, but the former has a longer lag phase.
This is due to the difference of time scale for events during the lag phase, and
those later in the growth curve, resulting in apparently identical growth curves
with vastly different lag times. The mean-field description given by equation 1.14
correctly accounts for the faster time scale of autocatalytic polymerisation, but
not the slower time scale of discrete primary nucleation; hence, it can reproduce
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the shape of the growth curve, but not the mean lag-time. Thus, the average
growth curve of the simulation and mean-field prediction would agree if the correct




























Mean of the kMC simulations
Mean-field prediction
Figure 3.5 Growth curves produced by kMC simulations of the heterogeneous
nucleation model for amyloid fibril self-assembly, along with the
mean-field prediction given in equation 1.14, where the parameter
values were mtot = 10 µM, N(0) = 0, nc = 2, kn = 3×10−7 M−1 s−1,
k+ = 5×104 M−1 s−1, k− = 3×10−8 s−1, kh = 24 M−1 s−1, ns = 2,
and V = 83×10−14 l. The average of the simulations was obtained
from the 150 replicates shown, using the method in §2.2.
The same observations hold for the growth curves produced by the heterogeneous
nucleation model in figure 3.5. However, here the average maximum aggregation
rate of the simulations — and indeed the shape of the growth curve above 0.5mtot
— also appears quite different to the mean-field prediction. This discrepancy
arises because the analytic solution in this form does not take full account of
monomer depletion and its impact on the heterogeneous nucleation mechanism.
Higher order corrections to the this solution, provided by Cohen et al. [12], do
capture these effects, but the increased complexity makes them impractical for use
in extracting parameters from experiential data. However, as the experimental
data appears best explained by the fragmentation model, I will have need of these
more complex solutions.
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3.3.3 The effects of system volume, primary nucleation and
seeding
I stated that the poor agreement between the average growth curve of the kinetic
Monte Carlo simulations and the mean-field prediction was due to the primary
nucleation process. This I will now illustrate by "seeding" the kinetics with a
number of preformed filaments prior to self-assembly, and in doing so, explain
the choice of simulated volume V = 0.83 pl.
The concentration of filaments present early on in the kinetics, determine the rate
of aggregation; hence, a high concentration will reduce or bypass the lag phase,
while a low concentration will allow autocatalysis (and primary nucleation) to
contribute to the formation of more filaments. The growth curves which were
shown in figures 3.4 and 3.5 where the rate of primary nucleation was assumed
to be low (δ  κ) are expected to be in the latter of these two conditions, and
indeed display an notable lag phase.
In these kinetic Monte Carlo simulations, the primary nucleation and autocataly-
sis processes always produce one filament per event, regardless of system volume;
thus, the choice of system volume dictates the relative contribution which this
one new filament makes to the concentration of all filaments. Hence, a single
filament in a small volume constitutes a "high concentration", and from the
above argument, if the simulation volume were too small, then a single nucleation
event would bypass the exponential growth phase completely, even if the primary
nucleation rate was very low.
As explained in §2.1, the system volume also affects the propensities of each
event. In the kinetic Monte Carlo simulation framework, it is assumed that every
event can be described by a Poisson process with a rate that scales inversely with
the concentration of particles produced. This is simply because the process of
producing a high concentration of a given species of particle requires more reaction
events than would the production of a lower concentration of the same species in
the same volume. Consequently, the rate of production of a high concentration
is slower than a lower concentration, even if both are treated as single events.
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Using primary nucleation as an example, the Poisson rate at which nuclei form
can be written as η/N(0), where η = knm
nc
tot/nc! is the propensity given in reaction 1.6
and N(0) = M(0)/nc = 1/NAV is the number concentration of nuclei produced. From
this, the rate at which nuclei form can be seen to scale with system size; in
smaller systems the waiting-time distribution is broader and nuclei are formed
more slowly. This particular effect will be revisited in §4 and §5.
A large portion of the variability in the lag phase of the growth curves in figures
3.4 and 3.5 can thus be explained by the width of the waiting-time distribution
for primary nucleation events at this particular volume, V = 0.83 pl. This I will
now illustrate by comparison of those growth curves with the ones in figure 3.6b.
These were produced using the same parameters as those in figure 3.4 for the
fragmentation model, but with primary nucleation disabled and the simulations
seeded with N(0) = 1/NAV filaments, as indicated. Here, the agreement between
the average of the simulation growth curves and the mean-field prediction is
improved, compared to the case where primary nucleation was active. However,
it is now apparent that the mean-field prediction also fails to account for monomer
depletion at later times in the fragmentation model.
The growth curves in figure 3.6 were obtained for different values of N(0) by
altering V in the range 83×10−16 − 83×10−13 l, but always starting with a single
filament. From the way that the lag-time decreases with decreasing volume in
these figures, it can be seen that when kn = 0 and N(0) > 0, in order for the
kinetics to produce the same mean lag-time as the experimental data at the
same protein concentration, the minimum system volume must be V = 1/NAN(0),
according to the lag-time equation 1.21, where N(0) = 2×10−12 M; hence
giving V = 0.83 pl.
The "kick" in the lower part of the growth curves in figure 3.6d is due to the
concentration of nuclei being slightly below the threshold at which additional
filament ends would make no appreciable difference to the rate of aggregation.
Consequently, a lower aggregation rate persists until the first autocatalysis event
generates extra growth-competent ends and boosts the rate of aggregation. This
occurs at a random time in each replicate and illustrates how a single rare event
can have a profound affect on the growth curve.
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(a) One nucleus in V = 83×10−13 l.


























(b) One nucleus in V = 83×10−14 l.


























(c) One nucleus in V = 83×10−15 l.



























Mean of the kMC simulations
Mean-field prediction
(d) One nucleus in V = 83×10−16 l.


























Figure 3.6 Comparison of growth curves produced at different system volumes (V )
when self-assembly is "seeded" with a single filament (N(0) = 1/NAV )
at t = 0 and primary nucleation is disabled (kn = 0); where the common
parameter values were mtot = 10 µM, nc = 2, k+ = 5×104 M−1 s−1,
k− = 0, and kf = 3×10−8 s−1. Each plot shows 150 replicate growth
curves produced by kMC simulations of the fragmentation model for
amyloid fibril self-assembly, along with the mean-field prediction given
in equation 1.14, and the average of the replicates (obtained using the
method in §2.2).
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3.3.4 Concentration scaling: maximum aggregation rate
The equivalent growth curves for heterogeneous nucleation are not shown because
the effects are almost identical and do not add to the understanding of the
processes involved.
3.3.4 The scaling of maximum aggregation rate with total
protein concentration
For the autocatalysis model, the maximum aggregation rate kmax is predicted to
scale with the total protein concentration according to κ. This takes the form
of a power law: for fragmentation κ ∼ m1/2tot, while heterogeneous nucleation with
secondary nucleus size ns, predicts κ ∼ m (ns + 1)/2tot .
Figure 3.7 shows these predicted scaling behaviour, along with the kinetic Monte
Carlo simulation results for both the fragmentation and heterogeneous nucleation
models. While the trend is broadly the same, the simulations depart from the
prediction at higher total protein concentrations and more strongly in the case of
the heterogeneous nucleation model. This is likely to be caused by the simulations
containing fewer filaments than is predicted in the mean-field limit, which means
that the increase in monomer abundance does not result in the expected increase
in aggregation rate.
Also shown in figure 3.7a are the experimentally determined maximum aggrega-
tion rates for bovine insulin. The large difference between these and the prediction
at high protein concentrations appears to be caused by a similar limitation of the
number of filaments, and will form the subject of §6.
3.3.5 The scaling of lag time with total protein
concentration
For the autocatalysis model, the lag-time equation 1.22 makes the strong
prediction that the lag time will scale with total protein concentration according
to τlag ∼ m−γtot for γ = (ns + 1)/2, where ns is the secondary nucleus size. For
the fragmentation model where ns = 0, this gives γ = 1/2, whereas for the
heterogeneous nucleation model, γ = 3/2 when ns = 2.
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(a) The fragmentation model where k− = 0 and kf = 3×10−8 s−1.
0 2×10−4 4×10−4 6×10−4






















(b) The heterogeneous nucleation model where k− = 3×10−8 s−1,
kh = 24 M−1 s−1, and ns = 2.
0 2×10−4 4×10−4 6×10−4























kMC simulations where N(0) = 2.0×10−12 M
kMC simulations where kn = 3×10−7 M−1 s−1
Mean-field prediction
Figure 3.7 The scaling behaviour of kmax with mtot in (a) the fragmentation
model, and (b) the heterogeneous nucleation model, where the
common parameter values were nc = 2, k+ = 5×104 M−1 s−1,
and V = 83×10−14 l. Each kMC simulation point is the mean of
150 replicates with error bars indicating the standard deviation (method
in §2.2); the lines are to help differentiate the data sets. For comparison,
the experimental data for bovine insulin and mean-field prediction
(equation 1.19) for the value of κ specific to each mode, are also shown.
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3.3.5 Concentration scaling: lag time
(a) The fragmentation model where k− = 0 and kf = 3×10−8 s−1.
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Bovine insulin experiments (γ = 0.358(16))
kMC simulations where N(0) = 2.0×10−12 M (γ = 0.4262(14))
kMC simulations where kn = 3×10−7 M−1 s−1 (γ = 0.727(15))
(b) The heterogeneous nucleation model where k− = 3×10−8 s−1,
kh = 24 M−1 s−1, and ns = 2.
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Bovine insulin experiments (γ = 0.358(16))
kMC simulations where N(0) = 2.0×10−12 M (γ = 1.296(12))
kMC simulations where kn = 3×10−7 M−1 s−1 (γ = 1.426(5))
Figure 3.8 The scaling behaviour of τ3 with mtot in (a) the fragmentation
model, and (b) the heterogeneous nucleation model, where the
common parameter values were nc = 2, k+ = 5×104 M−1 s−1,
and V = 83×10−14 l. Each kMC simulation point is the mean of
150 replicates with error bars indicating the standard deviation (method
in §2.2). The experimental results for bovine insulin are shown for
comparison. Each line indicates the best fit of the power law τlag ∝ m−γtot
to the data set (method in §2.3.2).
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The lag times that I obtained from both autocatalytic models with and without
seeding, are shown in figure 3.8, along with the experimental data previously
shown in figure 1.8. As I mentioned in §3.2, the experimental data appears
well reproduced by the seeded fragmentation model, and the value of γ obtained
for these, and for the heterogeneous nucleation model also in the absence of
primary nucleation, agrees very well with the scaling behaviour predicted by
equation 1.22; i.e. γ = 1/2 for the fragmentation model, and γ = 3/2 for the
heterogeneous nucleation model for ns = 2.
However, primary nucleation clearly increases the scaling exponent of both au-
tocatalytic models. Moreover, the scaling of lag time with protein concentration
appears no longer to resemble a power law at low protein concentrations. The
origin of this departure, or "kink", in the lag-time scaling behaviour, and the
increased scaling exponent in the presence of primary nucleation, will be the
subject of §5. For now, however, it should simply be noted that stochastic
effects of the primary nucleation process causes a departure from the mean-field
predictions at early times.
3.3.6 Evolution of the filament length distribution
As I have shown, stochastic effects can have a considerable impact on the growth
curves, and so it is important to determine whether they also influence the
distribution of filament lengths.
The mean-field description of autocatalytic polymerisation (see §1.3.2) provides
predictions for the distribution of filament lengths at both the long-time steady
state, and at earlier times when the filament population is in equilibrium with
the free monomer population. Cohen et al. [13] predicted that the shape of these
length distributions, at both points in the kinetics, would be different in both
models due to the difference in the way that fragmentation and heterogeneous
nucleation generate new filaments (see §1.3.4).
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3.3.6 Evolution of the filament length distribution
In the fragmentation model, each monomer junction along the length of a
filament has an equal probability of breakage; thus, the total probability that
a given filament breaks increases as the filament becomes longer. Consequently,
under the action of fragmentation, the length distribution is expected to collapse
towards shorter filaments, and fragments containing fewer than nc monomers will
disintegrate into free monomer. In the long-time steady state, this results in
a narrow skew normal distribution with a peak close to nc. At earlier times,
while sufficient free monomer is available, this is prevented by the action of
elongation increasing the length of all filaments, resulting in a broader skew
normal distribution.
In the heterogeneous nucleation model, new filaments are produced with a fixed
length ns. These become longer through the action of elongation, and hence the
number produced also increases due to autocatalysis. As the new filaments grow,
so more are created by heterogeneous nucleation. This positive feedback results
in a Poisson distribution. However, once the monomer population is consumed by
elongation and heterogeneous nucleation, depolymerisation will gradually cause
the distribution to collapse into an exponential distribution in the long-time
steady state.
Using the kinetic Monte Carlo simulation data, I will now show that another,
distinct distribution exists at times between the dynamic equilibrium at early
times and the long-time steady state, for both models; this I shall refer to as the
"end-point" distribution. In the fragmentation model, these distributions scale
according to the ratio 2mtotk+/kf (4), and are otherwise independent of the rate
constants and total protein concentration. For this reason I have normalised the
filament lengths by the predicted mean (equation 1.25 with the appropriate κ for
the model), making it easier to compare between the two models.
Filament length distributions produced by the fragmentation model are shown in
figure 3.9 for the three indicated points in the kinetics. At early times and around
the point where the aggregation rate is maximal, the distributions produced by
the kinetic Monte Carlo simulation match the mean-field prediction described
above. The end-point exponential distribution depicted in figure 3.9d is not the
steady-state distribution, but is instead an intermediate state between the peaked
distribution at earlier times and the much narrower, peaked distribution at later
(4) The equivalent for the heterogeneous nucleation model is 2m1−nstot k+/kh.
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(d) End-point: once all monomer has
been incorporated into filaments.
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Figure 3.9 Average filament length distributions (b–d) at specific points on
the average growth curve (a) of replicate kMC simulations of the
fragmentation model, where the parameter values were mtot = 10 µM,
nc = 2, N(0) = 0, kn = 3×10−7 M−1 s−1, k+ = 5×104 M−1 s−1,
k− = 0, kf = 3×10−8 s−1, and V = 83×10−14 l. Filament lengths
have been normalised by the predicted mean filament length 2k+mtot/κ
(equation 1.25 with the appropriate κ for the model). Each distribution
represents the mean of 150 replicate simulations with error bars
indicating the standard deviation (determined using the method
in §2.2).
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times. This intermediate distribution emerges once the monomer population
has become depleted and the length distribution begins collapsing into the long-
time steady state. At this point, longer filaments break and are not replaced.
This leads to a rapid increase in the number of short filaments, producing
the exponential distribution seen in figure 3.9d. The shape of the early-time
and end-point distributions shown here will be important in §6 for interpreting
experimentally determined filament length distributions.
It should be noted that, in a histogram where the bins are for ranges of
filament lengths as opposed to individual filament lengths, it would be difficult
to distinguish between this exponential and the very narrow peaked distribution
of the long-time steady state, due to coarse-graining. However, the former is
notably broader than the latter.
The error bars on each distribution in figure 3.9 indicate that the variability
between replicate simulations is highest at early times and in the number of
short filaments in the end-point distribution. The higher variance at early times
is simply a result of fewer filaments being present, making fluctuations more
apparent. Similarly, the large variance in the number of short filaments present
in figure 3.9d is caused by variations in the time at which the last few monomers
are incorporated into filaments and hence the differing amount of time that
fragmentation has had to generate short filaments.
In a similar way, the variability at early times is evident for the heterogeneous
nucleation model in figure 3.10, although the variability is more uniform over
the distribution than it was for the fragmentation model. However, the end-
point distribution in figure 3.10d is clearly different from that produced by the
fragmentation model and is caused by the same monomer depletion effect as
was seen to affect the maximum aggregation rate in §3.3.2. At early times a
Poisson distribution emerges as predicted above. This persists while sufficient
free monomer is available for the creation of new filaments, but as it decreases
fewer filaments are formed. At later times, the decline in formation of new
filaments results in a peaked filament length distribution. This peak is expected
to disappear once distribution has relaxed under the action of depolymerisation.
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(d) End-point: once all monomer has
been incorporated into filaments.
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Figure 3.10 Average filament length distributions (b–d) at specific points on
the average growth curve (a) of replicate kMC simulations of
the heterogeneous nucleation model, where the parameter values
were mtot = 10 µM, N(0) = 0, nc = 2, kn = 3×10−7 M−1 s−1,
k+ = 5×104 M−1 s−1, k− = 3×10−8 s−1, kh = 24 M−1 s−1, ns = 2,
and V = 83×10−14 l. Filament lengths have been normalised by
the predicted mean filament length 2k+mtot/κ (equation 1.25 with the
appropriate κ for the model). Each distribution represents the mean
of 150 replicate simulations with error bars indicating the standard
deviation (determined using the method in §2.2).
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Thus, stochasticity does not have a significant effect on the distribution of
filament lengths, and the variability that is present in these distributions is
due to fluctuations when a small number of filaments is present. However, for
both models of autocatalysis I have identified an interesting intermediate length
distribution which could not have been predicted from the analytic solution.
3.4 Discussion
Both the mean-field analytic solution and kinetic Monte Carlo simulations have
their advantages and limitations when trying to understand the effects of various
mechanisms on the formation of amyloid fibrils. The mean-field description
allows the rate constants to be determined from experimental data, and provides
predictions of the steady states which the system is expected to adopt at various
points in the self-assembly process under the influence of particular mechanisms,
both of which I shall be using again in §7. Stochastic simulations, on the other
hand, are able to capture the effects of fluctuations which arise when the number
of filaments present in the system is small, thereby highlighting the importance
of rare events in individual mechanisms at specific points during the aggregation
process.
The effects of stochasticity were most pronounced in the lag phase where the
growth competent species are both short and few in number meaning fluctuations
in either length or population have a large impact. The major contribution to
this variability was the primary nucleation process, which also had an affect
on the scaling behaviour of the lag-time with total protein concentration. By
disabling this process and introducing a small concentration of preformed fibril
seed I showed that the average behaviour of the replicate growth curves better
matched the mean-field prediction; however, as I pointed out, some variability is
still produced by autocatalytic polymerisation. Hence, the lag-time distribution,
and the scaling of the lag time with total protein concentration, both need further
investigation; this, I will present in §4 and §5, respectively.
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A similar departure of the kinetic Monte Carlo simulation results, from the mean-
field prediction, was also seen for the maximum aggregation rate. While the
scaling trend was broadly reproduced it was apparent that at higher protein
concentrations the aggregation rate was not as high as expected. This, I stated,
was likely to be due to a lower number of filaments being present than theoretically
possible, thereby restricting the rate at which monomer could be incorporated
into filaments. If indeed caused by this, then the larger difference between the
experimental results and the prediction would indicate that even fewer filaments
are present. This observation, in conjunction with other experimentally measured
differences between high and low concentrations of bovine insulin, lead to the
formulation of a modified fragmentation model in which fragmentation is arrested




The effects of primary nucleation
and autocatalysis on the lag-time
distribution
4.1 Introduction
Primary nucleation is thought to be an inherently stochastic process and that
its fluctuations should be detectable as variability in the lag time of replicate
experiments [45, 48, 111]. Hence, accurate measurement of the lag-time variability
under different conditions could allow the primary nucleation process to be probed
and may also provide a way to identify other processes important during the lag
phase. However, care is needed in interpreting the experimental data: it has been
noted that the lag-time variability can be markedly reduced by careful selection
of the environmental conditions [74].
A distribution of τφM lag times for bovine insulin (from the growth curves in
figure 3.1) is shown in figure 4.1 for a threshold fraction of φM = 0.1. Similar
distributions are obtained for other protein concentrations, and values of φM in
the range 0.03 . φM ≤ 0.1.
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Figure 4.1 The distribution of lag times from the growth curves of 131 µM bovine
insulin (shown in figure 3.1), for the lag time defined as the point the
growth curve when 10% of the maximum fluorescence value is reached.
Similar shape distributions are found for other concentrations of bovine
insulin, and when the lag times are extracted by fitting the maximum
aggregation slope (see §2.3.2).
As I noted in §3, the kinetic Monte Carlo simulations displayed more variability
in the length of the lag phase than in any other aspect of the growth curve.
While this variability is substantially larger when primary nucleation is active
(i.e. kn > 0), considerable variability is still produced by autocatalysis. This is
apparent in figure 4.2, which compares the distribution of lag times produced by
the fragmentation model, both with and without primary nucleation.
When primary nucleation is active, the distribution of lag times becomes close
to exponential, while those produced by autocatalysis (in the absence of primary
nucleation) have a much narrower, peaked distribution. In this chapter, I will
show that the exponential-like distribution arises when primary nucleation is
treated as a single rare event (i.e. formation of the first primary nucleus), while
the peaked distribution emerges from the fact that the time at which the threshold
is reached depends on a sequence of processes with random waiting-times such
that — when the number of steps in this sequence is large — the distribution of
times to reach the threshold can be described by central limit theorem [89].
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4.1 INTRODUCTION
(a) With primary nucleation:


































Figure 4.2 The distribution of lag times from kMC simulation growth
curves of the fragmentation model (§3) when: (a) primary
nucleation is active, as in figure 3.4; or (b) self-assembly
is seeded, as in figure 3.6b. The common parameter val-
ues were mtot = 10 µM, nc = 2, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. Here, the lag time is defined
as the point in the growth curve when 10% of the total protein
concentration had been incorporated into filaments. Similar shape
distributions are found for other values of mtot, and when the lag times
are extracted by fitting the maximum aggregation slop (see §2.3.2).
Interestingly, the simulation lag-time distribution in figure 4.2b is similar in
appearance to the experimental distribution in figure 4.1; this is unexpected as
the experimental kinetics are widely thought to involve primary nucleation. This
observation suggests that fluctuations within the autocatalytic process may be
responsible for a significant proportion of the variability seen experimentally.
The time at which a threshold concentration of aggregated protein Mφ = φM mtot
is reached, can be thought of as a first passage problem. First passage problems
are widely studied in statistical physics in situations where one wishes to compute
the probability distribution for the time at which a stochastic process first reaches
a defined threshold. In some cases these can be solved analytically [89].
By considering autocatalytic polymerisation as a stochastic first passage problem,
I will explore the waiting-time distributions associated with a generic autocat-
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alytic feedback process in §4.3. First however, I will discuss the waiting-time dis-
tributions for sequential polymerisation-like processes, as these are relevant to the
early kinetics as well as the discrete formation of a nucleus when nucleation is not
treated simply as a single step process. To do this, I will use "minimal models"
that focus on specific mechanisms or combinations of mechanisms. While these
explicitly neglect the contribution of all other mechanisms thought to be involved
in amyloid fibril self-assembly, the simplification means that the models can (in
most cases) be solved analytically with fewer assumptions. From these results,
complex behaviour can be understood in terms of very simple interactions,
thereby providing a way to identify the key contributors to specific aspects of
the early-time kinetics.
4.2 Waiting-time distributions for sequential
polymerisation-like processes
In this section I will model the self-assembly of fibrils as a random walker moving
along a line, where rightward steps correspond to an increase in fibrillar protein
content, and leftward steps correspond to a decrease in fibrillar protein content.
The aggregate being described may be a single filament, or an ensemble where
I consider the combined total monomer content of all filaments and not the
individuals.
In the case where multiple aggregates compete, multiple random walkers will
be considered, each describing the length of an individual filament. The first of
these Ns competing aggregates to reach the threshold size will thus define the first
passage time. As an example, it is believed that in primary nucleation, multiple
aggregates fluctuate in size through reversible, polymerisation-like processes until
one reaches a size nc. Thus, some of the steps along the line may have different
rates; for example, when the rates are time dependent due to effects such as
monomer depletion, or in the case of an energy barrier to nucleation.
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4.2.1 Reversible polymerisation
Where possible, I will use the same parameter values as in other chapters, but it
should be noted that many of the example distributions given below tend toward
the central limit theorem prediction when the number of steps involved, the
monomer concentrations, or the rate constants become large. For computational
convenience (reduced run-time) I will use a small threshold, φM = 0.03.
A small value of φM also means that the monomer population at the first passage
time will be close to its starting value, and so I can neglect monomer consumption
during the derivation of the analytic expressions for waiting-time distributions
throughout this section; thus, most of the analytic expressions that I present
here can be expected to only give accurate results for waiting-time distributions
when φM . 0.1.
4.2.1 Waiting times to reach an aggregation threshold by
reversible polymerisation
First, I will focus on the distribution of times taken to reach the threshold quantity
of aggregated protein Mφ when started from a preformed nucleus of size nc where
the only processes involved are polymerisation and depolymersiation. A first
passage time problem of this kind can be solved analytically, for the moments
of the probability distribution, using the one-dimensional discrete Fokker-Plank
equation [28], which is used to describe problems where a single particle is moving
on a one-dimensional lattice under the actions of diffusion and drift.
The one-dimensional lattice has two boundary conditions: a reflecting boundary
at a = nc, which prevents the possibility of the fibril disappearing; and an
absorbing boundary at b = MφNAV , which is the end point where aggregation
has reached the threshold. The position of the walker, representing the length
of the filament, can be changed by both addition and loss of monomers. This
gives a diffusion constant D = λ+ + λ−, where λ+ = 2k+mtot ≈ 2k+m(t) is the
elongation propensity and λ− = 2k− is the depolymerisation propensity. Since
filaments on average tend to grow over time, it will be assumed that λ+  λ−.
This bias toward growth can be described as drift, with rate ω = λ+ − λ−. Thus,
the walker describing the fibril’s length starts at lattice site a and performs a
biased random walk until it reaches b.
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Using the approach outlined in §A1 [28], the first two moments of the first passage
probability distribution were found to be





































































As the shape of the distribution cannot be calculated analytically, I will assume
that the waiting times follow a Gaussian distribution defined by these two
moments; this Gaussian approximation is shown in figure 4.3 together with
kinetic Monte Carlo simulation results for reversible polymerisation, for different
rates of depolymerisation. For the parameters used, this approximation appears
reasonable, producing very similar shaped distributions to the simulation results.
The increased distribution width when the depolymerisation rate is higher is the
result of an increase in the number, and the variability in the number, of steps
(both polymerisation and depolymerisation) necessary to reach the threshold.
Similarly, the shift of the distribution, indicating a longer mean waiting-time,
is also the result of the increased number of steps when the depolymerisation
rate is higher. Both of these can be understood by examining how the diffusion
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for k− = 0.01 s−1
for k− = 0.1 s−1
for k− = 0.2 s−1
Figure 4.3 Theoretical probability distributions of waiting times for a single
filament to reach a threshold length by reversible polymerisation,
for different depolymerisation rates, k−; the common parameter
values were mtot = 10 µM, nc = 2, kn = 0, k+ = 5×104 M−1 s−1,
and V = 83×10−16 l. The histograms contain waiting times from
1000 replicate kMC simulations, and the dashed lines are Gaussian
approximations for the theoretical predictions of the mean and variance,
given by equations 4.1 and 4.2, respectively.
constant D and drift constant ω change in opposition to one another with the
depolymerisation rate.
The slight offset of the mean of the theoretical prediction with respect to the
simulation data is a consequence of monomer depletion, which has been neglected
in deriving equations 4.1 and 4.2 but does affect the simulations. Hence, for
a higher depolymerisation rate and increased number (and variability in the
number) of steps, this offset becomes larger.
Depolymerisation is often neglected when dealing with amyloid fibril forma-
tion [55, 81, 82]. This is typically because the rate of depolymerisation is
vanishingly small compared to other processes until the number of filament
ends becomes large and the monomer population has been depleted; conditions
associated with later times. At early times however, the monomer population will
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be high, and elongation and primary nucleation will be much more significant
than depolymerisation. Therefore, for the rest of this chapter I will neglect
depolymerisation, and instead focus on elongation and nucleation events which I
will model using random walks with no backward stepping.
4.2.2 The Erlang distribution: waiting times to reach the kth
Poisson event
The waiting-time distribution for a sequence of k Poisson events, each with
individual rate λ, is given by the Erlang distribution
P (τ ; k, λ) =
λ(λτ)k−1e−λτ
(k − 1)! (4.3)
The mean and variance of this peaked distribution are defined through the
relations k/λ and k/λ2, respectively [89].
Below, I will show how this is useful for modelling rapid primary nucleation and
later for polymerisation with and without slow primary nucleation (§4.2.4).
No nucleation barrier
If primary nucleation is rapid (i.e. there is no appreciable nucleation barrier)
and treated as a single-step process (i.e. kn ≈ k+), then the number of growth-
competent ends will be very high. This will reduce the free monomer population
available for elongation and result in a large number of short filaments.
Consequently, the major contribution to reaching Mφ will come from nucleation,
and not elongation which can be neglected. This is not a particularly realistic
picture for fibril formation but I have included it for the sake of completeness.
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for V = 8.3×10−16 l
for V = 8.3×10−17 l
Figure 4.4 Theoretical probability distributions of waiting times for rapid primary
nucleation to incorporate a threshold fraction of the total protein con-
centration into filaments, for different system volumes, V ; the common
parameter values were mtot = 10 µM, nc = 2, kn = 5×104 M−1 s−1,
k+ = 0, and k− = 0. The histograms contain waiting times from
1000 replicate kMC simulations, and the dashed lines are the
theoretical prediction by equation 4.3.
Assuming that only primary nucleation contributes toward Mφ, then the
number of nuclei required is k = NAVMφ/nc, with rate λ = η/N(0) = NAV knm
nc
tot/nc!,
where N(0)/η is the rate of primary nucleation given in §3.3.3 assuming a constant
monomer concentration m(t) ≈ mtot. Figure 4.4 shows the distributions obtained
for waiting times derived from both equation 4.3 and kinetic Monte Carlo
simulations, for different values of V . The widths of these distributions depend
inversely on both V and mtot because fluctuations in the number of steps involved
are greater for a smaller number of particles, while the mean only depends on mtot.
The slight discrepancy between the predicted and simulated distributions is due
to monomer depletion effects, but the data are otherwise well described by the
Erlang distribution.
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4.2.3 Competition between aggregates: the formation of the
first primary nucleus
I now consider the case where primary nucleation is very slow. Here, the formation
of the first primary nucleus can be described as a competition between multiple
growing aggregates, each smaller than the nucleus size nc. The first of these to
reach the critical size nc will then typically dominate the subsequent growth. I
will treat this competition as a number of parallel one-dimensional random walks,
each with an Erlang distribution of first passage times.
In order to obtain a closed analytic expression for the distribution of waiting
times for the first of these Erlang processes to reach Mφ, the number of competing
processes Ns, must be known in advance. From a simulation point of view, Ns can
be fixed by defining "special" monomers which are known in advance to initiate
the formation of a nucleus, even though the time at which each does so, is not
known. It will be assumed that the Ns "special" monomers are indistinguishable
from any other monomer in all ways except that they cannot join to one another;
hence, each will only contribute to M(0) once it has formed an aggregate of the
minimal stable size nc (so that m(0) = mtot).
Initially I will treat these Ns "special" monomers as completely non-interacting.
This is not strictly true since they compete with one another through the
monomer population, but that case is a modification of the following.
A non-interacting race
Given Ns non-interacting elongation-like processes of the kind defined above, the
probability distribution for each to be the first to reach the critical length Mφ at
time τ is given by









4.2.3 Competing to be the first primary nucleus
where F (t; k, λ) is the Erlang probability distribution given by equation 4.3, and
the parameters k and λ have the same meaning as in §4.2.4. The distribution
of waiting times for the first out of all Ns aggregates to reach the threshold, can
thus be obtained by multiplying equation 4.4 by Ns:








Although equation 4.5 describes the outcome of a competition to form the first
primary nucleus, I will deliberately define the number of steps k = MφNAV − nc
in terms of nc
(1) and Mφ
(2), and the rate λ = 2k+mtot ≈ 2k+m(t) at which these
steps occur in terms of the elongation rate k+, so as to illustrate the distributions
produced by this model in a way that can be directly compared with the other
results in this chapter.
Equation 4.5 and the distribution of waiting times obtained from kinetic Monte
Carlo simulations are shown in figure 4.5 for different system sizes and values
of Ns. When Ns is small, the number of steps required to reach the threshold
is much smaller than the number of monomers per aggregate (k  mtot/N(0)),
and equation 4.5 agrees well with simulation. However, as Ns is increased, the
fibrils interact via the free monomer pool, causing the approximation m(t) ≈ mtot
to break down such that agreement between equation 4.5 completely fails
once k ≈ mtot/N(0). Fortunately it is simple to account for the rate of monomer
consumption, as I will now demonstrate.
Time dependent propensity: accounting for monomer depletion
The time dependence of m(t) can be accounted for by re-deriving the Erlang
distribution with λ = λ(t), and then reintegrating equation 4.4 (shown in §A2).
This introduces the integral Λ(τ) =
∫ τ
0
λ(t)dt in place of λτ in equation 4.3. The
waiting-time distribution for each of the Ns competing aggregates is then given
by
P (τ ; k, λ(τ)) =
λ(τ)(Λ(τ))k−1e−Λ(τ)
(k − 1)! (4.6)
(1) The starting size of each of the Ns aggregates in this example is larger than a single
monomer; hence these contribute to the aggregated monomer count.
(2) Rather than a fixed aggregate size, this is a fraction of the total protein concentration.
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for 1 filament in V = 8.3×10−15 l
for 10 competing filaments in V = 8.3×10−15 l
for 1 filament in V = 4.2×10−15 l
for 10 competing filaments in V = 4.2×10−15 l
Figure 4.5 Theoretical probability distributions of waiting times for the first of Ns
competing filaments to incorporate a threshold fraction of the total
protein concentration into itself, for different numbers of competing
filaments, and system volumes, V ; the common parameter values were
mtot = 1 µM, nc = 2, kn = 0, k+ = 5×104 M−1 s−1 and k− = 0. The
histograms contain waiting times from 1000 replicate kMC simulations,
and the dashed lines are the theoretical prediction by equation 4.5.
from which the waiting-time distribution for the first aggregate to reach the
critical size can be obtained:













Since the number of growth competent aggregates N(t) is constant in this
model (3) and the monomer concentration is conversed (mtot = m(t) +M(t)),
(3) In the absence of autocatalysis and primary nucleaiton, this is fixed by the number of
"special" monomers.
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where N(0) = Ns/NAV and NA is Avogadro’s constant. Again I have assumed
that the Ns "special" monomers that are present at the start do not contribute
to M(0) (so that m(0) = mtot). However, the assumption that mtot  N(0), on
which this is based, is certainly valid because primary nucleation has already
been defined as a rare occurrence.
As demonstrated in figure 4.6, equation 4.7 is in much better agreement with the
simulation data than was equation 4.5. However, equation 4.7 still fails when
the number of steps required is greater than the average amount of monomer per
aggregate, k & mtot
N(0)
. This condition is outwith the scope of this solution because
they assume a higher rate of primary nucleation, producing a larger number of
competing nuclei, in which case there would be a non-zero probability that none
of the fibrils reach Mφ because competition is too high and the total monomer
population is too small to be shared among the number of aggregates; i.e. the
monomer pool is used up in the subcritical aggregates. That said, fluctuations in
length caused by depolymerisation could eventually lead to one of them reaching
the threshold, but the associated waiting-time distribution for such events is
expected to be very broad due to the number of steps involved.
This example is also not strictly for primary nucleation but is a type of first-
past-the-post process. If equation 4.7 were used to describe primary nucleation
more realistically, k would be a constant, independent of V and mtot (something
like k = nc − 1, for example). Conversely, λ would still depend on the number of
competing proto-nuclei and hence V , and thus the variance in the waiting-time
distribution can be expected to scale far more strongly with the system size than
is evident in figure 4.6; i.e. the distribution would reach the deterministic limit
more rapidly than is apparent in the figure.
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for 1 filament in V = 8.3×10−15 l
for 10 competing filaments in V = 8.3×10−15 l
for 1 filament in V = 4.2×10−15 l
for 10 competing filaments in V = 4.2×10−15 l
Figure 4.6 Theoretical probability distributions of waiting times for the first of Ns
competing filaments to incorporate a threshold fraction of the total
protein concentration into itself with a time dependent rate, for the
same parameter values as used in figure 4.5. The histograms contain
waiting times from 1000 replicate kMC simulations and are identical to
those in figure 4.5, and the dashed lines are the theoretical prediction
by equation 4.7, where Λ(τ) = mtotN(0)
(
1− e−2k+N(0)τ).
4.2.4 Waiting times for the combined contribution from
multiple polymerisation processes
In the case of amyloid fibril formation, it is commonly thought that the elongation
of a number of filaments collectively contribute to reaching the threshold Mφ.
These could be formed through primary nucleation or autocatalysis, but for
simplicity I will first consider seeded self-assembly where a fixed number of
filaments Ns = N(0)NAV is present throughout, and the only active process is
filament elongation.
The waiting times for this elongation model are again be described by the Erlang
distribution (in §4.2.2), where the number of steps required for these seeds to
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collectively reach the threshold is k = MφNAV −Nsnc (4), and the stepping
rate λ = 2Nsk+mtot ≈ 2Nsk+m(t) (5), is given by the propensity in reaction 1.8
















for 1 filament in V = 8.3×10−16 l
for 10 competing filaments in V = 8.3×10−15 l
Figure 4.7 Theoretical probability distributions of waiting times for Ns filaments
to accrete a threshold fraction of the total protein concentration,
collectively, for different numbers filaments, and system volumes, V ;
the common parameter values were mtot = 1 µM, nc = 2, kn = 0,
k+ = 5×104 M−1 s−1 and k− = 0. The histograms contain waiting
times from 1000 replicate kMC simulations, and the dashed lines are
the theoretical prediction by equation 4.3.
Figure 4.7 shows waiting-time distributions for two different system volumes V ,
containing the same concentration of seeds N(0). These distributions were
obtained from kinetic Monte Carlo simulations only involving monomer addition,
and the theoretical prediction from equation 4.3. From the definitions in §4.2.2,
the width of these distributions are determined by V and mtot, and the mean
by mtot. However, Ns also plays an important role in both the mean and variance
because it affects the amount of material already present at t = 0 and the rate
at which new material is polymerised. Thus, although the concentration of seeds
is the same, the waiting-time distribution in a larger volume becomes narrower
because the higher rate of accretion of monomers produces a shorter waiting-time
(4) Here, the seeds contribute towards the threshold.
(5) Assuming an approximately constant monomer concentration at early times.
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between steps, and fewer monomers per seed filament are needed in order for the
threshold to be reached.
The distributions in figure 4.7 are expected in the case where polymerisation is
the sole contribution to the lag time. However, primary nucleation was seen to
dramatically alter the lag-time distribution in the kinetic Monte Carlo simulations
(figure 4.2). It is therefore also important to consider the effects of primary
nucleation on the lag-time distribution.
A single rate-limiting step: the effects of primary nucleation
When incorporating primary nucleation into the polymerisation model presented
above, it is necessary to treat the process as a single slow step; in difference to
previously treating it as a sequence of steps. This is because the first passage
time for the sequence of steps only has a closed form solution when at most
one step in the sequence has a different rate. For this slow step, I will use the
same propensity as given in §4.2.2 (i.e. α = η/N(0)) and assume that the step
produces Ns = N(0)NAV = 1 nucleus (6).
Using the approach described in §A2 — which is a variation of the derivation of
the Erlang distribution used above — I obtain the waiting-time distribution for
polymerisation:








where a single slow step occurs somewhere (unspecified) in the sequence. The
term 1− Γ(k, (λ− α)τ)/Γ(k) in the brackets is the cumulative distribution function
for the gamma distribution (7).
(6) While I only consider the case where a single nucleus is present, this expression is valid
for Ns ≥ 1.
(7) The gamma distribution is a generalised form of the Erlang for which k may be non-integer.
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for kn = 0.003 M−1 s−1 and V = 8.3×10−15 l
for kn = 10−3 M−1 s−1 and V = 8.3×10−15 l
for kn = 0.003 M−1 s−1 and V = 4.2×10−15 l
Figure 4.8 Theoretical probability distributions of waiting times for Ns filaments,
created by primary nucleation, to accrete a threshold fraction of the
total protein concentration, collectively, for different primary nucleation
rates, kn, and system volumes, V ; the common parameter values
were mtot = 1 µM, nc = 2, k+ = 5×104 M−1 s−1 and k− = 0. The
histograms contain waiting times from 1000 replicate kMC simulations,
and the dashed lines are the theoretical prediction by equation 4.8.
When α λ, the slow step (representing primary nucleus formation) dominates
the waiting-time distribution, resulting in an exponential distribution of lag times
with an offset as illustrated in figure 4.8 for different nucleation rates. This
distribution has the same shape as the waiting-time distribution of the slow step
itself, indicating that the waiting time is being almost entirely determined by the
single slow step. The offset is produced by the fact that there is a minimum time
taken by the elongation steps in order to reach Mφ, once the primary nucleus has
formed. For higher values of α, the distribution rapidly tends towards the shape
seen in figure 4.7 (i.e. without a slow step). Thus, rare primary nucleation can
dominate the lag time, but at higher primary nucleation rates the lag time due to
this one step can become negligible compared to the large number of elongation
steps. Both of these cases can be shown by series expansion of equation 4.8: the
former in the limit α/λ→ 0, the latter in the limit α ≈ λ.
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4.2.5 Implications for the autocatalysis simulations
(a) With primary nucleation:


































Figure 4.9 The distribution of lag times from kMC simulation growth curves of
the fragmentation model (previously shown in figure 4.2) when: (a)
primary nucleation is active, as in figure 4.2a; or (b) self-assembly is
seeded, as in figure 4.2b.
The model for amyloid fibril formation that best describes bovine insulin requires
primary nucleation, elongation and at least one of either fragmentation or
heterogeneous nucleation. In the above models I have ignored both of the
autocatalysis mechanisms and focused only on primary nucleation and elongation.
Hence, the analytic expressions that I derived are not be able to quantitatively
describe the distributions in figure 4.9, which were produced by kinetic Monte
Carlo simulations involving filament fragmentation. However, even in these it
is evident that primary nucleation can dominate the lag time and result in an
exponential distribution similar to the one given above for polymerisation with a
single slow step (figure 4.8).
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4.3 Waiting-time distributions for autocatalytic
polymerisation
Autocatalysis will accelerate aggregation by providing additional growth-competent
filament ends. Compared to nucleation-dependent polymerisation, this will
reduce the mean time to reach the aggregation threshold but it is not obvious what
effect it will have on the waiting-time distribution. In order to obtain a closed
form, analytic expression for the lag-time distribution produced by autocatalytic
polymerisation, equations 1.12 and 1.13, which respectively describe the change
in the number of filaments and concentration of fibrillar protein at time t, need to
be greatly simplified. This can be achieved by considering a new "coarse-grained"
model containing only two reactions — one increasing the quantity of protein in
filaments in proportion to the current number of ends (due to elongation), and
the other increase in the number of ends in proportion to the current quantity
of protein in filaments (due to autocatalysis) — and comparing the closed form,
analytic solution obtained for this model with kinetic Monte Carlo simulations of
this simplified model and the original model.
4.3.1 The waiting-time distribution for a simplified
autocatalytic polymerisation model
As in §4.2, I will neglect the effects of monomer depletion, which are expected
to be small during the lag phase. With this assumption, the reactions describing
elongation and the autocatalytic formation of new filaments can be simplified:
M Nµ−−→M+ 1 (4.9)
N Mν−−→ N + 1 (4.10)
These describe the increase in the number of filamentsN and their total monomer
contentM using the same feedback principle as contained in reaction 1.8 and 1.10,
but with time independent general rate constants ν and µ, respectively (8).
(8) The rates ν and µ can be related to the fragmentation and elongation propensities thus:
ν = kf and µ = 2mtotk+.
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Figure 4.10 Growth curves produced by kMC simulations of the simplified,
general autocatalytic polymerisation model described by reactions 4.9
and 4.10, where the parameter values were N0 = 1, M0 = 2,
µ = 1 s−1, ν = 3×10−8 s−1. These 10, 000 replicate growth curves
are only shown up to φM = 0.5, since the model is only valid at
"early times".
In the absence of monomer depletion, both N andM are free to grow indefinitely
from their initial values N0 and M0. Growth curves from kinetic Monte Carlo
simulation of this simplified, coupled growth model are shown in figure 4.10. In
these simulations the monomer population is not depleted and so aggregation is
only shown up to φM = 0.5. These growth curves strongly resemble the early time
portion of the growth curves for the full simulation presented in §3 for both the
fragmentation and heterogeneous nucleation model, suggesting that this simple
model is a realistic approximation for the early time behaviour of those models.
An analytic solution to a pair of simple coupled growth processes
An analytic expression describing the distribution of lag times for the growth
curves in figure 4.10 was obtained by my collaborator Juraj Szavitz-Nossan. As
the full derivation is not particularly illuminating to the results, I will only present
a brief description here (9).
(9) A more detailed derivation can be found in §A3.
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4.3.1 Simplified autocatalytic polymerisation
Using only reactions 4.9 and 4.10 (10), a general master equation for coupled
growth can be written thus:
dPN ,M
dt
=MνPN−1,M +NµPN ,M−1 − (Mν −Nµ)PN ,M (4.11)
This can be solved using Van Kampen’s system size expansion technique
with the small parameter 1/v = 1/NAV [59, 105], to obtain the probability
distribution PN ,M(t) of finding a specific number of filaments with a specific total
monomer content at time t. From this, the waiting-time distribution to reach Mφ
can be obtained in terms of the more familiar number concentration N(t) = N (t)/v
and fibrillar protein concentration M(t) = M(t)/v:
L(t) =










where F (t) (given in §A3) is a function describing the coupled exponential growth
process, and F ′ is its time derivative.
In the limit of large volume (i.e. where the Van Kampen approximation becomes
exact), equation 4.12 can be approximated by a Gaussian distribution, giving an



















This expression depends on the initial conditions M(0) and N(0), as well as the
rate parameters µ and ν, all of which are independent of the system size. On the
other hand, the variance of this Gaussian approximation scales inversely with the





Comparison of the simplified and full simulations, and analytic predication
Figure 4.11 shows the lag-time distributions obtained from kinetic Monte Carlo
simulations of the full and simplified autocatalytic polymerisation models along
(10) I will ignore primary nucleation and depolymerisation in this simplified model.
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kMC simulations of the full fragmentation model
kMC simulations of the simplified model
Theoretical prediction
Figure 4.11 The theoretical probability distribution of lag times for autocatalytic
polymerisation. The histograms contain lag times from replicate
kMC simulations of the fragmentation model (previously shown in
figure 4.9b), and simplified model (extracted from the replicate growth
curves in figure 4.10); and the curved line is the theoretical prediction
given by equation 4.12. The parameter values for the fragmentation
model were mtot = 10 µM, nc = 2, N(0) = 2×10−12 M, kn = 0,
k+ = 5×104 M−1 s−1,k−, kf = 3×10−8 s−1, and V = 83×10−14 l,
from which N0, M0, µ, and ν were derived.
with the prediction from equation 4.12. The level of agreement between the
distributions produced by both kinetic Monte Carlo simulations is encouraging,
and implies that the simplified model is able to capture a reasonable amount of
the early time behaviour of the full system.
The coarse-grained simulation only considers a simplified form of the fragmen-
tation mechanism: fragmentation should be proportional to the number of
monomer-monomer bonds (M(t)−N(t)) in all filaments and not the number
of monomers (M(t)) as I have assumed in the simple model. This will have
resulted in an overestimate of the fragmentation probability. Additionally,
monomer depletion was explicitly ignored in the coarse-grained simulations.
These factors are probably responsible for the broader distribution produced by
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the full simulation, as they both increase the number of steps necessary to reach
the threshold; although their influence does not appear to be particularly large.
Equation 4.12 is also in reasonable agreement with the distribution produced
by the simplified simulation but predicts a slightly lower mean lag-time. This
indicates that the simulation either involves more steps than the model accounts
for, or that each of these steps has a fractionally longer mean waiting-time than
expected. The former could be caused by a discrepancy in the monomer count
needed to reach φM , between the discrete simulation and continuum analytic
solution. The latter, more likely explanation, is that monomer depletion is causing
the rate of elongation to vary with time.
While this distribution successfully explains the lag-time distribution of the full
kinetic Monte Carlo simulations, it does not provide an adequate explanation for
the experimental lag-time distribution. From equation 4.14 it can be seen that
the width of the lag-time distribution scales inversely with the system volume:
predicting variance of the order of milliseconds for the volume of 100 µl (i.e. the
volume used in the experimental results shown). This is clearly many order of
magnitude smaller than the variability apparent in the experimental data and
hence, autocatalysis alone cannot fully account for the experimental lag-time
distribution. For this reason I will now discuss the effect that primary nucleation
has on these predictions.
4.3.2 The effect of primary nucleation on the waiting-time
distributions of an autocatalytic polymerisation model
When the rate of primary nucleation is much lower than that of autocatalysis, the
time between consecutive nucleation events will be long, and only the first nucleus
produced will be important to the kinetics: once this first nucleus is formed, the
kinetics will be dominated by autocatalytic polymerisation such that all other
nucleation events can be neglected. From this it can be seen that the total
waiting-time can be accounted for simply by adding an appropriately distributed
random time (representing the time at which the nucleus forms) to the waiting
time for autocatalytic polymerisation, where the initial conditions for the later
process are given by the primary nucleation event.
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As in the simulations, I will assume that the formation of a primary nucleus has







where the primary nucleation rate is given by η/N(0) (defined in §3.3.3), N(0) is
the concentration of nuclei produced and r is a random number drawn from the
uniform distribution in the interval (0, 1]. For the formation of a single nucleus,
the concentration of nuclei N(0) = 1/(NAV ) is dependent on system volume,
making it more likely that a nucleus forms in a larger volume where the number
of monomers is correspondingly higher. This also defines the "initial conditions"
for autocatalysis, M(0) = ncN(0) at t0.
(a) When V = 83×10−14 l,
















(b) When V = 83×10−12 l,
i.e. N(0) = 2×10−14 M at t = 0.
















Figure 4.12 The distribution of lag times from kMC simulation growth curves of
the simplified, general autocatalytic polymerisation model described
by reactions 4.9 and 4.10, for two system volumes, V , where
the first primary nucleation event is included as a start time t0,
randomly sampled using equation 4.15 for the seed concentrations,
N(0). The common parameter values were mtot = 10 µM, nc = 2,
k+ = 5×104 M−1 s−1, k− = 0, and kf = 3×10−8 s−1. These
distributions each contain lag times for 10, 000 replicate growth curves,
where the lag time is defined as the point in the growth curve
when 10% of the total protein concentration had been incorporated
into filaments.
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4.3.2 Inclusion of primary nucleation
This method was used to produce the lag-time distributions shown in figure 4.12;
combining the nucleation waiting time t0 defined above, with the simulation
results shown previously in figure 4.11.
From figure 4.12a it can be seen that, for the same volume and value of N(0)
as used in figure 4.11, the first primary nucleation event dominates the lag-time
distribution. This agrees very well with the lag-time distribution produced by
the full kinetic Monte Carlo simulation in which primary nucleation was active,
indicating that primary nucleation was indeed responsible for the shape of that
distribution (figure 4.2a).
Conversely, for a larger volume (shown in figure 4.12b) primary nucleation has
a higher probability, and thus t0 is small compared to the waiting time for
autocatalysis. This case qualitatively recovers the peaked distribution of lag
times produced by the full simulation of seeded autocatalytic polymerisation
(figure 4.11): the higher mean lag-time and reduced variance in figure 4.12b
is due to the larger volume, corresponding to a lower concentration of nuclei (as
discussed in §3.3.3) and larger number of monomers than was present in the full
simulation. Hence, in this case the lag time is dominated by autocatalysis, with
primary nucleation only contributing to the value of the mean.
Since the lag-time distribution in figure 4.12b is dominated by autocatalytic
polymerisation, its variance is likely to be described by equation 4.14, with only a
minor contribution from primary nucleation. Thus, for a volume comparable with
that used in the experimental results shown (i.e. 100 µl), the variability will still
be vanishingly small, as will the contribution from the first primary nucleation
event. Hence, this model shows that the experimentally observed lag-time
variability cannot be accounted for by nucleated, autocatalytic polymerisation
either.
As an aside, the above analysis only considered the possibility that a single nucleus
forms. For a larger volume, however, it can be seen from equation 4.15 that
the waiting time for the first nucleus will become vanishingly small, and thus it
is possible that more than one nucleus will form within a short space of time
(very early in the lag phase). If this is approximated by the "simultaneous"
formation of a fixed concentration of nuclei (i.e. that N(0) can be considered
volume independent), then the same analysis can be repeated but without the
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volume dependence in equation 4.15. Doing this, reveals that under these
conditions primary nucleation will always dominate the lag time, producing a
distribution similar to that shown in figure 4.12a. Hence, while this does produce
a distribution with variability that does not decrease with system volume, the
shape of the distribution does not match that of the experimental lag times shown
in figure 4.1, again indicating that primary nucleation cannot be the prominent
contribution to the lag phase.
4.4 Discussion
An understanding of the mechanisms responsible for the early stages of amyloid
fibril self-assembly is of particular importance as control of these mechanisms
presents the best opportunity to initiate or prevent this type of aggregation.
Unfortunately, the early stages of self-assembly are also the hardest to probe
experimentally and for this reason mechanisms involved at early times are often
inferred from the behaviour of the kinetics at later times.
Variability in the lag time of replicate experimental growth curves has been
thought to indicate fluctuations in the primary nucleation process [45, 48, 111]
and thus provide insight into these early-time mechanisms. The analytic results of
the minimal models that I presented in this chapter, predict that the fluctuations
in the processes of primary nucleation and autocatalytic polymerisation scale
inversely with system volume and become negligible at a volume comparable
with typical experiments; hence, neither primary nucleation nor autocatalytic
polymerisation, in the forms that I have investigated, can account for the
variability in lag times observed experimentally.
Moreover, in almost all of the situations where primary nucleation constituted a
slow step to self-assembly, the lag-time distributions were completely dominated
by the waiting time for this one rare event. This resulted in a shifted exponential
lag-time distribution — where the shift was caused by other, subsequent processes
such as polymerisation or autocatalysis — with a very different appearance to
the peaked distributions observed experimentally [45]. Thus, further indicating
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that a single rare event is unlikely to be responsible for the lag-time distributions
seen experimentally (11).
That said, I have only considered the formation of a primary nucleus by
polymerisation or as a single-step process, and neglected depolymerisation
in all but one case. Depolymerisation is often neglected, when seeking an
analytic solutions, by assuming that the abundance of free monomer favours
polymerisation at early times [6, 14, 15, 24, 55, 81, 82, 106]. However, given that
this process is seen to actually increase the variability with increasing volume, it
could be crucial at early times [12]. If short filaments are less stable and have
a much higher depolymerisation rate than longer filaments, then the effects of
depolymerisation are expected to be more apparent when filaments are short
and few in number. Thus, I expect depolymerisation to have an important
effect if taken into account in primary nucleus formation, or in the fragmentation
model (12).
Amyloid fibril self-assembly is notorious sensitive to the environmental conditions
and it has been suggested by Hellstrand et al. [43] that multiple factors may con-
tribute to the variability observed experimentally [43, 111]. Indeed, on their own,
the experimentally determined lag-time distributions (broad and approximately
Gaussian) may provide very little information about the mechanisms, as this
shape would be expected (from central limit theorem) for any sufficiently long
sequence of random events; i.e. the sum of many steps, each with randomly
distributed waiting-times. However, these distributions can be expected to
scale with the system volume and so a better understanding of the mechanisms
responsible for the variability might be found by comparing lag-time distributions
for different volumes. A method by which this could be achieved has already been
demonstrated by Knowles et al. [56] for the mean lag-time.
Finally, the effect that the system volume has on the waiting time, poses an
interesting question about the comparison between laboratory experiments and
those conducted in a volume comparable with a biological cell. The cellular
environment typically contains a far higher protein concentration than is used
experimentally, and in a much smaller and more crowded environment. Under
(11) Primary nucleation’s dominance during the lag phase will become important in the next
chapter where I explore the scaling of the mean lag-time with total protein concentration.
(12) It has been shown elsewhere that short filaments can have a different probability of
breaking [44, 47].
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such conditions aggregation might be expected to occur more readily and a
number of studies do appear to show this [65, 76, 116]. However, while those
studies used higher concentrations and "crowding agents" to simulate the cellular
environment, they were still conducted in volumes of the order of ∼ µl: under
these conditions, my findings indicate that the probability of primary nucleation is
expected to be very high. Hence, the aggregation propensity of proteins studied
in vitro might be significantly lower in vivo, and caution should be exercised




The effects of primary nucleation on
the scaling behaviour of the lag
time with total protein
concentration
5.1 Introduction
Most experiments on amyloid fibrils under typical laboratory conditions involve
protein concentrations of the order of µM and volumes in the range ml– µl.
These conditions mean that the system will contain a very large number of protein
molecules and thus can be considered to be in the deterministic limit. However,
volumes much closer to the cellular scale (of the order 10−10 l) have also been
investigated [56]. At these scales, Knowles et al. [56] reported an increase in lag
time with decreasing volume and speculated that this was due to a decrease in
the probability of primary nucleation.
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kMC simulations where kn = 3×10−7 M−1 s−1 (γ = 0.727(15))
kMC simulations where N(0) = 2.0×10−12 M (γ = 0.4262(14))
Figure 5.1 The scaling behaviour of τ3 with mtot in kMC simulations of the frag-
mentation model, when self-assembly either includes primary nucleation
(with rate kn) or is seeded (with N(0) preformed filaments); where the
common parameter values were nc = 2, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. Each kMC simulation point
is the mean of 150 replicates with error bars indicating the standard
deviation (method in §2.2); and the lines indicate the best fit of the
power law τlag ∝ m−γtot to the data set (method in §2.3.2).
Using kinetic Monte Carlo simulations, I demonstrated in §3 and §4 that primary
nucleation has a profound effect on the lag time and that this can be influenced
by system size, either by affecting the waiting-time distribution for the nucleation
event, or by changing the concentration of nuclei produced, or both. Simulation
results for the lag-time scaling behaviour (discussed in §3) are shown again in
figure 5.1: for the simulations where primary nucleation is active, it is apparent
that the scaling behaviour deviates from the predicted power law at low protein
concentration; i.e. at low protein concentrations, the lag times do not lie on a
straight line on this log-log plot.





5.2 EFFECTS OF PRIMARY NUCLEATION ON γ
is expected to describe the way that the lag-time scales with total protein
concentration, where different models predict different values of the exponent γ,
and A is an arbitrary scale factor independent of mtot. Predictions for the
exponent can be found by examining the protein concentration dependence of
the characteristic time scale of the model at hand as follows.
The nucleation-dependent polymerisation model with characteristic time scale
δ−1 = (2k+knmnctot/nc!)−
1/2 predicts an exponent γ = nc/2 ≥ 1 for nuclei of size nc ≥ 2,
as was seen in §1.3.1. In a similar way, the lag-time expressions for the
autocatalytic models presented in §1.3.3 all depend on the characteristic time
scale κ−1. This characteristic time scale is different for the two autocatalytic
mechanisms presented: for the heterogeneous nucleation model γ = (ns + 1)/2 for a
secondary nucleus size ns ≥ 1, while for the fragmentation model γ = 1/2. These
can both be expressed as γ = (ns + 1)/2 where fragmentation has an effective
secondary nucleus size of zero.
The fragmentation model is particularly important as it may explain the con-
centration scaling behaviour of a number of experimental systems, including the
bovine insulin data presented earlier, which show scaling exponent values γ < 1.
However, to obtain the analytic predictions for the scaling relations in the
fragmentation and heterogeneous nucleation models, Cohen et al. [15] assumed
that κ δ. In order to understand the results in figure 5.1 and determine how
the scaling exponent changes with primary nucleation rate kn, I will now explore
the consequences of relaxing this assumption.
5.2 The influence of the primary nucleation rate
on the lag-time scaling exponent in the
fragmentation model
I extracted lag times (according to the method in §2.3.2) from kinetic Monte Carlo
simulation growth curves of both fragmentation and heterogeneous nucleation
models, produced (as described in §3) for a range of primary nucleation rates
and total protein concentrations. The lag times from the fragmentation model
are shown in figure 5.2 as a function of total protein concentration, for primary
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kMC simulations where kn = 10−10 M−1 s−1
kMC simulations where kn = 1 M−1 s−1
Figure 5.2 The scaling behaviour of τ3 with mtot in kMC simulations of
the fragmentation model (described in §3), for different primary
nucleation rates in the range kn = 10−15 M−1 s−1 to kn = 1 M−1 s−1,
incremented by factors of 100; where the common parameter
values were N(0) = 0, nc = 2, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. Each kMC simulation point
is the mean of 150 replicates with error bars indicating the standard
deviation (method in §2.2), and the lines are to help differentiate the
data sets. The triangles illustrate specific scaling exponents and the
arrows are to indicate the position of a "kink" where the gradient of
the line changes.
nucleation rates in the range 10−10 ≤ kn ≤ 1 M−1 s−1 (1), with nc = 2; the data
for the heterogeneous nucleation model will be discussed later in §5.3.
From figure 5.2 it is evident that the primary nucleation rate kn indeed affects
the scaling behaviour and that the lag times for which γ < 1 appear sandwiched
between two other regimes where γ ≥ 1, as indicated by the triangles in figure 5.2.
This contour plot also shows the "kink" hinted at in figure 5.1, where the scaling
behaviour changes with changing protein concentration for a fixed value of kn, and
that the position of this kink is different for different primary nucleation rates.
(1) The units for the primary nucleation rate should be M−(nc−1) s−1, unless nc is defined.
In this chapter I look at cases where nc = 2, 4, and 8.
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Another, less prominent kink can also be seen at higher protein concentrations
for some primary nucleation rates, but was not apparent in figure 5.1.
Since values of γ must be obtained by fitting the power law equation 5.1 to data
over a range of protein concentrations, the changes in gradient of the data for
constant kn shown in figure 5.2, will influence the value obtained for a given value
of kn. The effect which changing the range of protein concentrations has on the
value of γ obtained, will be discussed later in §5.2.4, but for now, I will only use
lag times produced in the range of protein concentrations shown in figure 5.2.
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Mean-field prediction including primary nucleation
Figure 5.3 Theoretical predictions of the lag-time scaling exponent for different
primary nucleation rates. The values of γ were determined by fitting
lag times for total protein concentrations in the range 10–750 µM, to
the expression τlag ∝ m−γtot , where the lag times were obtained from:
the mean τ3 of 150 replicate growth curves of kMC simulations of the
fragmentation model, with error bars indicating the confidence in the
fitted value (i.e. the lag-time variance was not considered in the fit);
and evaluation of the mean-field equation 5.2, the simplified mean-field
equation 5.3, and the modified mean-field equation 5.4. The common
parameter values were N(0) = 0, nc = 2, k+ = 5×104 M−1 s−1,
k− = 0, kf = 3×10−8 s−1, and V = 83×10−14 l.
Using the method presented in §2.3.2, I obtained values of the scaling exponent γ
from kinetic Monte Carlo simulations over a range of primary nucleation rates
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(shown as black points in figure 5.3). These encompass a larger range of values
of kn than were shown in figure 5.2, so as to completely cover the transition
behaviour that I discuss below. It should be noted that the scaling exponent
of these simulation data is always higher than the mean-field prediction for the
fragmentation model (i.e. γ > 1/2); indeed it reaches a surprisingly large value
(γ = 2) when the rate of primary nucleation is low and autocatalysis is expected
to dominate. In order to understand this, the predictions for γ made by the
various mean-field models outlined in §1.3.4, need to be examined in more detail.
5.2.1 Analytic predictions for the lag-time scaling exponent
Equation 1.20, which I presented previously in §1.3.4, describes the lag time to
reach a threshold fraction of aggregate Mφ for a general model of autocatalytic










where D = δ2/κ2 and Φ = ln(1− φM).
A simpler form of this expression was also presented in equation 1.21, which is









In order to obtain γ from these lag-time expressions for an arbitrary value of kn,
it is necessary to use the same process as for the simulation data above, of fitting
to multiple lag times generated over a rage of protein concentrations. This is
because mtot appears in multiple places throughout each of these expressions, in
conjunction with both autocatalysis and primary nucleation (through κ and δ,
respectively). By altering the primary nucleation rate, the relative contribution
of these terms will change, affecting the concentration dependence of the entire
expression. Only in limiting cases is it possible to obtain the values of γ from
these expressions analytically, as I will show later in §5.2.1.
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The dashed line in figure 5.3 was produced from the lag times generated by the
simplified expression (equation 5.3). This line does come close to the predicted
value of γ = 1/2 when the primary nucleation rate is very low, but the equation
fails when the rate becomes too high. This is unsurprising, as the expression
was obtained from the more complicated equation 5.2 by assuming δ  κ, and
it is this assumption which fails when kn & 10−5 M−1 s−1. Hence, the lag times
produced by equation 5.2 (shown as a solid red line in figure 5.3) agree with the
simplified expression when the rate of primary nucleation is low, and are also able
to accurately describe the simulation data when the rate of primary nucleation
is high. It does not, however, reproduce the scaling behaviour apparent in the
kinetic Monte Carlo simulation data when the rate of primary nucleation is low;
the reason for this will be explained below.
Two regimes in which primary nucleation dominates the lag time
At a high rate of primary nucleation the kinetics are expected to be described
by the nucleation-dependent polymerisation model where the scaling exponent
is predicted to be γ = nc/2 for nc ≥ 2 (see §1.3.1). This is indeed the case in
figure 5.3, and is the reason for the higher scaling exponent value, seen in the
data in the lower half of figure 5.2. The value of kn where γ starts to decrease
from γ = 1, is where the propensities of autocatalysis and primary nucleation
are comparable. The conditions for this transition will be described in the next
section.
The strong deviation of the γ values produced by the kinetic Monte Carlo
simulations, from those predicted by equation 5.2 for the fragmentation model —
as evident on the left hand side of figure 5.3 — can be understood by considering
the competition between primary nucleation and autocatalytic polymerisation
when the rate of primary nucleation is low. If δ  κ, then autocatalytic
polymerisation is expected to out-compete primary nucleation and dominate the
kinetics. However, autocatalytic polymerisation cannot operate until the first
primary nucleus has formed (as described previously in §4). Consequently the
formation of the first primary nucleus is critical to all subsequent autocatalytic
polymerisation. As I have already stated, primary nucleation is slow in this
regime, so its contribution to the lag time can be treated independently from
that of autocatalytic polymerisation. To do this I use a similar argument to the
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one in §4.3; here, I first consider the time taken to form the first nucleus, and
then separately the lag time for seeded autocatalytic polymerisation with a seed
concentration N(0) as determined by the first nucleation event.
As in §4, every primary nucleation event can be treated as a Poisson process
with rate η/N(0), where η = knm
nc
tot/nc! is the propensity given in reaction 1.6
and N(0) = M(0)/nc = 1/NAV is the number concentration of nuclei produced per
volume V . From this, the mean waiting-time τPoisson = N(0)/η can be obtained;
i.e. the mean-field behaviour of primary nucleation (2). Provided ncN(0) < Mφ
then the waiting time for the first nucleation event can simply be added to that
of autocatalytic polymerisation (equation 1.20), to give a complete mean-field














where D = δ2/κ2 and Φ = − log(1− φM) as before, and the logarithms are base e.
Since η = δ2/2k+, equation 5.4 predicts that when δ  κ, necessarily τφM  τPoisson,
and the concentration scaling will be dominated by τPoisson, giving γ = nc. Once
the rate of primary nucleation becomes high enough, τPoisson becomes negligible
compared to τφM , even if only a single primary nucleus is formed, and the scaling
changes to that of autocatalytic polymerisation. The solid blue line in figure 5.3
shows the prediction of equation 5.4, which describes the kinetic Monte Carlo
simulation data extremely well over the entire range of primary nucleation rates.
Thus, the picture which emerges from the simulations is one in which primary
nucleation dominates the lag-time scaling of the fragmentation model when the
rate at which it occurs is either very low or very high. Lag times produced by
equation 5.4 for different primary nucleation rates are shown in figure 5.4, along
with the simulation data from figure 5.2. This plot makes a clear prediction
for experiments: if lag times are obtained over a wide enough range of protein
concentrations, these will not be described by a single power-law, but rather
exhibit a number of transitions between power-laws, each with a different value of
the scaling exponent. The transitions between these different scaling exponents
(2) A missing mean-field description of primary nucleation was also the cause of the
discrepancy between the average of the simulation growth curves and the mean-field
prediction, in figures 3.4 and 3.5 (§3.3.2).
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Theoretical prediction when kn = 10−20 M−1 s−1
Theoretical prediction when kn = 1014 M−1 s−1
Figure 5.4 Theoretical prediction of equation 5.4, for the scaling behaviour of τφM
with mtot in the fragmentation model, with different primary nucleation
rates in the range kn = 10−20 M−1 s−1 to kn = 1014 M−1 s−1,
incremented by factors of 100; where the common parameter
values were N(0) = 0, nc = 2, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. Also shown are the kMC
simulation data from figure 5.2. The triangles illustrate specific scaling
exponents.
will manifest as kinks when the lag times are plotted as a function of protein
concentration, as in figure 5.4, and are caused by a change in the mechanism
dominating the lag phase (either of the two primary nucleation regimes, or that
of autocatalytic polymerisation).
The conditions for the transitions between the regime dominated by autocatalysis
and either of those dominated by primary nucleation can be obtained analytically
by inspecting limiting cases of equation 5.4, as I will now show.
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Conditions for the transitions between autocatalysis dominated and
primary-nucleation dominated lag-time scaling regimes
When kn is large, primary nucleation dominates the kinetics and the first term in
equation 5.4 can be neglected. This allows a series expansion in O(ΦD−1) of the








which recovers the observed scaling γ = nc/2. The condition D  Φ can thus be
used to obtain the value of kn > Φkfm
1−nc
tot nc! necessary for primary nucleation to
dominate the lag phase. For values of kn smaller than this, either autocatalytic
polymerisation or slow primary nucleation will dominate the lag time, as I now
show.
When kn is small, the first term in equation 5.4 becomes large and the dominant
















/δ2 in this expression scale differently
with kn, with important consequence for the lag-time scaling.
As kn → 0, D will vanish faster than the rate at which log (Φ−1D)→ −∞ (3).
Because of this, the second term in equation 5.6 vanishes, recovering γ = nc;
i.e. primary nucleation-dominated lag-time scaling.
When the primary nucleation rate is not quite so low, but still in the limit de-
scribed by equation 5.6, the first term in the equation vanishes, recovering γ = 1/2
as predicted by the autocatalysis model for fragmentation. This is conditional on
the primary nucleation rate being





(3) This can be shown from the definition limx→0 x log(x) = 0.
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where k∗n is the value of the nucleation rate at the transition and is given by the
















The value of k∗n needs to be extracted from equation 5.7 numerically, but
even without doing so it can be seen from the above condition on kn that





primary nucleation will always dominate the lag time and there
will be no regime in which γ = 1/2 is found. This is indeed seen in figure 5.4, where
the two transition kinks have merged when the rate of primary nucleation is high.
In summary, the transitions between the different scaling behaviours are defined
by:





when rapid primary nucleation domi-
nates the entire growth curve;
(5.8a)





when autocatalysis dominates the entire
growth curve (including the lag-time);
and
(5.8b)
kn ≤ k∗n when slow primary nucleation dominates
the lag time, but autocatalysis domi-
nates the subsequent growth;
(5.8c)
where k∗n is given by the solution to equation 5.7.
5.2.2 How the system volume alters the scaling behaviour
observed
The results that I have presented so far, have been obtained for a volume
of V = 0.83 pl. I will now show how changing this volume affects those
results, and in particular how it alters the region of parameter space for which
autocatalysis dominates the lag time.
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Since equation 5.2 was obtained from the mean-field expression 1.14, the only
volume dependence in equation 5.4 comes from the term for the first primary
nucleation event, for which the waiting-time scales inversely with the system
volume V in which the single nucleus forms. In larger volumes with the same
protein concentration, the probability of nucleation will be higher, and the
mean waiting-time to the first primary nucleation event, shorter. Consequently,
changing V will only affect the region of parameter space in which self-assembly
is dominated by the slow formation of the first primary nucleus.
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Theoretical prediction when kn = 10−28 M−1 s−1
Theoretical prediction when kn = 1014 M−1 s−1
Figure 5.5 Theoretical prediction of equation 5.4, for the scaling behaviour of τφM
with mtot in the fragmentation model, with different primary nucleation
rates in the range kn = 10−28 M−1 s−1 to kn = 1014 M−1 s−1,
incremented by factors of 100; where the common parameter
values were N(0) = 0, nc = 2, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−6 l (larger than in figure 5.4). The
triangles illustrate specific scaling exponents.
Lag times predicted by equation 5.4 for a volume 108 times larger than in
figure 5.2, are shown in figure 5.5 (4). In this, the three different scaling regimes
are now more distinct, with the upper right portion dominated by slow nucleation,
and the lower left by fast nucleation.
(4) Here, V = 83 µl is closer to a typical, in vitro experimental volume.
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5.2.3 Effect of the primary nucleus size on γ
The larger volume has decreased the range of values of kn over which slow
nucleation dominants the lag phase, and thus extended the crossover region
where γ = 1/2 is now evident. This can be understood from equation 5.7, which
states that when a small concentration of filaments is produced by the first
nucleation step, the value of k∗n will also be small and thus increase the range of
values of kn for which condition 5.8b, holds. Thus, increasing the volume extends
the range of total protein concentrations for which autocatalytic polymerisation
(γ = 1/2) is dominant. This is interesting because it suggests that γ = 1/2 scaling
may be more prominent in laboratory experiments, which are typically performed
in large volumes, than in situations where the volume is comparable to that of a
biological cell.
5.2.3 The influence of primary nucleus size
In both of the regions where primary nucleation dominates the lag time (i.e. high
and low nucleation rates), the primary nucleus size nc affects γ by altering the
concentration dependence of the primary nucleation rate. Figure 5.6 shows that,
by increasing nc, the curves for γ as a function of kn, shift towards higher kn
while (qualitatively) maintaining their shape. Additionally, the range of kn for
which γ is a minimum becomes narrower as nc increases: with increased nc,
k∗n becomes larger and the first primary nucleation event dominates the lag time
for a broader range of kn values. However, it would be extremely difficult to use
this to determine nc with any confidence, without examining the scaling behaviour
of a wide range of protein concentrations.
5.2.4 How the choice of protein concentrations can influence
which scaling behaviour is found
From the contour plots in figures 5.4 and 5.5 it is easy to see that, at different
protein concentrations, different values of kn are required in order to obtain
the same value of γ; i.e. to obtain γ = 1/2 at high protein concentrations, the
primary nucleation rate needs to be lower than it would be for a lower protein
concentration.
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(a) Theoretical predictions when
V = 0.83 pl.
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Theoretical prediction when nc = 2
Theoretical prediction when nc = 4
Theoretical prediction when nc = 8
(b) Theoretical predictions when
V = 83 µl.
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Figure 5.6 Theoretical prediction of equation 5.4, for the lag-time scaling exponent
at different primary nucleation rates, for three sizes of primary nucleus,
nc, if the system volume is (a) the same as in figure 5.4, and (b) the
same as in figure 5.5. The values of γ were determined by fitting lag
times for total protein concentrations in the range 10–750 µM, to the
expression τlag ∝ m−γtot . The common parameter values were N(0) = 0,
k+ = 5×104 M−1 s−1, k− = 0, and kf = 3×10−8 s−1.
The total protein concentration affects equation 5.4 by altering both η and δ, but
also appears in κ. This means that the relative contribution of autocatalysis —
compared to that of primary nucleation — is affected. Hence, both the range
and value of concentrations over which the lag time is measured will affect the
scaling behaviour seen for a specific primary nucleation rate. This dependence of
the scaling behaviour on the protein concentration range is currently not widely
recognized in the literature. Since the lag-time scaling exponent is often used to
identify the mechanisms responsible for amyloid fibril self-assembly, this could
lead to incorrect assumptions about the mechanisms involved.
To illustrate this effect, the values of γ obtained from the contours in figure 5.4
for two distinct ranges of total protein concentration are shown in figure 5.7. I
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5.2.4 Effects of protein concentration range on γ
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Theoretical prediction when mtot is in the range 10–750 µM
Theoretical prediction when mtot is in the range 1–75 mM
Figure 5.7 Theoretical prediction of equation 5.4, for the lag-time scaling exponent
at different primary nucleation rates, when a different range of
total protein concentrations is used to determine γ: the values of
γ were determined by fitting lag times for the two total protein
concentrations ranges, to the expression τlag ∝ m−γtot . The common
parameter values were N(0) = 0, nc = 2, k+ = 5×104 M−1 s−1,
k− = 0, kf = 3×10−8 s−1, and V = 83×10−14 l.
elected to use the smaller volume to illustrate this because of the way that at
lower total protein concentrations, the two kinks merge. Figure 5.7 demonstrates
that by choosing a particular range of protein concentrations, the value of kn for
which the transitions between primary nucleation dominated and autocatalytic
dominated lag times are observed, will shift, and the minimum value of γ may
also change.
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5.3 The influence of the primary nucleation rate
on lag-time scaling exponent in the
heterogeneous nucleation model
Thus far in this chapter, I have only discussed the modified lag-time expression
(equation 5.4) in terms of the fragmentation model. However, this model is com-
pletely generalisable and can be easily extended to described the heterogeneous
nucleation model as well; to do this I simply use the appropriate definition of κ
(equation 1.18 from §1.3.3).
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Theoretical prediction when kn = 10−20 M−1 s−1
Theoretical prediction when kn = 1014 M−1 s−1
Figure 5.8 Theoretical prediction of equation 5.4, for the scaling behaviour
of τ3 with mtot in the heterogeneous nucleation model, with
different primary nucleation rates in the range kn = 10−28 M−1 s−1
to kn = 1014 M−1 s−1, incremented by factors of 100; where the com-
mon parameter values were N(0) = 0, nc = 2, k+ = 5×104 M−1 s−1,
k− = 3×10−8 s−1, kh = 24 M−1 s−1, ns = 2, and V = 83×10−14 l.
The triangles illustrate specific scaling exponents.
Figure 5.8 shows the lag times predicted by equation 5.4 if this deffition for κ is
used; i.e. the heterogeneous nucleation with a secondary nucleus size ns = nc = 2.
These can be directly compared with figure 5.4, since both plots are the same in
all regards except the method of autocatalysis.
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5.3 THE HETEROGENEOUS NUCLEATION MODEL
The scaling exponent predicted for the heterogeneous nucleation-dominated
model is γ = (ns + 1)/2, and can indeed be seen in figure 5.8 at higher protein
concentrations. For the value of ns used, this γ value lies between those produced
by the two primary nucleation dominated regimes (5) unlike in the fragmentation
model where it was lower than the exponent of either primary nucleation-
dominated regime (6).
Interestingly, in the fragmentation model, the scaling exponent of γ = 1/2 is
transient; at low protein concentrations the lag time is dominated by slow primary
nucleation, whereas at high protein concentrations it is dominated by rapid
primary nucleation, with the regime dominated by fragmentation sandwiched
between these. This is not the case for the heterogeneous nucleation model
when ns = nc because, at high protein concentrations, the autocatalytic formation
of filaments will occur more rapidly than primary nucleation. The effect can be
seen better in figure 5.9, where a larger system volume has been used; once again,
a larger system volume increases the range of total protein concentrations over
which a γ value indicative of autocatalysis can be found.
The condition ns = nc, however, is a special case: when nc ≥ ns + 1, a sufficiently
high primary nucleation rate will always dominate the lag time, regardless of
the protein concentration; whereas, when 2nc ≤ ns + 1, a sufficiently low rate
of primary nucleation will always dominate the lag time, also regardless of the
protein concentration. This can be understood analytically from conditions 5.8a,
b, and c, by substituting the appropriate κ, and also graphically from the
convergence of the lines of constant kn in figures 5.8.
(5) The scaling exponent for lag times produced by the heterogeneous nucleation with ns = 2,
is γ = 3/2, which lies between γ = 2 and γ = 1 for the slow and rapid primary nucleation
regimes with nc = 2, respectively.
(6) The scaling exponent for lag times produced by the fragmentation model is γ = 1/2, which
is less than both γ = 2 and γ = 1 for the slow and rapid primary nucleation regimes
with nc = 2, respectively.
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Theoretical prediction when kn = 10−28 M−1 s−1
Theoretical prediction when kn = 1014 M−1 s−1
Figure 5.9 Theoretical prediction of equation 5.4, for the scaling behaviour
of τ3 with mtot in the heterogeneous nucleation model, with
different primary nucleation rates in the range kn = 10−28 M−1 s−1
to kn = 1014 M−1 s−1, incremented by factors of 100; where the com-
mon parameter values were N(0) = 0, nc = 2, k+ = 5×104 M−1 s−1,
k− = 3×10−8 s−1, kh = 24 M−1 s−1, ns = 2, and V = 83×10−6 l
(larger than in figure 5.8). The triangles illustrate specific scaling
exponents.
5.4 Discussion
The models for primary nucleation and autocatalysis predict different scaling
behaviour of the lag time with total protein concentration, and this has been used
as a means to identify which of the processes controls the kinetics [17]. However,
the scaling behaviours predicted by some models may be indistinguishable when
considered independently from other aspects of the kinetics [63]. Moreover, there
may be scenarios in which the scaling behaviour is actually ambiguous as I will
now discuss.
In this chapter I presented simulations and theoretical analysis which predict
that, if measured over a wide range of protine concentrations, plots of lag time as
a function of protein concentration should show "kinks" where there is a change
in the mechanism dominating the lag phase. Such kinks have not previously
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been discussed in the literature but lag-time data has been published which may
indicate their presence [43, 87, 110, 111]. In other cases, the kinks may occur at
protein concentrations that are not accessible experimentally, which means that
the scaling behaviour will remain the same over all concentrations considered.
However, if only a narrow range of protein concentrations is examined, these kinks
could be missed, or dismissed as fluctuations in the data, which could explain why
they have not been reported previously. Consequently, fitting a single power law
to lag-time data taken from a too narrow a range of protein concentrations can
result in an incorrect value of the scaling exponent by unwitting inclusion of part
of one or both transitions.
Moreover, I demonstrated that under certain conditions the scaling behaviour
predicted by autocatalysis cannot be seen at all, even though autocatalytic
mechanisms are present in the model. At low primary nucleation rates or low
protein concentrations, the waiting time to the formation of the first filament is
significantly longer than the time scales of the rest of the kinetics, resulting in
lag times dominated by primary nucleation even though the growth curves are
otherwise dominated by autocatalysis (as demonstrated in figures 3.4 and 3.5).
Consequently, the absence of lag-time scaling behaviour predicted by mechanisms
such as autocatalysis over the range of protein concentrations examined does
not necessarily mean that the kinetics are not otherwise dominated by these
mechanisms. Therefore, I would advise examining as wide a range of protein
concentrations as is experimentally feasible before attempting to extract a scaling
exponent.
Curiously, the scaling exponent for bovine insulin (7) is lower than the minimum
value predicted by the autocatalysis model (i.e. less than γ = 1/2 for the
fragmentation model). Moreover, scaling exponents of this kind (i.e. γ < 1/2)
have been consistently reported in the literature [18, 27, 53, 55, 74, 83, 94, 117],
and even more may be evident if kinks are present as I speculated earlier [43, 87,
110, 111]. These lower values of the scaling exponent cannot be explained by the
models that I have discussed here, and may represent another, as yet unknown,
aggregation process with yet another scaling behaviour.
(7) The lag times for bovine insulin were given in figure 1.8.
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As seen in the previous chapter, the system size again determines which process
will dominate the lag phase and hence the conditions under which scaling
behaviour indicative of autocatalysis can be observed. At very small volumes
and low protein concentrations, only the primary nucleation dominated scaling
behaviours will be observed. This is because the average waiting-time for the first
primary nucleus is much longer than the lag-phase defined by autocatalysis alone
when the rate of primary nucleation is low (see §4). This implies that even in the
crowded cellular environment, the confinement of necessarily high concentrations
of protein into small volumes may help prevent the initial stages of aggregation,
thereby greatly increasing pathogenic latency of hereditary amyloidosis [56]. Such
effects are likely to be missed by most laboratory experiments which utilise much
larger volumes [11, 65, 76, 108, 116]. Hence, caution should be exercised when
drawing comparison between these experiments and in vivo behaviour [100], since








The general autocatalytic polymerisation model presented in §1.3.2 predicts that




However, the maximum aggregation rates of the bovine insulin growth curves in
figure 3.1 appear to only match this prediction at low protein concentrations, and
only for the fragmentation model (when κ =
√
2k+kfmtot)
(1). This can be seen
from figure 6.1.
(1) The fragmentation model predicts kmax ∝ m1/2tot, while the heterogeneous nucleation model
predicts kmax ∝ m3/2tot with a secondary nucleus size of ns = 2.
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Theoretical prediction for fragmentation
Theoretical prediction for heterogeneous nucleation when ns = 2
Figure 6.1 The scaling behaviour of kmax with mtot in bovine insulin
experiments, compared with the theoretical predictions (mean-field
equation 6.1) of the fragmentation (with kf = 3×10−8 s−1) and
heterogeneous nucleation (where kh = 24 M−1 s−1 and ns2) models,
where k+ = 5×104 M−1 s−1 is common to both. Each point represents
the mean maximum aggregation rate of between 140 and 200 replicate
experiments at a particular concentration with error bars indicating the
standard deviation. The arrow indicates the critical fibril concentration
(CFC), which will be the focus of this chapter. These were extracted
from growth curves using the method described in §2.3.2.
For the fragmentation model, while there is good agreement at low protein con-
centrations, the maximum aggregation rate for the experimental data saturates
and possibly even decreases at higher protein concentrations. This effect cannot
be explained by the experimental data having reached the diffusion limit, as the
elongation rate constant k+ = 5×104 M−1 s−1 is far lower than the theoretical
diffusion limit for a molecule of the size of bovine insulin; moreover, with an
increased availability of monomers at higher protein concentrations, one would
expect a reduction in the average time between consecutive encounters of a
filament end a free monomer, not an increase.
Interestingly, the addition of salt (NaCl) to the experimental samples changes this
behaviour as shown in figure 6.2. At the lowest salt concentration the maximum
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Bovine insulin experiments with 0 M NaCl
Bovine insulin experiments with 0.1 M NaCl
Bovine insulin experiments with 0.24 M NaCl
Bovine insulin experiments with 0.34 M NaCl
Bovine insulin experiments with 0.49 M NaCl
Figure 6.2 The scaling behaviour of kmax with mtot in bovine insulin experiments
when self-assembly occurs in the presence of different concentrations
of NaCl salt. Each point represents the mean maximum aggregation
rate of between 140 and 200 replicate experiments at a particular
concentration with error bars indicating the standard deviation; the lines
are to help differentiate the data sets. These maximum aggregation
rates were extracted from growth curves using the method described
in §2.3.2.
aggregation rate increases dramatically but the saturation behaviour is preserved.
Higher concentrations of salt give a lower maximum aggregation rate, and the
trend eventually inverts once the salt concentration exceeds ∼ 0.4 M; i.e. for very
high salt concentrations, the maximum aggregation rate decreases with increasing
salt.
The lag times are also affected by the addition of salt but in a different way, as
shown in figure 6.3. Here the scaling exponent γ (discussed in §5) decreases in the
presence of a small concentration of salt but then increases with further addition
of salt. This drop in the average lag-time is simply linked to the increase in
maximum aggregation rate. As these effects are linked, both can be understood
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Bovine insulin experiments with 0 M NaCl (γ = 0.358(16))
Bovine insulin experiments with 0.1 M NaCl (γ = 0.277(13))
Bovine insulin experiments with 0.24 M NaCl (γ = 0.56(5))
Bovine insulin experiments with 0.34 M NaCl (γ = 0.65(4))
Bovine insulin experiments with 0.49 M NaCl (γ = 0.75(6))
Figure 6.3 The scaling behaviour of τ3 with mtot in bovine insulin experiments
when self-assembly occurs in the presence of different concentrations
of NaCl salt. Each point represents the mean lag-time of between 140
and 200 replicate experiments at a particular concentration with error
bars indicating the standard deviation; the lines are the best fit of the
power law τlag ∝ m−γtot to each data set. These lag times were extracted
from growth curves using the method described in §2.3.2.
by examining the filament length distributions in the absence of salt at both low
and high protein concentration.
During most of the aggregation process, the fragmentation model is predicted
to produce a broad, skew normal filament length distribution containing both
long and short filaments. Upon completion of aggregation, this is expected
to collapse into a narrow distribution containing a large number of very short
filaments (see §1.3.2 and §3.3.6).
The filament length distributions obtained from TEM images of bovine insulin
fibrils at low and high protein concentrations are shown in figures 6.4 and 6.5,
respectively. These appear quite distinct from one another: the length distribu-
tion obtained at a low protein concentration can indeed be described as a narrow
distribution, with a peak close to zero (i.e. most fibrils are very short); by contrast,
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(a) Fibril length distribution.
















(b) Example TEM image with a 1 µm
scale bar.
Figure 6.4 Experimental fibril length distribution (a), and an example of the
transmission electron microscope images from which the length
distribution was obtained (b), for mtot = 35 µM bovine insulin without
salt.
(a) Fibril length distribution.















(b) Example TEM image with a 0.5 µm
scale bar.
Figure 6.5 Experimental fibril length distribution (a), and an example of the
transmission electron microscope images from which the length
distribution was obtained (b), for mtot = 700 µM bovine insulin
without salt.
113
CHAPTER 6. ARRESTING FRAGMENTATION
the length distribution obtained at a high protein concentration is much broader
and clearly peaked at much longer filament lengths.
While the predicted length distribution for the fragmentation model matches the
experimental data at low protein concentrations, at high protein concentrations
they fail to describe both the long-time steady state length distribution and
the maximum aggregation rate. Interestingly, however, the shape of the length
distribution found experimentally at high protein concentrations does match the
length distribution predicted by the fragmentation model at earlier times; i.e. a
broad skew normal distribution, as described in §3.3.6. This observation will play
a key part in the development of a model that can explain the experimental data,
as I demonstrate later in this chapter.
The total protein concentration at which the maximum aggregation rate stops
increasing, appears to be the same concentration at which the length distribution
in the long-time limit changes shape. This value (140 µM insulin) also coincides
with reported changes in the viscosity of the sample, and its circular dichroism
(CD) spectrum, after aggregation has completed, suggesting a difference in the
morphology of the fibrils [74]. The coincidence of an apparent morphological dif-
ferences in the fibrils, and difference in the kinetics and fibril length distributions,
all point to mechanistic changes that prevent the maximum aggregation rate
from increasing beyond a certain value and prevent the length distribution from
relaxing to the expected shape in the long-time limit. This change in the protein
aggregation mechanism is likely to be linked to changes in the fibril structure.
In the fragmentation model, the two factors that affect the maximum aggregation
rate, apart from total protein concentration, are the elongation and fragmentation
rates. The shape of the experimental length distributions at the end-point,
suggest that fragmentation is being suppressed at higher protein concentrations,
as this would prevent the length distribution from collapsing. In the case where
no salt was added, such a reduction in the fragmentation rate must happen late
enough in the kinetics that it does not affect the lag time, but early enough
so as to affect the maximum aggregation rate and before monomer depletion
effects result in the collapse of the length distribution. Conversely, for higher salt
concentrations the suppression of fragmentation must be earlier, since in this case
an effect on the lag-time scaling is also observed.
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An ad hoc way to satisfy these constraints in the model is to decrease the value
of the fragmentation rate constant when a threshold concentration of fibrillar
protein, or number of fibrils, has formed. This is motivated by the experimental
observation that viscosity increases at higher protein concentrations, indicating
the possibility that a gel network has formed which might stabilise the fibrils
against breakage. The CD spectra also indicate changes in the fibril structure
which might imply lateral fibril association (2), or "bundling", which has been
observed to occur in bovine insulin [49] and could be expected to stabilise fibrils
against breakage. Both of these effects would require a sufficient density of fibrils,
but it is not obvious whether this pertains to the number of fibrils, or their total
protein content.
Using the same kinetic Monte Carlo simulation approach as in §3, I will now
explore the consequences of suppressing fragmentation: first by assuming that
this happens at a critical concentration of fibrillar protein (CFCM), and then
later see how the effect changes for a critical number of fibrils (CFCN).
6.2 A critical fibrillar protein concentration
transition
In order to suppress fragmentation when the fibrillar protein concentration
reaches a critical value, I first need to determine that value (the CFCM) from the
experimental data. Obviously, reducing the rate of fragmentation will only affect
the maximum aggregation rate (in the way seen in figure 6.1), if the change occurs
before the maximum aggregation rate has been reached; this point is typically
close to M = 0.5mtot in both the experimental and simulated growth curves.
From figure 6.1, the maximum aggregation rate departs from the prediction when
the total protein concentration is around mtot = 140 µM. Hence, this must be
approximately double the value of the CFCM in order for the effect to be observed
at the appropriate point. For this reason I shall use CFCM = 70 µM throughout
this chapter unless otherwise specified.
(2) I use the term lateral association to differentiate this from filament end-joining seen in the
next chapter.
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0 CFCM














Figure 6.6 The fragmentation rate at different concentrations of fibrillar pro-
tein M(t), when treated as a step transition. The fragmentation rate kf
changes abruptly once M(t) = CFCM, from k0f when M(t) < CFCM,
to k∗f when M(t) ≥ CFCM.
My first approximation for a transition in the rate of fragmentation will take
the form of a step function as shown in figure 6.6. This illustrates how
the fragmentation rate depends on the fibrillar protein concentration M(t).





f below the CFCM, where k
∗
f may be zero. This transition was added
to the fragmentation model of autocatalytic self-assembly, previously discussed
in §3, which included fragmentation and polymerisation; in this chapter, I do not
include primary nucleation since its effects are not relevant to the phenomena
under study here.
6.2.1 The effects to aspects of the growth curve, of
arresting fragmentation
First, I will examine the effect of this fragmentation cutoff on the growth curves
produced by kinetic Monte Carlo simulation: example growth curves are given
in figure 6.7 for total protein concentrations below and above the CFCM. These
illustrate how the growth curves of protein concentrations below the threshold are
unaffected, while those above the threshold approach their plateau more gradually
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Example of when fragmentation is not arrested



























Figure 6.7 Growth curves produced by kMC simulations of a fragmentation model
with fragmentation arrested once the concentration of aggregated
protein reaches CFCM = 70 µM (i.e. k∗f = 0 in figure 6.6), for
a total protein concentration: (a) which is not affected by the
transition, and (b) which is affected by the transition. For
both protein concentrations, 150 replicate growth curves are shown,
along with an example of the growth curve produced when
fragmentation is not suppressed. The common parameter values were
nc = 2, N(0) = 2× 10−12 M, kn = 0, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l.
than when fragmentation was not suppressed, thereby shifting the maximum
aggregation rate to an earlier point in the growth curve.
By definition, the lag time τφM to reach a threshold concentration of aggregated
protein Mφ = φM mtot (see §1.3.4) will only be affected by the arrest of fragmen-
tation if Mφ ≥ CFCM. This is borne out in figure 6.8, where the only lag times
affected are those for protein concentrations significantly above the CFCM.
The effect on the maximum aggregation rate, of arresting fragmentation in this
way, can be seen in figure 6.9 for two different values of CFCM. This illustrates
an unexpected and subtle consequence of the transition in fragmentation rate
at the CFCM: when the value of CFCM is lowered, the trend in the maximum
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Bovine insulin experiments with 0 M NaCl (γ = −0.358(17))
kMC simulations with no CFCM (γ = −0.4262(14))
kMC simulations where CFCM = 1.3×10−4 M (γ = −0.456(8))
kMC simulations where CFCM = 7×10−5 M (γ = −0.483(12))
Figure 6.8 The scaling behaviour of τ3 with mtot in a fragmentation
model with fragmentation arrested at different concentrations of
aggregated protein, CFCM; where the common parameter values were
nc = 2, N(0) = 2× 10−12 M, kn = 0, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. Each kMC simulation point
is the mean of 150 replicates with error bars indicating the standard
deviation (method in §2.2). The experimental results for bovine insulin
are shown for comparison. Each line indicates the best fit of the power
law τlag ∝ m−γtot to the data set (method in §2.3.2).
aggregation rate changes for protein concentrations above the threshold; i.e. the
curvature of the graph in figure 6.9 for the points above the CFCM appears to
invert. This effect will be important in the next section, where I examine the
behaviour of the maximum aggregation rates produced experimentally in the
presence of salt (shown in figure 6.3).
Thus, an abrupt transition in the rate of fragmentation upon reaching a specific
concentration of aggregated material, is able to reproduce the experimentally
observed effect on the maximum aggregation rate while leaving the lag times
almost unaffected.
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Bovine insulin experiments with 0 M NaCl
kMC simulations with no CFCM
kMC simulations where CFCM = 1.3×10−4 M and k∗f = 0
kMC simulations where CFCM = 7×10−5 M and k∗f = 0
kMC simulations where CFCM = 7×10−5 M
and k∗f = 3×10−10 s−1
Figure 6.9 The scaling behaviour of kmax with mtot in a fragmentation
model with fragmentation arrested at different concentrations of
aggregated protein, CFCM; where the common parameter values were
nc = 2, N(0) = 2× 10−12 M, kn = 0, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. Each kMC simulation point
is the mean of 150 replicates with error bars indicating the standard
deviation (method in §2.2); the lines are to help differentiate the data
sets. For comparison, the experimental data for bovine insulin is also
shown.
The influence of salt: Changing the CFCM
As I demonstrated in figure 6.9, by lowering the CFCM it is possible to alter the
curvature of the maximum aggregation rate data for protein concentrations above
the CFCM. Hence, by appropriate choice of CFCM, it is possible to reproduce
the effect illustrated in figure 6.2, where increasing amounts of salt invert the
curvature of the graphs of maximum aggregation rate plotted as a function of
protein concentration. However, first I will address the large increase in maximum
aggregation rate apparent for the smallest concentration of salt.
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kMC simulations where k+ = 5×104 M−1 s−1
and CFCM = 7×10−5 M (∼ 0 M NaCl)
kMC simulations where k+ = 106 M−1 s−1
and CFCM = 7×10−5 M (∼ 0.1 M NaCl)
kMC simulations where k+ = 106 M−1 s−1
and CFCM = 3.5×10−5 M
kMC simulations where k+ = 106 M−1 s−1
and CFCM = 8.7×10−6 M (∼ 0.49 M NaCl)
Figure 6.10 The scaling behaviour of kmax with mtot in a fragmentation model
with fragmentation arrested at different concentrations of aggregated
protein, CFCM, and with different elongation rates, k+; where
the common parameter values were nc = 2, N(0) = 2× 10−12 M,
kn = 0, k− = 0, kf = 3×10−8 s−1, and V = 83×10−14 l. Each kMC
simulation point is the mean of 150 replicates with error bars indicating
the standard deviation (method in §2.2); the lines are to help
differentiate the data sets. The bovine insulin experimental data in
figure 6.2, are also shown here as pale solid lines, for qualitative
comparison.
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6.2.1 Effects to growth curves
It is expected that the presence of salt will lower the Coulomb repulsion between
free monomers and growing fibril ends, by screening the charge on both species.
This will effectively increase the rate of elongation and hence increase the
maximum aggregation rate. The extent to which it does this is unknown, but it
is possible to match the experimental data for the lowest salt concentration in
figure 6.2, by increasing the elongation rate of the simulation by a factor of 20.
The effect of doing this is illustrated in figure 6.10, alongside the experimental
data from figure 6.2.
Above a certain salt concentration, the charge screening effect is expected to
saturate such that the elongation rate will not increase further by the addition
of more salt. For the purposes of this model, I will assume that this occurs
at around 0.1 M NaCl, since this is where the highest values of the maximum
aggregation rate are seen in the experimental data. The decrease in the maximum
aggregation rate upon further addition of salt can instead be explained by
reducing the value of the CFCM, as is also illustrated in figure 6.10 (where the
higher elongation rate has been kept).
This decrease of the CFCM value with increasing salt concentration can also
be rationalised by considering the effects of charge screening. The CFCM, as I
have defined it, represents a condition at which the mechanical properties of the
filaments change in conjunction with some sort of lateral filament association (3).
Much like monomer addition, this lateral filament association is likely to be
hindered by Coulomb repulsion and thus the addition of salt may increase the
rate at which filaments associate, in much the same way as it increases the rate
of elongation. Since I do not consider the rate of lateral association explicitly in
the simulations, this effect can be manifested as a decrease in the CFCM value in
this model.
The surface area of a filament is significantly larger than that of a growth-
competent end, and so I expect screening effect to saturate more rapidly for the
elongation rate than for lateral filament association. Consequently, even though
the elongation rate quickly saturates, the addition of more salt could be found to
lower the CFCM further, below the minimum value (corresponding to the highest
salt concentration) shown in figure 6.10.
(3) The change in sample viscosity and CD spectrum are both assumed to indicate structural
differences between fibrils formed at protein concentrations above and below the CFCM.
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kMC simulations where k+ = 5×104 M−1 s−1
and CFCM = 7×10−5 M (γ = −0.483(12))
kMC simulations where k+ = 106 M−1 s−1
and CFCM = 7×10−5 M (γ = −0.480(17))
kMC simulations where k+ = 106 M−1 s−1
and CFCM = 3.5×10−5 M (γ = −0.52(2))
kMC simulations where k+ = 106 M−1 s−1
and CFCM = 8.7×10−6 M (γ = −0.64(2))
Figure 6.11 The scaling behaviour of τ3 with mtot in a fragmentation model
with fragmentation arrested at different concentrations of aggregated
protein, CFCM, and with different elongation rates, k+; where
the common parameter values were nc = 2, N(0) = 2× 10−12 M,
kn = 0, k− = 0, kf = 3×10−8 s−1, and V = 83×10−14 l. Each kMC
simulation point is the mean of 150 replicates with error bars indicating
the standard deviation (method in §2.2). Each line indicates the best
fit of the power law τlag ∝ m−γtot to the data set (method in §2.3.2).
The bovine insulin experimental data in figure 6.3 has not been shown
here because the trends are too similar and the figure would become
unclear.
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6.2.2 Effects to the length distribution
It can be seen that this combination of raising the elongation rate and then
lowering the CFCM, qualitatively reproduces the effects of salt on the maximum
aggregation rate as observed experimentally (figure 6.10). In addition it also
captures the effect that the addition of salt has on the lag time, by similarly
lowering the lag time and then increasing the concentration dependence, as shown
in figure 6.11.
6.2.2 The effects to the filament length distribution, of
arresting fragmentation
Having established that the above mechanistic transition is able to reproduce the
maximum aggregation rate and lag times observed experimentally, I will now look
at its effects on the filament length distribution.
For total protein concentrations above the CFCM, suppression of fragmentation
can prevent the length distribution from relaxing into the shape expected in the
long-time steady state. When k∗f > 0, the same length distribution produced by
concentrations below the CFCM will result at very long times, but the time taken
for it to reach this state will increase with decreasing k∗f , so that the apparent end-
point length distribution may be very different. Only in the limit where k∗f = 0
can the shape of the length distribution strictly be frozen.
Figure 6.12 shows the end-point length distributions for the growth curves in
figure 6.7. As expected, no effect is seen for the protein concentration below the
CFCM, but the length distribution obtained at a protein concentration above the
CFCM now takes the form of a skew normal distribution (i.e. the shape present
at the earlier time when it became frozen). While this is in qualitative agreement
with the experimental data, it is clear that this simulated length distribution is
significantly narrower than the length distribution found experimentally and also
has a much longer mean filament length.
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(a) mtot = 35 µM.
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(b) mtot = 700 µM.
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Figure 6.12 Average filament length distributions at the end-point of replicate
kMC simulations of a fragmentation model with fragmentation
arrested once the concentration of aggregated protein reaches
CFCM = 70 µM (i.e. k∗f = 0 in figure 6.6), for a total protein
concentration: (a) that is not affected by the transition, and (b) that
is affected by the transition; where the common parameter values were
nc = 2, N(0) = 2× 10−12 M, kn = 0, k− = 0, kf = 3×10−8 s−1,
and V = 83×10−14 l. Filament lengths have been normalised by
the predicted mean filament length 2k+mtot/κ (equation 6.3). Each
distribution represents the mean of 150 replicate simulations with error
bars indicating the standard deviation (determined using the method
in §2.2).
I have presented the distributions in figure 6.12 in terms of the mean filament
length at equilibrium so as to remove the dependence on the choice of elongation
and fragmentation rate (as discussed previously in §3.3.6). By doing this, I also
highlight the large difference between the mean filament length of these two
distributions. The origin of this difference can be understood by considering again
the mechanisms which lead to the formation of the length distribution; i.e. that
longer filaments are more likely to fragment, thus driving the length distribution
toward shorter filaments, while elongation acts to push the distribution towards
longer filaments.
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6.2.2 Effects to the length distribution
The mean filament length for protein concentrations above the CFC
When fragmentation is arrested, the length distribution will be frozen but some
monomer may remain, not yet having been incorporated into filaments. This
extra material has an equal probability of being added to any filament. Thus,
the shape of the length distribution is expected to remain unchanged but the
average length of each filament is expected to increase according to the number
of filaments and free monomers present. The extent of this shift in the mean
filament length can be expressed analytically as follows.
The mean filament length at time t is given by the ratio of the fibrillar protein





where the expressions M(t) and N(t) depend on the rates of elongation and
fragmentation up to that time. For the steady-state condition describing the
length distribution at intermediate times — i.e. when the system has relaxed
and the monomer concentration can be assumed constant [13] — this gives the




If the length distribution is frozen, the remaining free monomer will be
m(tCFCM) = mtot −M(tCFCM)
which, if added uniformly to all filaments, will cause the mean (given by
equation 6.3) to increase by approximately
mtot −M(tCFCM)
N(tCFCM)
From this, the mean filament length of the end-point length distribution can be
found analytically in the case where k∗f = 0, by equating equations 6.2 and 6.3,
giving
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which defines the extent to which equation 6.3 is increased, and gives in the actual









Thus, for a concentration of 700 µM with CFCM = 70 µM, equation 6.4 correctly
predicts that the mean of the filament length distribution will be an order of
magnitude higher than given by equation 6.3 (as apparent in figure 6.12b).
From this it can be seen that, in order for the simulation to reproduce the
experimental length distribution at high protein concentrations, it would be
necessary for more filaments to be present at the point where fragmentation is
arrested. As I will now discuss, this cannot be accomplished simply by increasing
the fragmentation rate prior to the threshold.
6.2.3 Softening the transition
0 CFCM













When A = 5×105 M−1
When A = 5×104 M−1
Figure 6.13 The fragmentation rate at different concentrations of fibrillar
protein M(t), when treated as a smooth transition, for two value
of the "sharpness" constant A. The fragmentation rate kf changes
gradually as M(t) crosses CFCM, from k0f when M(t) < CFCM, and
decaying to zero.
126
6.2.3 Softening the transition
The simplicity of the sharp transition is appealing, particularly as it reproduces
most of the behaviour seen experimentally. However, the physical processes which
this transition is approximating are unlikely to be so abrupt. Lateral association
of filaments is likely to be a much more gradual process which begins while M(t)
is still below the CFCM, and continues even after it has been passed. For this





1− tanh (A[M(t)− CFCM])
)
where A is the transition sharpness, and it has been assumed that k∗f = 0. The
shape of this transition is illustrated in figure 6.13.
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kMC simulations where A→∞ (hard cut-off)
kMC simulations where A = 5×105 M−1 (smooth decay)
kMC simulations where A = 5×104 M−1 (smoother decay)
Figure 6.14 The scaling behaviour of kmax with mtot in a fragmentation model
with fragmentation gradually suppressed, according to the factor
A, as the concentration of aggregated protein increases; where
the common parameter values were CFCM = 70 µM, nc = 2,
N(0) = 2× 10−12 M, kn = 0, k+ = 5×104 M−1 s−1, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. Each kMC simulation point
is the mean of 150 replicates with error bars indicating the standard
deviation (method in §2.2); the lines are to help differentiate the data
sets.
For this gradual cutoff, the growth curves and lag times are affected only as much
as they were by the abrupt cutoff; and only when the transition is very soft, is
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Figure 6.15 Average filament length distributions at the end-point of repli-
cate kMC simulations of a fragmentation model with frag-
mentation gradually suppressed (as in figure 6.13) as the
concentration of aggregated protein increases, for a total pro-
tein concentration: (a) that is not affected by the transi-
tion, and (b) that is affected by the transition; where the
common parameter values were A = 5×104 M−1,CFCM = 70 µM,
nc = 2, N(0) = 2× 10−12 M, kn = 0, k− = 0, kf = 3×10−8 s−1,
and V = 83×10−14 l. Filament lengths have been normalised by
the predicted mean filament length 2k+mtot/κ (equation 6.3). Each
distribution represents the mean of 150 replicate simulations with error
bars indicating the standard deviation (determined using the method
in §2.2).
an effect apparent in the maximum aggregation rate, as shown in figure 6.14.
However, the end-point length distributions shown in figure 6.15 are also largely
unaffected by this smoothed cutoff: for the protein concentration below the
CFCM there is no difference, while the protein concentration above the CFCM
only displays a slight broadening and shift of the mean towards shorter filament
lengths. Hence, this does not constitute a significant improvement over the
simpler model, and similar effects on the kinetics and the length distributions
are also found for other, more complicated forms of cutoff function.
The reason why changing the cutoff function makes little difference compared
to the simple, abrupt transition is that the number of filaments present,
simultaneously defines the length distribution, the maximum aggregation rate,
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and other aspects of the kinetics. This number is largely formed during a narrow
window of time at the end of the lag phase. Consequently a smoothly decaying
fragmentation rate for concentrations above the CFCM, will have little effect as
most of the filament population is formed before the CFCM is reached; and while
the contribution to the kinetics after the CFCM will be important for keeping the
mean filament length down, it also raises the maximum aggregation rate.
In conclusion, if the CFC is defined in terms of a threshold concentration of
fibrillar protein — and almost regardless of how the transition is implemented
— the reduction in fragmentation rate upon crossing the threshold gives a
satisfactory explanation of the lag time and maximum aggregation rate trends.
It also explains the difference in shape of the length distributions for protein
concentration below and above the CFCM, where those above the threshold are
frozen in their early-time state but shifted towards longer filaments lengths.
I will now look at the effects of defining the CFC in terms of the number
concentration of filaments CFCN rather than CFCM and in doing so, resolve
the issue with the length distributions.
6.3 A critical fibril number concentration
transition
Defining the critical fibril concentration (CFC) as a quantity of protein incorpo-
rated into fibrils was the obvious choice since the value of the CFCM could easily
be deduced from the experimental kinetics. This is not so intuitive for a transition
in fragmentation rate that occurs at a critical fibril number concentration (CFCN).
So as to produce an effect comparable with that of the transition at the CFCM,
I will define CFCN as the number of filaments present in the equilibrium length
distribution for a protein concentration mtot = 2CFCM. I can then use the
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where κ =
√
2k+kfmtot, from which the relation between CFCN and CFCM can






It is worth noting that for a threshold defined in terms of the number
of filaments, any total protein concentration can reach the threshold pro-
vided mtot/nc > CFCM = 70 µM. This is because fragmentation will continue
to generate new filaments until either the threshold is reached or all filaments
are reduced to their minimum stable length. In practice however, the protein
concentration at which this occurs will be higher than I have indicated due to
the fact that even the shortest stable filament can fragment, thereby reducing
the number of filaments. Consequently, some of the protein concentrations which
were unaffected in the previous section by the CFCM, may now be affected by
the CFCN. Additionally, low total protein concentrations will be arrested with
a proportionally higher fraction of the monomer population in filaments, than
higher concentrations (4). This will have important ramifications for the length
distribution, discussed below.
For simplicity, I will reuse the step transition function from §6.2 (illustrated for
the CFCN in figure 6.16). This I implemented in kinetic Monte Carlo simulations
of the fragmentation model as before, with the fragmentation rate going to zero
once N(t) = CFCN.
Effects on aspects of the growth curve
The point in the kinetics where the CFCN is reached, depends on the total protein
concentration: when mtot > CFCM (used in equation 6.5 to define CFCN), the
CFCN will be reached after passing the CFCM; when mtot < CFCM, the CFCN
must necessarily be reached first (since, by definition, the CFCM can never be
reached). However, for all total protein concentrations considered, the maximum
aggregation rate is always reached before the critical number of fibrils have
formed. Consequently, the change in fragmentation rate at the transition has
(4) Low protein concentrations will have fewer filaments relative to mtot, than will higher
protein concentrations.
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Figure 6.16 The fragmentation rate at different concentrations of fibrils N(t),
when treated as a step transition. The fragmentation rate kf changes
abruptly once N(t) = CFCN, from k0f when N(t) < CFCN, to k
∗
f
when N(t) ≥ CFCN.
little effect on the lag time or maximum aggregation rate, as will be seen in
figures 6.19 and 6.20, which I present shortly in §6.4.
Effects on the filament length distribution
While the lack of effect on the maximum aggregation rate indicates that this
CFCN model is not able to explain that aspect of the experimental data, the
effects which it has on the length distributions are more encouraging.
Shown in figure 6.17 are the end-point length distributions produced by the model
implementing a change in fragmentation rate at the CFCN. These are similar to
those shown previously in figure 6.12, where the fragmentation rate changed at
the CFCM. In figure 6.17, both the low and high protein concentrations are
arrested in such a way as to produce a shape more closely resembling that of the
experimental length distributions shown in figures 6.4 and 6.5. Moreover, the
mean filament length in both cases has changed dramatically: the low protein
concentration here has a higher mean filament length than seen in the CFCM
model, while the high protein concentration has a lower mean filament length
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Figure 6.17 Average filament length distributions at the end-point of
replicate kMC simulations of a fragmentation model with
fragmentation arrested once the concentration of fibrils
reaches CFCN =
√
2CFCMkf/k+ = 9.2×10−3 µM (i.e. k∗f = 0
in figure 6.16), for a total protein concentration: (a)
where mtot < CFCM, and (b) where mtot > CFCM; where
the common parameter values were nc = 2, N(0) = 2× 10−12 M,
kn = 0, k− = 0, kf = 3×10−8 s−1, and V = 83×10−14 l. Filament
lengths have been normalised by the predicted mean filament
length 2k+mtot/κ (equation 6.3). Each distribution represents the
mean of 150 replicate simulations with error bars indicating the
standard deviation (determined using the method in §2.2).
than seen in that model. This is due to the earlier arrest of fragmentation at
lower protein concentrations.
Since the CFCN occurs later in the kinetics than the CFCM (for protein
concentrations higher than CFCM) for the parameters used here, it is possible
to combine their effect provided that for the CFCM, k
∗
f > 0, while for the CFCN,
k∗f = 0. In this way fragmentation would be suppressed early enough to affect the
maximum aggregation rate, but arrested late enough that a sufficient number of
filaments are present to keep the mean filament length low.
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6.4 A TWO-TRANSITION MODEL
6.4 Two transitions: combining the CFCM and
CFCN models
I will now explore the effects of combining both transitions into a single model.
There are a number of ways by which this could be done, but I will only consider
the case where the fragmentation rate is reduced to a non-zero value k∗f at the
CFCM and then to zero at the CFCN. The reason for this choice is obvious: only
protein concentrations above the CFCM can be affected by it, and so arresting
fragmentation upon crossing the CFCM will produce the same affects as in §6.2.
I tested several different values of the lower fragmentation rate k∗f and found that
these produce very similar behaviour to that given below for k∗f = 0.1kf , except
when k∗f is either very low or very high: when k
∗
f is very low, the results tended
towards those where fragmentation is arrested at the CFCM (see §6.2), while
higher values — closer to the initial fragmentation rate — produce similar results
to those where only the CFCN was implemented (see §6.3).
Effects on the filament length distribution
The filament length distributions produced when both transitions in the fragmen-
tation rate are considered in the same model, are shown in figure 6.18. These can
be compared with the length distributions obtained by either of the transitions
individually (figures 6.12 and 6.17), revealing that this combination produces
length distributions very similar in appearance to those of the CFCN model, and
importantly, the experimental data (also shown in figure 6.18).
For mtot < CFCM, the narrow distribution given in figure 6.17 is again produced
because the only threshold that is crossed at these protein concentrations is the
CFCN. For mtot > CFCM, however, the length distribution is much broader and
contains shorter filament lengths than the length distributions produced by either
of the thresholds individually.
133
CHAPTER 6. ARRESTING FRAGMENTATION
(a) Stochastic simulations
when mtot = 35 µM.
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when mtot = 700 µM.
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(c) Bovine insulin experiments
when mtot = 35 µM.
















(d) Bovine insulin experiments
when mtot = 700 µM.















Figure 6.18 Filament length distributions from kMC simulations and bovine insulin
experiments. (a) and (b) are the average, at the end-point,
of replicate simulations of a fragmentation model with fragmen-
tation slowed to k∗f = 3×10−9 s−1 once M(t) = CFCM = 70 µM,
and arrested once N(t) = CFCN =
√
2CFCMkf/k+, for two total
protein concentrations; where the common parameter values were
nc = 2, N(0) = 2× 10−12 M, kn = 0, k− = 0, kf = 3×10−8 s−1,
and V = 83×10−14 l. Filament lengths have been normalised by
the predicted mean filament length 2k+mtot/κ (equation 6.3). Each
distribution represents the mean of 150 replicate simulations with error
bars indicating the standard deviation (see §2.2). (c) and (d) are the
experimental data previously shown in figures 6.4 and 6.5, respectively.
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6.4 A TWO-TRANSITION MODEL
From this, it appears that the experimental length distributions at high protein
concentrations can be explained by the suppression of fragmentation early on in
the kinetics. However, in order to explain the experimental length distributions
at all protein concentrations the fragmentation rate also needs to be fully arrested
later in the kinetics. This has an interesting effect on the maximum aggregation
rate as I will explain next.
Effects on aspects of the growth curve
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Bovine insulin experiments (γ = −0.358(17))
kMC simulations where k+ = 5×104 M−1 s−1,
CFCN = 9.2×10−9 M and there is no CFCM (γ = −0.4294(17))
kMC simulations where k+ = 106 M−1 s−1,
CFCN = 9.2×10−9 M and CFCM = 7×10−5 M (γ = −0.473(9))
Figure 6.19 The scaling behaviour of τ3 with mtot in a fragmentation model with
fragmentation slowed to k∗f = 3×10−9 s−1 once M(t) = CFCM (if
applicable), and arrested once N(t) = CFCN =
√
2CFCMkf/k+; where
the common parameter values were nc = 2, N(0) = 2× 10−12 M,
kn = 0, k+ = 5×104 M−1 s−1, k− = 0, kf = 3×10−8 s−1,
and V = 83×10−14 l. Each kMC simulation point is the mean
of 150 replicates with error bars indicating the standard deviation
(method in §2.2). The experimental results for bovine insulin are
shown for comparison. Each line indicates the best fit of the power
law τlag ∝ m−γtot to the data set (method in §2.3.2).
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Since both of the threshold conditions are sufficiently late in the kinetics, they
have little effect on the lag time; indeed, the only change in lag time occurs when
the fragmentation rate is reduced at the CFCM. This is evident from figure 6.19,
which also includes the case where the fragmentation rate is only affected by the
CFCN.
A similar effect is also found for the maximum aggregation rate with the original
elongation rate (figure 6.20). When there is a reduction in the fragmentation
rate only at the CFCN, the maximum aggregation rate scales as it did for
the fragmentation model without a transition. On the other hand, if the
fragmentation rate is also reduced at the CFCM, the maximum aggregation rate
behaves as it did in §6.2 without the cutoff at the CFCN, now scaling with total





If the elongation rate is increased, however, then longer filaments will be produced
earlier in the kinetics. This results in an increased rate of filament formation
through fragmentation, despite the rate constant having been reduced upon
passing the CFCM threshold. Consequently, more filaments are formed until
the CFCN is reached and fragmentation is arrested (at a later point in the
kinetics). Thus, reducing the fragmentation rate will have less effect on the
maximum aggregation rate for protein concentrations where the CFCM is crossed
significantly earlier than CFCN, compared with those (lower concentrations) for
which the two transitions are closer together. This effect becomes more apparent
when the CFCM threshold is lowered
(5) because the reduced fragmentation rate k∗f
is active earlier in the kinetics. This is the reason for the difference in maximum
aggregation rate for high protein concentrations in figure 6.20, compared with
those in figure 6.10.
In order for these results to match the experimental data, the CFCN must be lower
than predicted by equation 6.5 such that fragmentation is arrested much closer
to the CFCM (i.e. CFCN does not scale in the way I assumed in equation 6.5).
This, therefore, presents an interesting question, since this model appears to
(5) Because of the way that I have defined them through equation 6.5, reducing the CFCM
will also lower the CFCN.
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kMC simulations where k+ = 5×104 M−1 s−1,
CFCN = 9.2×10−9 M and there is no CFCM
kMC simulations where k+ = 5×104 M−1 s−1,
CFCN = 9.2×10−9 M and CFCM = 7×10−5 M
kMC simulations where k+ = 106 M−1 s−1,
CFCN = 2.0×10−9 M and CFCM = 7×10−5 M
kMC simulations where k+ = 106 M−1 s−1,
CFCN = 1.4×10−9 M and CFCM = 3.5×10−5 M
kMC simulations where k+ = 106 M−1 s−1,
CFCN = 7.2×10−10 M and CFCM = 8.7×10−6 M
Figure 6.20 The scaling behaviour of kmax with mtot in a fragmentation model
with fragmentation slowed to k∗f = 3×10−9 s−1 once M(t) = CFCM
(if applicable), and arrested once N(t) = CFCN =
√
2CFCMkf/k+,
for different values of CFCM and k+; where the common
parameter values were nc = 2, N(0) = 2× 10−12 M, kn = 0, k− = 0,
kf = 3×10−8 s−1, and V = 83×10−14 l. Each kMC simulation point
is the mean of 150 replicates with error bars indicating the standard
deviation (method in §2.2); the lines are to help differentiate the data
sets. The bovine insulin experimental data in figure 6.2, are also shown
here as pale solid lines, for qualitative comparison.
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describe the experimental data very well in the absence of salt, but the two
critical concentrations must be affected by salt in a different way, in order to
reproduce all of the experimentally observed behaviour.
6.5 Discussion
It is now widely thought that short filaments (protofilaments or oligomers) are
the pathogenic species in many amyloid diseases [33, 52, 62, 67, 95, 100, 112].
As such, preventing their formation is clearly important. Xue et al. [112] have
also indicated that it is not only the short filaments formed during the early
stages of aggregation that are toxic but also those formed through fragmentation
of mature fibrils. Thus, preventing fragmentation could be effective means to
reduce the number of short fibrils produced and thereby limit cell damage.
In this chapter, I have looked at a modification to the fragmentation model
of filament self-assembly in which the fragmentation rate is reduced when a
critical filament concentration (CFC) is reached. This model was based on
the assumption that filament bundles — formed by the lateral association of
filaments — have a lower probability of fragmentation than the filaments not
in bundles. This I motivated by an apparent change in the kinetics and
morphological properties of experimental samples, above a particular total protein
concentration.
From this model it can be seen that when the rate of fragmentation is significantly
reduced (perhaps to zero) the creation of new filaments is suppressed (6). This
means that the number of short filaments present, will be maximal at some point
before, or exactly when, the CFC is reached, but can be expected to decline
thereafter. Interestingly, Taylor et al. [100] have reported that the highest level
of cell damage occurs during the exponential growth phase of the growth curve,
with significantly lower rates of cell damage before and after this point. This
could indicate that a similar transition to that which I have proposed for insulin,
also suppresses fragmentation during fibril formation of amyloid-beta. If this
is the case, then it should be possible to change the point in the growth curve
(6) This assumes that filament elongation continues to use up the monomer population,
thereby preventing further primary, or secondary nucleation.
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where maximal cell damage is observed, by altering the environmental conditions
in such a way as to change the CFC threshold condition.
In the case of bovine insulin it appears to be possible to lower the CFC by
adding increasing concentrations of salt. However, the effect that this had on the
maximum aggregation rate could only be reproduced when fragmentation was
actually arrested at the CFCM; i.e. instead of merely suppressing fragmentation
at the CFCM and then arresting it at the CFCN. This implies that the relationship
between the two threshold criteria (CFCN and CFCM), which I assumed to be
proportional to one another, may be more complicated; for example, the salt
concentration perhaps changes both the threshold at which the fragmentation rate
is reduced, and the value of the rate constant after the threshold is passed. This
could be seen as an extension of the charge screening effect: increasing the rate
of bundle formation and increasing their thickness, and thereby simultaneously
lowering the threshold concentration and reducing the possibility that a bundle
undergoes fragmentation.
The formation of bundles from individual amyloid filaments is a widely recognised
phenomenon [61], but the actual process of lateral filament association has only
been observed relatively recently [49, 66, 69] and the properties of these bundles
are still largely unknown. As such, it is unclear whether all bundles can be
expected to provide comparable resistance against fragmentation, or indeed how
common bundle formation is for filaments made from different proteins.
The model that I presented, only implemented a coarse-grained description of
the connection between the critical filament concentration, and the suppression
or arrest of fragmentation. If lateral filament association were explicitly
implemented in such a model it would be possible to compare the average bundle
thickness with those measured experimentally [49, 60, 66]. However, this would
require additional information on the properties of bundles; for example, whether
bundles can join to one another, whether the addition of new filaments to a
bundle depends on the bundles size, and whether filaments within bundles have
a different rate of elongation to those on their own.
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The rationale that salt lowers the CFC by allowing easier lateral association of
filaments, was based on the assumption that the filaments had a weak Coulomb
repulsion which is screened by the presence of salt. If so, then a similar effect
should be produced by other factors that can influence the bundling affinity of a
given protein; for example, the helical twist of the fibrils themselves [61], or effect
of different solvents on a protein that contains a large number of hydrophobic
amino acids. The bundling propensity for filaments of a given protein may,
therefore, explain why the fibrils formed by ovalbumin under certain conditions
appear more flexible than those formed by insulin (comparing figures 1.2a and b,
in §1.2) or those of ovalbumin under different conditions [60, 107].
A recent study of ovalbumin fibrils by Lara et al. [60] indicates that a higher
persistence length (more rigid fibrils) might be correlated with increased fibril
thickness. This poses an interesting question about the internal structure of fibrils
and the importance of lateral filament association. However, their findings also
seem to indicate that the average length of the thicker fibrils decreases over time,
while the average length of the thinner fibrils increase; i.e. clearly the opposite
of the prediction that bundling prevents fragmentation. This effect is almost
certainly related to filament end-joining (which I discuss in the next chapter)
where the thicker filaments are not fragmenting more, but rather the thinner ones
are rejoining more. Hence, there may be an interesting link between a filaments
flexibility, and its tendency to fragment, end-join or laterally associate.
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Chapter 7
The effects of filament end-joining
and the formation of amyloid loops
7.1 Introduction
Loop-like amyloid fibrils have been observed in a number of protein systems,
using a variety of imaging techniques [41, 101, 102]. As an example, figure 7.1
shows looped and non-looped fibrils of ovalbumin.
The fibrils present in samples where loops have been found, appear more flexible
than in systems where loops are not reported (compare, for example, figures 1.2a
and b). This is not surprising as loop formation requires that the fibrils are
flexible enough that their ends are able to meet and join. Hence, the existence
of loops indicates that the internal structure of some fibrils may be different, and
that an alternative aggregation pathway involving end-joining is at work.
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Figure 7.1 Transmission electron micrograph of amyloid fibrils and loops formed
from ovalbumin. The sample was taken from experiments performed
by my collaborators Ryan Morris and Jason Kalapothakis, after the
fluorescence signal had plateaued. This image has a 0.2 µm scale bar.
The two processes of end-joining — where a fibril can form a loop, or grow by





where kj is the rate of association of two filament ends and is the same in
both reactions. For reasons which I will discuss shortly in §7.1.1, the loop
formation reaction 7.2 also depends on the length l, of the filament, and hence
the probability Ploop(l) that its ends find one another.
In this chapter, I will look at two models involving filament end-joining. The first,
in §7.2, will consist of the reactions 7.1 and 7.2 above, as well as reaction 1.8 for
elongation by monomer addition. The second model, in addition to these, will
contain reactions 1.10 and 1.7 for the fragmentation of filaments (this can be
regarded as reversible end-joining) and to account for the instability of filaments
shorter than nc, respectively. However, for reasons which I will now explain, the
primary nucleation reaction will not be used in either model.
(1) Reaction 7.1 was previously given as reaction 1.26 in §1.3.5.
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Figure 7.2 Replicate growth curves for the self-assembly of amyloid fibrils
from 19 µM ovalbumin, previously shown in figure 1.12, with
an inset highlighting the unexplained drop in fluorescence at the
very early times (showing 0− 150 Minutes). These 9 replicates
were obtained simultaneously, by my collaborators Ryan Morris and
Jason Kalapothakis, and have been normalised by the maximum
fluorescence of each curve.
Typical growth curves produced by the aggregation of ovalbumin are shown in
figure 7.2. Curiously, many of the proteins which appear to form loops also
produce this shape of growth curve with little or no appreciable lag phase.
The growth curves of other proteins which normally do have a lag phase, can be
made to resemble those in figure 7.2 by "seeding", i.e. adding preformed fibrils
to the sample at t = 0. This suggests that the aggregation of proteins such as
ovalbumin which do not require seeding to produce growth curves without a lag
phase, may involve a different nucleation pathway to the one normally considered
(see §1.3.1). Since many of these proteins appear to undergo end-joining as well,
it can be assumed that they have a higher affinity for aggregation in general
such that these alternative nuclei form rapidly, acting like seeds. Hence, while
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nucleation may be important in these kinetics, the mechanism can be reasonably
approximated by seeding with a known number of fibrils.
7.1.1 The probability of filament end-joining
For a model in which two arbitrary filament ends can join, there are two scenarios
that need to be considered: that the ends of two different filaments join together,
and that both ends of the same filament meet and form a loop. The first of these
is straightforward to model, while the second is slightly more complicated.
The probability for two filaments to end-join
There are four ways in which two filaments can combine into a single, longer
filament, but I will treat these as equivalent since it is only the length of the
resulting filament that will matter in my simulations (2). Thus, I can write the
total probability at time t for any two of the N(t) filaments to meet and join, as
Pjoin(t) = kjN(t)(N(t)− 1) ≈ kjN2(t) (7.3)
where the approximation is due to the conversion between an discrete number of
filaments, and their concentration as a continuous variable.
The probability that filament forms a closed loop
In order to find the probability that a single filament forms a loop, I first need to
obtain the probability that the two ends of a single filament meet. There are a
number of models to describe the probability of loop formation for a polymer [42,
50, 57, 70, 114]. These treat the polymer as a chain of inflexible segments, each
of length lp (referred to as the persistence length), each of which may consist of
a large number of monomers. Simple models treat the entire polymer as a freely
jointed chain of these segments, while more sophisticated models, such as the one
that I use, impose constraints on the maximum flexibility of the joints.
(2) It should be noted that I also ignore the possibility that the point where two filaments
join may be weaker and hence subject to a higher probability of fragmentation than those
formed by monomer addition.
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While the amyloid fibrils in figure 7.1 appear more flexible than those seen for
other proteins (3) they must have some rigidity. This will define the minimum
fibril length lmin necessary for a loop to form. For this reason, I will use the
worm-like chain model for polymers with finite flexibility [42, 50] to describe the









This model assumes that, under the influence of random perturbations, the
polymer will move and bend but its two ends will remain on average within
a spherical volume prescribed by the radius
√〈R2(l)〉, known as the polymer’s
radius of gyration. This can be used to define the probability that the two ends
are separated by a given end-to-end vector ~R(l) [22]:












Hence, the probability that the two ends meet can be obtained by set-
ting |~R(l)| = 0 in equation 7.5 and imposing the minimum contour length lmin:






if l ≥ lmin
0 else
(7.6)
This was the probability used in reaction 7.2.
From equation 7.6 it can be seen that loop formation becomes less likely
with increasing filament stiffness (persistence length) due to the increase in
mean square end-to-end distance and lmin; similarly, even for a highly flexible
filament, the probability that its two ends meet will decrease as it grows, such
that Ploop(l)→ 0 as l→∞ (4). From this, the total probability that any one of
(3) The insulin fibrils in figure 1.2a appear less flexible than those for ovalbumin in figure 1.2b.
(4) The ends will act as two independent random walkers in an infinite three dimensional space
when l→∞.
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where Nl(t) is the number of filaments of length l at time t.
Using these relations, I will now consider a simple model for filament polymeri-
sation by monomer addition and end-joining, and how this relates to the growth
curves found experimentally for ovalbumin (figure 7.2).
7.2 A simple model for filament end-joining
In constructing a model comprising elongation by both end-joining and monomer
addition, I first note that for a sufficiently high elongation rate, the probability
of a filament forming a loop rapidly becomes negligible compared to that of two
filaments joining end-to-end (5). Because of this, I can neglect loop formation and




Using this, I construct a pair of differential equations to describe the rate
of change of the fibrillar protein concentration M(t) and the concentration of








where k+ is the elongation rate, kj is the rate of end-joining, andm(t) = mtot −M(t)
is the free monomer concentration at time t.
(5) This can be seen from the way that equation 7.6 scales with l: at a high rate of elongation,
the fibrils will rapidly become long enough that Ploop(l) is negligible.
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At this point it is worth highlighting the non-linearity that filament end-joining
introduces through equation 7.9, as this will present a problem later when
considered in conjunction with filament fragmentation (§7.3). Earlier in the
thesis, similar non-linearity, introduced by the primary nucleation mechanism
to the autocatalysis model, was neglected by assuming that the rate of primary
nucleation was low and that its effect on the monomer population was small
(§1.3.3). However, this cannot be done for the end-joining mechanism because
the association rate kj is unknown and, moreover, end-joining is the only means
by which the number of filaments — or more accurately, the number of growth-
competent ends — is depleted. For now however, this non-linearity will not cause
a problem because the equations for M(t) and N(t) are only partially coupled;
i.e. equation 7.8 depends on equation 7.9 but not vice versa.
As mentioned above, many of the loop forming proteins exhibit little or no lag
phase in their growth curves (this was evident in figure 7.2 for ovalbumin). These
are similar in appearance to high seed concentration growth curves described
in §3.3.3; thus, I have ignored primary nucleation in equations 7.8 and 7.9,
and will assume that the system starts with a high concentration of short
filaments N(0) = M(0)/nc.
Using these initial conditions, I am thus able to solve equations 7.8 and 7.9
analytically and obtain the following expressions for the time evolution of the
concentrations of fibrillar protein and number of filaments:





7.2.1 Comparing predicted and experimental growth curves
Using the fitting technique in §2.3.1, I obtained values for the parameter
combinations 2k+/kj, and kjN(0), along with M(0), by fitting equation 7.10 to the
average growth curve of the ovalbumin data in figure 7.2. Although it is trivial
to fit equation 7.10 for the individual parameters k+, kj, and N(0), instead, the
lack of constraints in this model means that their fitted values are sensitive to
the choice of starting values (which is not the case for the combinations); indeed,
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Fitted theoretical prediction of the filament end-joining model were
2k+/kj = 2.34(4), kjN(0) = 1.54(5)×10−5 M s−1,
M(0) = 1.12(11)×10−6 M
Theoretical prediction when kj = 0
Figure 7.3 An example fit of equation 7.10 to experimental data; in this case, the
mean of the replicate growth curves shown in figure 7.2 for 19 µM
ovalbumin, with error bars indicating the standard deviation. Also
shown is the theoretical prediction for polymerisation without end-
joining.
unlike the fit for bovine insulin in §3.2, it is not possible to extract values for the
individual parameters, due to the lack of additional information (for example, the
mean filament length).
The best fit of equation 7.10 to the experimental data, is shown in figure 7.3,
along with a growth profile for polymerisation without end-joining (6). From this
figure, it is clear that the end-joining model produces a better fit to the data; by
comparing these growth curves, it can be seen that filament end-joining slows the
rate of aggregation at intermediate times. This is due to the reduced number of
growth-competent ends, which decreases the rate of elongation.
Similar slowing of the aggregation rate can also be seen in the experimental
growth curves, indicating that filament end-joining is indeed involved. However,
(6) An expression for polymerisation without end-joining can be found by solving equation 7.8
with time independent N ; here, I have plotted this solution, making use of the fitted
parameter values for 2k+N(0).
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it appears that this may be slightly more pronounced in the experimental data
than predicted by the model; i.e. the rate of aggregation in the experimental data
at very early times, appears slightly higher and then turns over slightly more
rapidly.
The shallower curvature of the intermediate section of the experimental growth
curve suggests that the number of ends changes less rapidly here, than at early
times. This behaviour is indicative of a non-zero asymptotic limit to the minimum
number of growth-competent ends present; i.e. if left unchecked, filament end-
joining would result in zero ends — all filaments having irreversibly formed into
closed loops. However, here it appears that end-joining cannot reduce the number
of ends beyond an "equilibrium" value. One method by which this can be achieved
is the introduction of fragmentation into the model, making filament end-joining
reversible.
7.3 A mean-field model for reversible filament
end-joining
In the previous section, I considered a model containing only monomer addition
and filament end-joining, which resulted in an easily separable pair of differ-
ential equations for the concentrations of fibrillar protein M(t) and number
of filaments N(t). However, combining end-joining and fragmentation into a
single model, renders the model difficult to solve analytically; the equivalent pair




= 2k+m(t)N(t)− kfnc(nc − 1)N(t) (7.12)
dN
dt
= −kjN(t)2 + kf (M(t)− (2nc − 1)N(t)) (7.13)
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where k+ is the elongation rate, and m(t) = mtot −M(t) is the free monomer
concentration. The first term in each equation also appeared in the simpler
model (7), and the second term in each equation (filament fragmentation with rate
constant kf) is the same as appeared in the fragmentation model (equations 1.12
and 1.13, in §1.3.3); again, I have ignored primary nucleation.
Starting from equations 7.12 and 7.13, I will now describe the method by which
closed-form analytic expressions for M(t) and N(t) were obtained (8) for a model
describing monomer addition and reversible filament end-joining.
7.3.1 Obtaining a closed-form analytic solution
Careful examination of equations 7.12 and 7.13 reveals two physically meaningful






which is unstable and acts as a source; and one at M∗
N∗
 =






which is stable and describes the steady state in the long-time limit (9).
When the rate of fragmentation is significantly lower than the rates of either elon-
gation or filament end-joining (i.e. kf  k+, kj), the stable point (equation 7.15)
(7) These terms described the rate of change of the fibrillar protein concentration M(t) (from
equation 7.8) and the concentration of filamentsN(t) (from equation 7.9), under the actions
of elongation by monomer addition and end-joining, respectively.
(8) This process is described in more detail in §A3, and was identified by my collaborator
Juraj Szavitz-Nossan.
(9) Another fixed point exists for M∗ < 0, which will not be considered for obvious reasons.
150
7.3.1 Obtaining a closed-form analytic solution







From this, it can be seen that the steady-state value M∗ is simply, as expected,
the point where all protein has aggregated, and the steady-state value N∗ is
determined by a dynamic equilibrium between the creation of filaments through
fragmentation and their loss through filament end-joining.
Equations 7.12 and 7.13 can now be simplified by rewriting them in terms of
the dimensionless variables m(τ) = M(t)/M∗ and n(τ) = N(t)/N∗, making use of the






=− r n(τ)2 + rm(τ) (7.18)
where terms O(kf/k+) and O(kf/kj) have been neglected, r = kj/2k+ is the dimen-
sionless ratio of the rates of filament end-joining and elongation, and time has
been rescaled to the dimensionless parameter τ = 2k+N
∗ t. Interestingly, t/τ is
















where I have used equation 7.16 to approximate N∗.
An approximate solution to equation 7.18 can be found by first solving for m(τ)
in the long-time limit when n→ 1. Here, m(τ) takes the form of an exponential
approach from m0 = M(0)/M∗, to the steady state m(∞) = 1. Using this







where the parameter B(z) is defined in terms of the Bessel functions Jν(z)
and Yν(z), and the constant b set by the initial conditions m0 and n0. From
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this approximation of n(τ), a solution to equation 7.17 for m(τ), can now be
found by evaluating
m(τ) = 1− (1−m0)e−
R τ
0 n(τ) (7.21)















Equation 7.22 thus describes the evolution of the fibrillar protein concentra-
tion in terms of dimensionless quantities m0 = M(0)/M∗, n0 = N(0)/M∗, r = kj/2k+
and τ = 2k+N




. I will now explore the
predictions of this solution and how they compare with kinetic Monte Carlo
simulations of a model consisting of monomer addition, filament breakage and
reassociation, and where filaments shorter than nc disintegrate (reactions 1.8,1.10,
7.1, and 1.7, respectively).
7.3.2 Comparing the mean-field prediction to kinetic Monte
Carlo simulation
The assumptions made while obtaining equation 7.22 were that fragmentation
was rare compared to elongation and filament end-joining (i.e. kf  k+, kj), and
that n(τ) could be adequately described by approximating m(τ) as an exponential
approach to the steady state; i.e. solving equation 7.18 form(τ) in the limit n→ 1,
then using this to solve equation 7.18. The assumption that m(τ) can be
approximated as exponential approach means that this solution is only valid when
the initial rate of aggregation is the maximum rate of aggregation; indicating
that the seed concentration N(0) must be high, and in fact N(0) ≥ N∗. This
constrains the maximal value for the rate of fragmentation, through the definition
of N∗ ∝ √kf in equation 7.16, thus ensuring that the first of the two above listed
approximations is also fulfilled.
For completeness, kinetic Monte Carlo simulation results will be presented for
both N(0) < N∗ and N(0) ≥ N∗, but for the reasons given above, equation 7.22
will only be considered in conjunction with the latter case.
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The effects of a low seed concentration: N(0) < N∗
When few seeds are present — perhaps because of a low rate of nucleation —
fragmentation will dominate the growth curve in the same way as it did in the
autocatalytic model (§3).
At early times there is a low probability of filament end-joining, due to the low
population of filaments. Fragmentation also has a low probability at this time,
until a sufficient amount of material has been accreted. Once this happens and
new filaments are produced through fragmentation, the probability that they
recombine also increases. Consequently, the early-time kinetics are expected to
be as they were in the autocatalysis model, but the steady state equilibrium
between breakage and rejoining means that fewer growth-competent ends will be
present at later times. Hence, the growth curves are expected to appear different




























Figure 7.4 Growth curves produced by kMC simulations of a reversible filament
end-joining model for amyloid fibril self-assembly, where the
parameter values were mtot = 10 µM, nc = 2, N(0) = 1 N∗,
kn = 0, k+ = 5×103 M−1 s−1, k− = 0, kj = 5×104 M−1 s−1,
kf = 5×10−9 s−1, V = 83×10−14 l, and for a monomer size of 26 Å,
lp = 36 nm and lmin = 205 nm. Of the 150 replicate simulations, 3
posses lag times exceeding 106 minutes, and therefore have not been
shown.
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The growth curves produced by kinetic Monte Carlo simulations of this model
with a low seed concentration are shown in figure 7.4. These are indeed sigmoidal
and somewhat reminiscent of the growth curves produced by the heterogeneous
nucleation model (see figure 3.5 in §3.3.2). This similarity is due the restriction
on the number of filaments present (10) having much the same affect as monomer
depletion did on the heterogeneous nucleation of new filaments.
When k+ < kj, the steady state number of filaments N
∗ at the point where the
rate of aggregation is maximal, will be lower than the number of fibrils present
in the fragmentation model. As a result, the maximum aggregation rate, which
previously scaled with κ in the autocatalysis model (without end-joining), will
be limited by the characteristic rate κ/√r, according the equilibrium number of
filaments.
In spite of not including a nucleation step, there is a surprisingly large variability
in lag time between the growth curves in figure 7.4. This variability is due to the
high rate of filament end-joining which causes increased fluctuations in the small























Figure 7.5 The time evolution of the number of filaments in the kMC simulation
growth curves shown in figure 7.4. These have been normalised by the
predicted equilibrium number of filament, N∗.
(10) Those filaments formed through fragmentation, recombine, limiting the number of
filaments present, to N∗ in the long-time limit.
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The time evolution of the number of filaments according to kinetic Monte Carlo
simulations are shown in figure 7.5. As expected, the number of filaments tends
to N∗ in the long-time limit.
The effects of a high seed concentration: N(0) ≥ N∗
When a large number of short filaments are present at early times the rate of
fragmentation will be negligible compared to the rate of filament end-joining.
Initially, this will result in a rapid decrease in the number of growth-competent
ends as it did in the simpler model without fragmentation. However, once
the total fibrillar protein concentration is sufficiently high, and the number of
filaments has been sufficiently reduced, the rate of fragmentation will become
comparable with that of rejoining, thus establishing an equilibrium in the number
of filaments.






















Mean of the kMC simulations
Mean-field prediction
Figure 7.6 The time evolution of the number of filaments in the kMC simulation
growth curves shown in figure 7.7, along with the mean-field prediction
given in equation 7.20. These have been normalised by the predicted
equilibrium number of filaments, N∗. The average of the simulations
was obtained from the 150 replicates shown, by interpolating each curve
into continuous time and then computing the mean 〈N(t)〉, at discrete
time intervals.
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From figure 7.6, it can be seen that fragmentation first becomes comparable with
rejoining, relatively early in the kinetics, and that the equilibrium established is
unstable: this is indicated by the existence of a minimum in the curve. Once the
equilibrium is established, the rate of fragmentation increases as the concentration
of fibrillar protein increases, and the number of filaments tends to the long-time
steady state value N∗.
This behaviour is reproduced fairly well by the mean-field expression (equa-
tion 7.20), although the minimum in N(t) (in figure 7.6) is lower than the average
for the simulations. This discrepancy arises from neglecting terms O(kf) in the
derivation of equation 7.20, which become important only in establishing the
equilibrium by damping the rapid decrease in the number of filaments. Because
of this, when kf becomes vanishingly small, agreement between equation 7.20 and
the simulation results will improve (11).
Figure 7.7 shows the growth curves (i.e. M(t)) corresponding to the data shown
in figure 7.6. From these it can be seen that the minimum in the number of
filaments (in figure 7.6) is responsible for an abrupt change in aggregation rate
just after the early-time rapid growth (in figure 7.7). Here, the gradual increase
in the number of filaments that can be seen in figure 7.6 balances the depletion
of the monomer population, thereby reducing the curvature of the growth curve.
These simulated growth curves are similar in appearance to the experimental
growth curves of ovalbumin displayed in figure 7.2.
Because equation 7.20 underestimates the number of filaments present during this
quasi-linear portion of the growth curve, equation 7.22 underestimates the total
monomer content of these filaments during the same time period. This causes the
discrepancy between the mean-field prediction and the average of the simulation
results at around 103 minutes in both figures 7.6 and 7.7.
The significantly lower variability between the replicate curves for M(t), com-
pared to those for N(t), is caused by two factors. Firstly, the threshold number
of filaments is much smaller than the total number of monomers, so a change in
the number of filaments is more apparent than a change in their total monomer
content. The other factor is the negative feedback between fragmentation and
rejoining, where small perturbations about the equilibrium number of filaments at
(11) In the limit where kf → 0, this model will recover the prediction of the simple model
in §7.2.1.
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Mean of the kMC simulations
Mean-field prediction
Figure 7.7 Growth curves produced by kMC simulations of the reversible
filament end-joining model for amyloid fibril self-assembly, along
with the mean-field prediction given in equation 7.22, where the
parameter values were mtot = 10 µM, nc = 2, N(0) = 750 N∗,
kn = 0, k+ = 5×103 M−1 s−1, k− = 0, kj = 5×104 M−1 s−1,
kf = 5×10−9 s−1, V = 83×10−15 l, and for a monomer size of 26 Å,
lp = 36 nm and lmin = 205 nm. The average of the simulations was
obtained from the 150 replicates shown, using the method in §2.2.
a particular time by one of these two mechanisms are corrected by the other. If the
correction overshoots the equilibrium value, a feedback condition is established
and the number of filaments begins to oscillate about the equilibrium value.
7.3.3 Loop formation and its effect on the mean filament
length
Loop formation was included in the simulations using reaction 7.2, but was not
taken into account in the analytic prediction. As expected, this appears to
have had a negligible impact on the kinetics, which depend on the equilibrium
in the number of filament ends and their combined monomer content, and
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(a) Fibril length distribution.
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(b) Loop length distribution.
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Figure 7.8 The average distribution of (a) filament and (b) loop lengths
at the end-point of the replicate kMC simulation growth curves
shown in figure 7.7. Each distribution represents the mean of
150 replicate simulations with error bars indicating the standard
deviation (determined using the method in §2.2), and has been
normalised by the predicted mean filament length, equation 7.23. The
minimum filament length required to form a loop causes an offset from
the origin in the loop length distribution.
not significantly on how the ends and monomer content are distributed among
individual filaments.
The extent of the difference between the simulation and analytic prediction can
be understood by considering the total probability for fragmentation, which is
proportional to the total number of monomer-monomer bonds: a filament has
one fewer of these bonds than it has monomers, whereas for a loop the number
of monomers and bonds is equal. Consequently the probability of fragmentation
in the kinetic Monte Carlo simulations will be higher than is predicted by the
analytic solution, by a factor proportional to the number of loops in the system.
This number is always smaller, and usually much smaller, than the total number
of monomers in fibrils, and hence the effect is negligible.
The mean filament length at time t is given by M(t)/N(t) (equation 1.25 in §1.3.4).
For the reversible end-joining model, this can trivially be obtained in the long-
time limit (i.e. M∗/N∗) by using the approximate values for this steady state
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However, this does not account for loops, which contribute to M(t) but not
to N(t) (12), thereby reducing the mean filament length. In order to obtain the
true mean filament length, the concentration of protein in loops at equilibrium
(M∗loops) would also be needed:
lim
t→∞




As can be seen from figure 7.8, this correction is small because the average
loop length is much smaller than the average filament length. This is why the
mean filament length in figure 7.8a appears indistinguishable from the prediction,
despite having neglected loop formation in the analytic solution.
While the mean loop length is small by comparison to the mean filament
length, the number of loops at the end-point is comparable with the number
of filaments N∗. In the simulations, loop formation is reversible so a stable
equilibrium is expected to become established between the numbers of loops and
filaments.
The number of loops present in the kinetic Monte Carlo simulations are shown in
figures 7.9a and b, for N(0) < N∗ and N(0) ≥ N∗, respectively. The time range
shown in the plots was chosen to ensure that the equilibrium values of M∗ and N∗
had been reached, but it is apparent from both of these figures that the number
of loops has not equilibrated by this time.
When N(0) ≥ N∗, the large number of filaments initially available results in
a higher rate of loop formation at early times. This causes the appearance
of a large number of loops early on in the kinetics (see figure 7.9b). This
number remains fairly constant throughout aggregation and only starts increasing
further once aggregation is close to completion; i.e. when fragmentation begins
to cause the disintegration of filaments into shorter pieces which have a higher
probability Ploop(l) of forming a loop. By contrast, when N(0) < N
∗, loops only
(12) Loops contribute to the total aggregated protein concentration, but not to the number of
growth-competent filaments.
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(a) When the initial number of filaments is below the equilibrium
value (i.e. for the growth curves in figure 7.4).



















(b) When the initial number of filaments is above the equilibrium
value (i.e. for the growth curves in figure 7.7).




















Figure 7.9 The time evolution of the number of loops in the kMC simulation
growth curves shown in figures 7.4 and 7.7; when (a) N(0) N∗,
or (b) N(0) N∗. These have been normalised by the predicted
equilibrium number of filaments, N∗.
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7.3.3 Filament and loop lengths
emerge later in the kinetics, again when the number of filaments has started to
noticeably increase due to fragmentation.
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7.4 Predictions of a reversible filament end-joining
model applied to ovalbumin
As I demonstrated in §7.3.2, a model comprising filament elongation, breakages
and rejoining, and started with a high seed concentration, produces growth curves
similar in appearance to those of ovalbumin in figure 7.2; these display rapid
aggregation initially, but abruptly slowing to quasi-linear growth that is not found
in the absence of filament breakage (see §7.2). Using this model in a similar way
to the approach presented in §3.2, I have obtained fitted parameter values from




























Fitted mean-field prediction were r = 1.12(2), τ/t = 1.356(8)×10−5 s−1,
m0 = 2.5(4)×10−9 and n0 = 4.81(8)
Figure 7.10 An example fit of equation 7.22 to experimental data; in this case,
the mean of the replicate growth curves shown in figure 7.2 for 19 µM
ovalbumin, with error bars indicating the standard deviation.
As shown in figure 7.10, the quality of the fit for the model with fragmentation and
end-joining is much better than that of the simpler model without fragmentation
(figure 7.3), and, while this does not give direct access to the rate constants, the
fit parameters are far more robust to the choice of starting values. Values of
these fitted parameters similar to those given in figure 7.10, are were also found
for other concentrations of ovalbumin.
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The value of r ≈ 1 is particularly interesting as it indicates that the rates of
elongation and filament end-joining are comparable; indeed, it suggests that the
rate of end-joining is roughly double that of elongation. This may imply that a
free monomer must undergo some sort of conformational rearrangement before,
or upon docking, whereas filament ends already posses the necessary β-sheet
conformation and can thus join more rapidly.
Unlike the analysis of bovine insulin in §3.2, the mean filament length is not
experimentally known for ovalbumin, due to the high degree of filament and loop
entanglement that is apparent in figure 7.1. Because of this, the rate constants
and initial conditions cannot be extracted from the fitted parameter values
without first defining one of the rates. Therefore, so as to perform kinetic Monte
Carlo simulations of these parameters, I will choose a slower rate of elongation
than that found for bovine insulin (see §3.2) which appeared to have a much
higher overall rate of aggregation.
7.4.1 Stochastic simulations of ovalbumin aggregation




, allow the initial concentration of fibrils N(0) to be calculated.
Since M∗ ≈ mtot (from 7.16), the parameter M(0)M∗ should also provide information
on the initial concentration of filaments; however, the normalised fluorescence
signal at t = 0 is much higher than 2.5×10−9 (i.e. the fitted value of M(0)
M∗
from
figure 7.10), and exhibits unexplained behaviour at very early times as illustrated
by the inset in figure 7.2. For this reason, and because the kinetics are more





This gives the rate constant and initial condition values k+ = 5×103 M−1 s−1,
kj = 1×104 M−1 s−1, kf = 1×10−9 s−1, N(0) = 6×10−3 µM. These are physically
realistic, but are unlikely to be the exact values of the relevant parameters as I
have had to assume one of the values.
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Figure 7.11 The growth curves (a), and the corresponding time evolution of
the concentration of filaments (b), produced by 150 replicate kMC
simulations of the reversible filament end-joining model for amyloid
fibril self-assembly, where the parameter values were mtot = 10 µM,
nc = 2, N(0) = 300 N∗, kn = 0, k+ = 5×103 M−1 s−1, k− = 0,
kj = 1×105 M−1 s−1, kf = 1×10−9 s−1, V = 83×10−15 l, and for a
monomer size of 26 Å, lp = 36 nm and lmin = 205 nm.
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Growth curves
Examples of kinetic Monte Carlo simulations performed using the rates and
initial conditions determined above, are shown in figures 7.11a and b, for the
growth curves and evolution of the number of filaments, respectively. These
are reasonably independent of the choice of elongation rate since all other rates
and the initial conditions rescale accordingly: only the scale of the time axis is
affected.
These growth curves have a similar degree of variability to those in figure 7.2,
found experimentally. However, these simulations are for a volume many orders
of magnitude smaller than was used for the experiments. Thus, following on
from my discussed in §4, it would appear that the experimental kinetics have
substantially higher variability than can be accounted for simply by a difference
in the number of filaments present.
Filament and loop length distributions
As mentioned previously, the length distribution is hard to determine experimen-
tally due to the high degree of filament and loop entanglement. Recently a length
distribution for ovalbumin was published by Lara et al. [60] but did not provide a
corresponding distribution of loop lengths. Consequently, in order to verify that
the loop length distributions produced by the kinetic Monte Carlo simulations
are realistic I will compare them qualitatively to the distributions of loop lengths
for another amyloid loop forming protein, Apolipoprotein C-II (apoC-II), which
were reported by Hatters et al. [42] and Yang et al. [114].
The length distributions for both loops and filaments found at the end-point
of kinetic Monte Carlo simulations of a reversible end-joining model, are shown
together in figure 7.12 with lengths given in terms of the modified mean filament
length (equation 7.23).
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(a) Fibril length distribution.
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(b) Loop length distribution.
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Figure 7.12 The average distribution of (a) filament and (b) loop lengths
at the end-point of the replicate kMC simulation growth curves
shown in figure 7.11. Each distribution represents the mean of
150 replicate simulations with error bars indicating the standard
deviation (determined using the method in §2.2), and has been
normalised by the predicted mean filament length, equation 7.23. The
minimum filament length required to form a loop causes an offset from
the origin in the loop length distribution.
The filament length distribution (figure 7.12a) is similar in appearance to the
one produced (in the long-time limit) by the fragmentation model without end-
joining (see §3.3.6). This is because longer filaments and loops have a higher
probability of breaking (thus forming a larger population of short filaments).
However, this distribution does not collapse in the way seen for that model, due
to the equilibrium between filaments breaking and rejoining (since there are more
short filaments, they have a high probability of rejoining). This monotonically
decaying distribution of filament lengths is almost identical to that found by
Lara et al. [60] for worm-like fibrils of ovalbumin.
In contrast, the loop length distribution (figure 7.12b) is mostly affected by
the high population of short filaments from which to form loops and the shape
of the probability function Ploop(l) (equation 7.6). This length distribution is
qualitatively very similar to that reported by Hatters et al. [42] (power law),
but very different from that reported by Yang et al. [114] (a skew normal
distribution). The distribution that I obtain is a steeply decaying function
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with a sharp peak at the minimum loop contour length, strongly resembling
the probability function for loop closure Ploop(l) (equation 7.6). This function,
however, decays less steeply than does the loop length distribution. This
steeper distribution is the combined result of the decreasing probability of loop
formation with length (13), and the underlying filament length distribution (14) in
figure 7.12a: the high population of short filaments present at the end-point will
readily form loops, whereas the sparse population of longer filaments will not.
These results suggest that the underlying filament length distributions of the
studies performed by both Hatters et al. [42] and Yang et al. [114] may be
qualitatively different: the former being a decaying distribution similar to
figure 7.12a, while the latter may be a skew normal distribution reminiscent of the
fragmentation model with fragmentation arrested at a critical fibril concentration
(see §6). This could be supported by the fact that Lara et al. [60] observe an
exponential filament length distribution for worm-like ovalbumin fibrils, but a
peaked distribution for straighter ovalbumin fibrils (these also display higher
fragmentation). Hence, similar differences in the structure of apoC-II fibrils could
lead to similar filament length distributions.
Thus, it should be possible to determine an appropriate expression for the
probability of loop formation (i.e. equation 7.6) by comparing experimentally
measured length distributions of both filaments and loops found in the same
sample.
7.5 Discussion
While the models which I have presented in this chapter are not the first attempt
at understanding the significance of loop formation in the kinetics of amyloid fibril
formation [5, 41, 101, 114], they do provide closed-form analytic descriptions
of the time evolution of the concentrations of fibrillar protein and number of
filaments.
(13) The higher probability of that short filaments form loops, coupled with the minimum
contour length lmin defines the prominent peak in figure 7.12b.
(14) The probability for loop formation scales with the available number of filaments of a
particular length.
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The simple model, in which end-joining was not reversible, provided an adequate
description of the growth curves experientially observed for ovalbumin. However,
in these experimental data I noted a subtle departure from the prediction that
I argued could only be accounted for by an equilibrium state in the number of
growth-competent ends, with a non-zero value. By incorporating fragmentation
into the model, this equilibrium condition could be satisfied.
The resulting model for reversible end-joining predicts that, when the initial
number of filaments is much higher than the equilibrium number, the growth
curves will have a high initial aggregation rate that rapidly decreases, leading
to quasi-linear growth. Growth curves similar in appearance to these — where
the maximum rate of aggregation occurs at the start — have been produced
experimentally by a number of other proteins, including amyloid beta (Aβ) [4,
29, 30, 79, 98]. While these may only indicate that a high seed concentration is
present, there are a few for which loop formation has also been observed, including
alpha-synuclein (α-syn) and Apolipoprotein C-II (apoC-II) [41, 51, 102]. As such
this model is expected to be reasonably widely applicable to the self-assembly of
a number of different fibril forming proteins.
Unfortunately, the analytic solution obtained for this model can only be used
in cases where the initial seed concentration of filament ends is higher than
the equilibrium steady state value. However, the model does not rule out the
possibility that sigmoidal growth curves exist in conjunction with end-joining, and
using kinetic Monte Carlo simulations I demonstrated that growth curves with
sub-critical concentration of seeds may appear very similar to those predicted
for heterogeneous nucleation. This, in conjunction with the previous remark,
suggests that there could be many other proteins for which fibril end-joining is
an important process, but that these have yet to be identified.
While a number of proteins have been seen to form amyloid loops, these may
be unusual for being both flexible and able to end-join. As I speculated in the
previous chapter, fibril flexibility may only indicate that the filaments are not
able to associate laterally into bundles, which would imply that flexible filaments
might be found in the absence of loops (i.e. flexible filaments that are unable
to end-join). Unfortunately, this is hard to test because failure to find loops
does not mean that they are not present, particularly since flexible filaments are
often found more entangled. That aside, flexible filaments have been reportedly
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produced by a few proteins with no remarks about loop formation, and this may
indicate that filament flexibility need not imply end-joining [4, 39, 40, 60, 79].
The corollary to highly flexible filaments that are unable to end-join, is of course
that end-joining can happen between stiff fibrils that cannot form loops. However,
this can be expected to have a low probability of occurring between bundles of
filaments, due to the low probability that the ends of the two bundles correctly
align in experimentally observable time. Indeed, the findings of Lara et al. [60]
appear to indicate that this is true of ovalbumin, where the thicker, straighter
fibrils tend to fragment over time (becoming shorter), while the thinner, more
flexible ones appear to become longer over time. This implies that filament
flexibility, end-joining and bundle formation may be related in some way.
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In this thesis, I have shown how the system volume and protein concentration can
be expected to alter the early-time kinetics of amyloid fibril self-assembly, and
have explored the effects of lateral filament association and filament end-joining
on the overall kinetics and filament length distribution. Each chapter makes
distinct predictions regarding particular aspects of the self-assembly process.
From these, two recurring themes emerge which raise important questions about
the structure of amyloid fibrils, and whether experiments conducted in vitro are
indicative of in vivo phenomena.
In chapter 4, I explored the waiting-time distributions produced by combinations
of the processes of primary nucleation, polymerisation, and autocatalysis (by
fragmentation or heterogeneous nucleation); for each model, I found that the
distribution became narrower with increasing numbers of reactants (i.e. larger
volume, higher protein concentration, or both). These revealed that the
distributions of experimentally observed lag times are unlikely to be caused
simply by fluctuations in the waiting times of these processes. Additionally, since
these lag times are probably influenced by numerous factors rather than a single
process, it may not be possible to determine which processes contribute without
additional information; for example, examining the distributions produced at
different volumes.
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Most of the waiting-time distributions that I investigated, were obtained by
neglecting depolymerisation. However, in the case where depolymerisation was
included, it was found to be affected differently by the system volume, when
compared with the other processes. Hence, further investigation of the effects of
reversible polymerisation, particularly if it were length dependent, could provide
additional insight into the experimentally observed lag-time variability.
In chapter 5, I demonstrated that "kinks" can appear in a plot of lag-time as
a function of total protein concentration when the process dominating the lag
phase changes at particular protein concentrations. Since these kinks become
most apparent only when a wide range of protein concentrations are considered, I
speculated that some of the plots reported in the literature [43, 87, 110, 111]
may indicate their presence but not overtly enough to have been remarked
on. Hence, the transition in these should become obvious if the experiments
were repeated over a broader range of protein concentrations. However, the
model also shows that under certain conditions — for example, particular system
volumes or primary nucleation rates — these kinks may not be observed if the
protein concentration at which the scaling exponent changes is not accessible
experimentally.
Since this model was based on the analytic lag-time expression for the auto-
catalytic polymerisation model, it cannot address values of the lag-time scaling
exponent below γ = 1/2, predicted by that model. However, γ < 1/2 has been
reported for various proteins [18, 27, 53, 55, 74, 83, 94, 117] which indicates
that an, as yet unidentified combination of processes must be affecting the lag
phase of amyloid fibril formation, for some proteins, under certain conditions.
However, these may still exhibit a change in scaling behaviour at particular
protein concentrations, and this could be used as a means to identify the origin
of these unexplained scaling exponent values.
The combined findings of chapters 4 and 5, demonstrate how crucial the system
volume can be in determining which of primary nucleation or autocatalysis
dominates the lag phase. At a volume comparable with a single biological
cell, these results indicate that the lag time should be dominated by primary
nucleation: compared with larger volumes, the average lag-time at the cellular
scale is expected to be much longer and the variance between replicates is
expected to be greater. Hence, confining high concentrations of protein to small
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compartments within cells could be thought to have an evolutionary advantage,
since it might help to mitigate the nucleation of any aggregate (not only amyloid
fibrils), for similar reasons.
Given the way that the system size is expected to affect both the mean and
variance in waiting time, experiments performed in volumes comparable with that
of a single cell, should provide the best means to understand the early stages of
amyloid fibril self-assembly. As such, further development of the microfluidics
technique reported by Knowles et al. [56] could be of interest, particularly if it
can be used to study effects in live cells. Indeed, the long average waiting-time
for primary nucleation within a single cell might indicate why most amyloid
diseases are associated with later life. However, the variability in nucleation
time is unlikely to explain the variability in the age at which a disease is
detectable, as many other factors (for example, the rate of cell damage) can be
expected to influence this even after fibrils begin to assemble. Hence, microfluidics
experiments of this kind present the best chance of resolving such questions.
Moving away from the effects of system size and the early-time kinetics: in
chapters 6 and 7, I explored the consequences of lateral filament association
and filament end-joining. While these were discussed in separate chapters, recent
work by Lara et al. [60] may indicate that they are related. This raises important
questions about different morphologies of amyloid fibrils, and the processes by
which these form.
In chapter 6, I demonstrated that a modified version of the fragmentation model
— in which fragmentation is arrested once a critical concentration of filaments
is reached — was able to explain aspects of the experimental kinetics of bovine
insulin which could not otherwise be captured by the fragmentation model. This
modified model resulted in significantly higher populations of short filaments
for total protein concentrations below the critical concentration, compared with
those protein concentrations above it. Moreover, the model predicted that for
total protein concentrations above the threshold, the highest concentration of
short filaments occurred during the exponential growth phase, which coincides
with the highest rate of cell damage reported [100] for amyloid beta. This implies
that a similar transition may exist for amyloid beta as for bovine insulin; hence, it
should be possible to find environmental conditions under which fibrils form, but
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very little cell damage is observed. Clearly this could be of immense importance
to the understanding and potential prevention of amyloid diseases.
In this model, I assumed that bundle formation by lateral filament association
was responsible for the link between the critical filament concentration and the
change in fragmentation rate. However, I only considered a coarse-grained imple-
mentation of this link: the same results would be expected if the fragmentation
rate were affected by the critical concentration via another mechanism. Hence,
in order to verify that bundle formation is indeed responsible for suppressing
fragmentation, lateral filament association will need to be modelled explicitly,
and the resulting bundle width compared with that obtained experimentally.
However, such a model will probably require a better understanding of the bundle
formation process; for example, whether the addition of new filaments to a bundle
depends on the bundles size.
Finally, in chapter 7 I presented analytic solutions to models in which filaments
are able to grow by monomer addition and end-joining. Using these I was able
to obtain fitted values of the model parameters from experimental growth curves
of ovalbumin, which, when simulated, produced kinetics very similar to those
observed experimentally. The agreement of this model with the experimental
results indicates that an equilibrium number of filaments exists for the system;
thus, if the rate of fragmentation were artificially increased temporarily (perhaps
through sonication), then the short filaments produced would be expected to
reassemble into longer filaments over time.
The experimental results of a number of other proteins that exhibit similar
growth curves and apparent end-joining [41, 51, 102], may also be explained
by this model. If so, then filament end-joining could be a widely occurring and
important process in the formation of amyloid fibrils. However, the analytic
solutions that I presented, do not consider the origin of the high concentration
of seeds necessary to produce the observed growth curves, nor do they take into
account the formation of loops, which are clearly observed for some proteins
and not others. Consequently, these solutions provide a useful and general
understanding of some of the effects of end-joining, but the model clearly requires
further development to address early-time behaviour and further understand loop
formation.
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A number of fibril forming proteins which have been linked with cell damage (for
example Aβ and α-syn) also display kinetics similar to those of the end-joining
model [4, 29, 30, 41, 51, 79, 98, 102]. While the medical implications of end-joining
and loop formation are currently unclear, the end-joining mechanism will reduce
the number of filament ends and shift the distribution of filament lengths towards
longer filaments. This is in contrast to both fragmentation, which increases the
number of filament ends and reduces their individual length, and bundling, which
leaves the number of filament ends unchanged but reduces the exposed surface
area. Hence, each of these mechanisms can be expected to exhibit differing degrees
of damage to the cell, but which of them can be considered the most dangerous
will only be determined through extensive in vivo studies.
While presented in separate chapters, it can be seen how lateral filament
association and end-joining may affect one another. Individual filaments and
thin bundles can be expected to have a higher flexibility than thicker bundles;
thus, loop formation of the latter will be less likely. Indeed end-joining in general
is likely to be harder for thicker bundles due to the reduced probability that
the ends of all individual filaments in the bundle align appropriately. Similarly,
if a threshold concentration of filaments is required for bundles to form, then
end-joining may prevent their formation by keeping the number of filaments
below this threshold (depending on the equilibrium value, N∗). Consequently,
if the rate of lateral association or end-joining of filaments were affected by
environmental factors such as the addition of salt, it might explain the change in
physical appearance and kinetics exhibited by some proteins upon changing the
experimental environment [35, 37, 60, 96].
The self-assembly properties of amyloid fibrils and other protein complexes have
provided inspiration for the design of novel materials [36, 73, 109, 115] and also
as a template or scaffold for the assembly of other materials [10, 88, 93]. In all
such applications, the fibrils may be subject to sheer or tensile stresses, and so
the structural properties of the fibrils will be very important. Hence, control of
the fibril thickness is expected to be useful, as this can allow greater flexibility or
resistance to breakage. Indeed, if bundle formation and end-joining are related, it
may be beneficial to sacrifice strength in favour of the self-healing properties that
thinner bundles may provide. While such advances in materials technology might
not be expected for some time, identifying existing materials with potentially
useful properties, is an important first step.
175
CHAPTER 8. CONCLUSIONS AND OUTLOOK
In this thesis I have made extensive use of "minimal models" in order to
explore the effects of particular mechanisms. Such models are often used
to explore the behaviour of biological systems, which are often intractably
complicated. By neglecting the microscopic details of the processes thought to
be involved in amyloid fibril self-assembly, I was able to infer how adjustment
of the environmental conditions could determine which mechanism dominates
the lag phase and also control the filament length distribution. These findings
clearly have important implications for amyloid fibril self-assembly, but more
experimental work is needed in order to verify the predictions of the model.
Consequently, the questions raised by amyloid fibril self-assembly, and indeed
most problems faced by science in the 21st century, can only be addressed by a




A1 First passage times for reversible
polymerisation using the backward
Fokker-Plank equation
For a single particle performing a random walk on a one dimensional lattice, the
time T at which it leaves an interval (a, b) can be obtained by making use of the
backward Fokker-Plank equation [28]. This approach is general, but here I will
consider only the case of one reflecting barrier at a and one absorbing barrier
at b. Hence, for a particle starting at x, where a ≤ x ≤ b, the waiting time T is
defined as the time at which the particles position is x = b.
The probability that the particle is still in the interval (a, b) at time t is given by∫ b
a
dx′p(x′, t|x, 0) ≡ G(x, t) (A1.1)
whereG(x, t) is an as yet unknown function. The condition p(x′, 0|x, 0) = δ(x− x′),
along with the fact that a is reflective and b immediately absorbing, can be used
to find the boundary conditions on G:
G(x, 0) =
1 if a ≤ x ≤ b0 else (A1.2)
G(b, t) = 0 (A1.3)
∂xG(a, t) = 0 (A1.4)
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APPENDIX
The probability P (T ≥ t) that the time at which the particle leaves is greater
than t, is actually the same as equation A1.1, meaning that
p(x′, t|x, 0) = p(x′, 0|x,−t) (A1.5)
and the dynamics are time reversible.
By writing the backward Fokker-Plank equation for p(x′, t|x, 0) it can be seen
that G(x, t) obeys












Because the function G(x, t) is also the probability that T ≥ t, equation A1.6
can be used to obtain a solution to any moment of the exit-time probability
distribution P (T ).








A2 DERIVATION OF ERLANG-LIKE DISTRIBUTIONS
A2 Waiting-time distributions for sequential
Poisson processes with variable rates
The derivation of the distributions in §4.2.2, §4.2.3, and §4.2.4 all follow the same
basic principle.
For a process with time dependent rate λ(t) and Poisson distributed waiting-
times, the probability that the kth event in a sequence occurs in the inter-
val t→ t+ dt is given by
Pk(t+ dt) = Pk(t) (1− λ(t)dt) + Pk−1(t+ dt)λ(t)dt (A2.1)
which, by the finite difference approximation, gives
dPk(t)
dt
= λ(t) (Pk−1(t)− Pk(t)) (A2.2)
This can be solved iteratively by starting with the condition P0(0) = 1 that no









If λ is time dependent, then Λ(t)→ λt which recovers the Erlang distribution
(equation 4.3). If, on the other hand, each step may have a different rate, then
the probability of the kth event occurring in time t→ t+ dt is
Pk(t+ dt) = Pk(t) (1− λk,k+1(t)dt) + Pk−1(t+ dt)λk−1,k(t)dt (A2.4)
where the rate of going from step k − 1 to step k is λk−1,k. This can also be
solved iteratively, and converges to a closed from when at most one step has the
different rate α 6= λ:












A3 THE VAN KAMPEN SYSTEM SIZE EXPANSION
A3 The Van Kampen system size expansion
The Van Kampen approximation is a technique developed by van Kampen [105]
for finding an approximate solution to a given master equation in the stochastic
limit (i.e. far from the deterministic limit). This involves finding a small
parameter, typically the inverse of the system size 1/V , about which the equations
can be expanded.
My collaborator, Juraj Szavitz-Nossan, identified that this approach could be
used to find the waiting-time distribution L(t) for the cooperative growth of a
pair of coupled reactions (N (t) and M(t)) to reach a threshold (Mφ = M/NAV ),
where the reactions depend on time-independent rate constants (ν and µ).
The pair of coupled reactions for the increase in the number of filaments N or
their total monomer contentM by a single filament or monomer, can be written
as
N Mν−−→ N + 1 (A3.1)
M Nµ−−→M+ 1 (A3.2)
and also in the form of a master equation
dPN ,M
dt
=MνPN−1,M +NµPN ,M−1 − (Mν −Nµ)PN ,M (A3.3)
In these, the small parameter will be 1/v = 1/NAV , where V is the system volume
and NA Avogadro’s constant. Using this small parameter, two new continuous








where M(t) and N(t) will turn out to be the familiar concentrations of fibrillar
protein and number of filaments, at time t. Expressing the left hand side of
equation A3.3 in these continuous variables gives
d
dt
P (M,N , t) = d
dt














and so the entire master equation (1) becomes


















+O(v − 1/2) (A3.6)














These can be trivially solved to show that both M(t) and N(t) grow exponentially
from their initial values M(0) and N(0); a number of approaches exist for
finding ∂P̃ (w, u, t), but I will not present these steps as they do not add to
the understanding of the model.
Using the probability distribution, the distribution of waiting times L(t) for M(t)
to reach Mφ, can be found by considering the probability that in the inter-
val [t, t+ dt], M(t) passes Mφ, assuming that it had not passed it at t:
L(t)dt = Prob[M(t) > Mφ, t+ dt]− Prob[M(t) > Mφ, t] (A3.9)
for which








dw P̃ (w, u, t) (A3.10)
The solution to this, is the lag-time distribution
L(t) =










(1) Here, I also write the transition rates µ and ν in terms of w and u.
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It should be noted that this distribution does not give a unit integral over all t
when v becomes "small". This indicates that there is a non-zero probability that
the threshold will never be reached when the number of particles becomes small.
The probability of this can be found from the complementary error function,
which also allows the definition of "small" to be understood in terms of a critical
volume vc. This is given by
lim
t→∞







e−v/vc , v  vc












The mean and standard deviation of L(t) can be found by approximating the
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